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Abstract 
The Role of Wnt Signaling in Oligodendrocyte Development 
Keith Feigenson 
Judith Grinspan, Ph.D. 
 
 The developmental regulation of the central nervous system is established through 
a complex network of signaling factors that control the timing of cell generation, 
specification, migration, and differentiation. Oligodendrocytes, the myelinating cells of 
the central nervous system, originate during embryonic stages in ventricular zones and 
are responsive to many of these inductive and inhibitory signals as they migrate, mature, 
and interact with axons. The specific timing and regulation of these actions are critical to 
axonal conductance. Many signals that promote oligodendrocyte specification and 
differentiation are active ventrally, and more recent studies have examined the less well 
known actions of several inhibitory dorsal signaling factors, among these the Bone 
morphogenic proteins (BMPs) and Wnt signaling factors. 
 I investigated the role of the canonical Wnt signaling pathway in oligodendrocyte 
development, both in vivo and in vitro. In primary oligodendrocyte precursor culture 
systems, canonical Wnt activity inhibits the differentiation of precursors, maintaining 
them in the precursor stage without causing a change in proliferation, cell death, or cell 
fate determination. Following these studies, I generated mice with a gain of function Wnt 
signaling mutation targeted to cells of oligodendroglial lineage. These mice had 
significant delays in myelin forming cell development early in development, but seemed 
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to recover upon reaching adulthood. Together, these findings indicate that Wnt activity is 
sufficient to delay oligodendrocyte maturation in vivo and in vivo.  
 I also investigated the interaction between the Wnt and BMP signaling pathways 
during oligodendrocyte development. Using pharmacological and genetic paradigms, I 
found that when the canonical BMP signaling pathway is abrogated, neither BMP nor 
Wnt manipulation has any effect on oligodendrocyte differentiation in culture. In 
contrast, blocking the canonical Wnt signaling pathway does not limit the activities of 
BMP, suggesting that the effect of Wnt signaling on oligodendrocyte development is 
dependent on BMP signaling, but not vice versa. These two facets of my thesis offer 
insight into the signaling mechanisms regulating the timing of oligodendrocyte 
development, and could have implications for the treatment of demyelinating disorders 
and central nervous system injury.  
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Introduction 
Thesis goals and rationale 
Oligodendrocyte (OL) development is regulated by inhibitive and inductive 
signaling factors in the local environment. The generation of oligodendrocyte precursor 
cells (OPCs) in ventral regions and the relatively late appearance of specific populations 
of OLs in dorsal regions of the neural tube have long suggested these areas contain 
inhibitors of OL maturation and specification, originally shown by Wada et al. (Wada et 
al., 2000). One group of signaling molecules present in the dorsal neural tubes is the Wnt 
family of secreted factors, which are well known to have effects on many developmental 
and cellular processes, including proliferation, specification, and patterning. For these 
reasons, the Wnts are attractive candidates to be inhibitors of OL maturation. 
Early experiments showed that Wnt signaling inhibited OL differentiation in 
vitro, but the extent of this inhibition was unknown, as was the specific mechanism of 
action (Shimizu et al., 2005; Kim et al., 2008). The first aim of my thesis was to 
investigate to what extent gain and loss of function Wnt signaling affected OL 
development in vivo and in vitro. My second aim was to analyze the interaction between 
Wnt signaling and the other major family of dorsal signaling factors, the bone 
morphogenic proteins (BMPs). Taken together, the results of my thesis experiment 
identify a role for Wnt in central nervous system (CNS) myelination. 
 
Oligodendrocyte background 
Myelin composes the insulating, fatty membrane that wraps axons and allows 
neural signals to be conducted quickly and efficiently. In the vertebrate CNS, myelin is 
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synthesized by OLs as part of their plasma membrane (Bunge, 1968). Damage to the 
myelin sheath results in improper signal communication, leading to axonal degeneration 
and impaired neural functioning (Waxman et al., 1991). White matter regions of the CNS 
are composed largely of axons and myelin and are disturbed in a number of disorders, 
generally associated with three types of pathology: autoimmune disorders (such has 
multiple sclerosis), genetic disorders (such as Pelizaeus Merzbacher Disease), and injury 
(such as periventricular leukomalacia). Recently, alterations in myelin or white matter 
have been associated with other diseases and disorders, such as schizophrenia, bipolar 
disorder, and autism spectrum disorder (Volpe, 2001; Herbert et al., 2003; Barley et al., 
2009; Mahon et al., 2010). Understanding the regulatory components that generate 
mature OLs under normal developmental conditions is crucial to forming treatments for 
such disorders. 
Oligodendrocyte precursor cells (OPCs) originate in the pMN domain of the 
ventral spinal cord as early as E12.5 in rodents (Warf et al., 1991; Pringle and 
Richardson, 1993; Ono et al., 1995). Later in development, small populations of OPCs 
are generated in dorsal regions of the spinal cord, hindbrain, and telencephalon 
(Cameron-Curry and LeDouarin, 1995). After generation, OPCs migrate radially and 
dorsally until they come into contact with nascent axons, during which time they are 
exposed to a spectrum of signaling factors, influencing their migration, proliferation, 
differentiation, and axonal interaction. More signals contribute to the process of wrapping 
the myelin sheath around axons, promoting survival, negotiating appropriate positions, 
and binding membrane proteins (Lubetzki et al., 1993; Colognato, 2002; Chan et al., 
2004; Piaton et al., 2010). Each mature OL is capable of myelinating segments of up to 
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40 distinct axons. Myelination is not complete until several weeks after birth in rodents 
and up to 30 years in humans (Lajtha et al., 1977).  
Two steps characterize OL development: specification of multipotent neural 
precursor cells to the oligodendroglial lineage and the ensuing differentiation of these 
cells into fully functional OLs. In both cases, transcription factors and growth factors 
play large roles as both activators and repressors of fate induction (Fig 1.1). Initial 
transplantation and injury studies indicated that the notochord contains OPC inductors, 
such as Sonic Hedgehog (Shh), a major ventralizing signal generated in the notochord 
and floorplate (Echelard et al., 1993; Roelink et al., 1994; Roelink et al., 1995; Trousse et 
al., 1995; Orentas and Miller, 1996; Pringle et al., 1996; Maier and Miller, 1997). Shh 
signaling induces multipotent neuroepithelial cells to commit to the motor neuron or OPC 
lineage in a concentration and timing specific manner, depending on a combination of 
subsequently active transcription factors (Roelink et al., 1994; Roelink et al., 1995; 
Pringle et al., 1996; Richardson et al., 1997; Orentas et al., 1999; Kessaris et al., 2001). 
Ensuing expression of Olig1/2 and Neurogenin-1/2 promotes the formation of motor 
neurons. Neurogenins are subsequently downregulated, allowing for the ventrally 
expressed Nkx2.2 to expand dorsally into the pMN, interact with Olig1/2, and specify 
OPCs (Zhou et al., 2001; Zhou and Anderson, 2002). Even at the precursor stage, 
however, cells retain some measure of plasticity, as they can be converted to astrocytes 
with BMP4 application in vitro (Mabie et al., 1997; Grinspan et al., 2000a).  
After specification, OPCs are exposed to multiple signals that control the specific 
times at which they migrate, proliferate, and differentiate (Fig. 1.2). Initial signals that 
promote proliferation and survival include fibroblast growth factors (FGFs), 
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neuregulin-1, platelet-derived growth factor A (PDGFA), CXCL1, neurotrophin-3 (NT3), 
and retinoic acids (Noble et al., 1988; Richardson et al., 1988; Noll and Miller, 1994; 
Barres et al., 1994a; Vartanian et al., 1999; Wu et al., 2000). OPCs at this stage appear 
bipolar and express several identifying antigens, many of them receptors for growth 
factors, such as the monoclonal antibody A2B5, platelet-derived growth factor alpha 
receptor (PDGFR!), and ErbB (Raff, 1989; Pringle et al., 1992; Lemke, 1996). 
Differentiation only begins once OPCs have exited the cell cycle, and there is 
evidence that OPCs have a default set of proliferative cycles before this can occur (Barres 
and Raff, 1994; Ibarrola et al., 1996; Tang et al., 2000). Premature removal of growth 
factors, addition of thyroid hormone (T4), and activation of retinoic acid receptors, 
however, can induce differentiation (Raff et al., 1990; Barres et al., 1994; Billon et al., 
2002). Many transcription factors are intricately and combinatorially involved in the 
differentiation process, including Olig1/2 (Zhou et al., 2001; Zhou and Anderson, 2002; 
Xin et al., 2005; Ligon et al., 2006; Maire et al., 2009), ASCL1/MASH1 (Parras et al., 
2004; Battiste et al., 2007; Kim et al., 2007), several members of the Sox family (Stolt, 
2002; Stolt et al., 2003; Finzsch et al., 2008; Kuspert et al., 2010), Pax6 (Mizuguchi et 
al., 2001), Nkx6.1, Nkx6.2 (Cai et al., 2005), and Nkx2.2 (Qi et al., 2001; Vallstedt et al., 
2005). Upon differentiation, cells extend processes, contact neurons, and express myelin 
proteins, such as myelin basic protein (MBP), proteoplipid protein (PLP), and lastly 
myelin oligodendrocyte glycoprotein (MOG).  
A major event in the developmental progression of maturing cells is the activity 
of histone deacetylases (HDACs), recruited by such factors as YY1 to the promoters of 
inhibitory factors. Histone deacetylation promotes differentiation in precursors that have 
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exited the cycle, and plasticity can be induced by their inhibition (Marin-Husstege et al., 
2002; Shen et al., 2005; He et al., 2007; Lyssiotis et al., 2007). HDACs bind repressive 
transcription factors, such as inhibitor of DNA binding proteins (IDs) and Hes family 
members, which inhibit bHLH transcription factors, such as Nkx2.2 and Sox10, known to 
promote myelin producing genes (Kondo and Raff, 2000; Wang et al., 2001a; Gokhan et 
al., 2005; Liu et al., 2006; Marin-Husstege et al., 2006). These interactions illustrate how 
HDACs can directly enhance differentiation by blocking the activity of inhibitory factors 
(Gokhan et al., 2005; Li et al., 2007). 
In contrast to ventral regions of the developing CNS, dorsal regions contain 
secreted signals that are inhibitory toward OPC differentiation and antagonistic to Shh 
(Wada et al., 2000). Notable among them are the Wnt and BMP signaling families. Other 
dorsal factors include Notch (Wang et al., 1998; Genoud, 2002; Park and Appel, 2003), 
Lingo-1 (Mi et al., 2005; Lee et al., 2007), and p57kip2 (Kremer et al., 2009). These 
signals are important regulators of OL development, preventing premature migration, 
impaired differentiation, and abnormal OL to neuron ratios. 
 
Wnt Signaling 
The Wnts are a large family of secreted glycoproteins that serve as signaling 
molecules in many different processes throughout embryogenesis. They are 
evolutionarily conserved across many different species, including C. elegans and D. 
melanogaster. In the developing mammalian system, there are 19 members of the Wnt 
family, and they are involved in processes encompassing embryonic patterning, cell 
proliferation, cell migration, cell specification, and cell differentiation, with stage- and 
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context- specific effects (Dorsky et al., 1998; Patapoutian and Reichardt, 2000; Coyle-
Rink et al., 2002; Megason and McMahon, 2002; Braun et al., 2003; Zechner et al., 2003; 
Hirabayashi et al., 2004; Bonner et al., 2008). Wnt signaling has been implicated in 
cancers, degenerative diseases, injury, and other post developmental contexts. The best 
understood Wnt signaling system is the canonical pathway (Fig. 1.3). In canonical Wnt 
signaling, the Wnt ligand binds to a two-part membrane receptor composed of the 
7-transmembrane Frizzled (Fz) and low-density lipoprotein receptor-related protein 
(LRP5/6). This interaction initiates a signaling cascade, beginning with phosphorylation 
Disheveled (Dvl) and then of the LRP5/6 cytoplasmic tail (Tamai et al., 2004; Davidson 
et al., 2005; Zeng et al., 2005). This in turn binds axin and recruits it away from a 
destruction complex. Without Wnt stimulation, the destruction complex is normally 
composed of glycogen synthase 3 (GSK3), casein kinase I (CKI), adenomatosis polyposis 
coli (APC), and axin, among several other molecules (Itoh et al., 1998; Kishida et al., 
1999; Peters et al., 1999). One of its primary functions is to bind "-catenin, an essential 
effector of canonical Wnt signaling, facilitating its phosphorylation (Liu et al., 2002). 
Under these circumstances, "-catenin is marked by the destruction complex for 
ubiquitination and subsequent degradation in the proteosome, limiting its cytosolic half-
life (Rubinfeld et al., 1996; Yost et al., 1996; Yamamoto et al., 1999; van Noort et al., 
2002). When canonical Wnt signaling is activated, however, "-catenin accumulates in the 
cytoplasm and translocates to the nucleus, where it displaces Groucho in the T-cell 
factor/lymphoid enhancer factor (TCF/LEF) transcription complex (Behrens et al., 1996; 
Molenaar et al., 1996; Cavallo et al., 1998; Kramps et al., 2002; Hoffmans et al., 2005; 
Stadeli and Basler, 2005; Arce et al., 2006; Mieszczanek et al., 2008). This conformation 
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change alters the TCF complex from that of a transcriptional silencer of Wnt target genes 
to an activator of the same targets (Stadeli et al., 2006; Willert and Jones, 2006; Parker et 
al., 2008; Ye et al., 2009).  
Traditionally, Wnts have been classified as having either ‘canonical’ or ‘non-
canonical’ activities. While Wnt activity can induce action that is independent of "-
catenin, there is growing evidence that the pathways are complexly intertwined, and even 
non-canonical pathways can interact with arms of the canonical pathways (van 
Amerongen and Nusse, 2009). The first of these pathways is the Wnt/jun N-terminal 
kinase (JNK) pathway, which regulates planar cell polarity, and is involved in processes 
of cell motility, such as convergent-extension, migration, neurulation, and gastrulation 
(Djiane et al., 2000; Wallingford et al., 2000; Habas et al., 2001; Choi and Han, 2002; 
Habas et al., 2003). The other significant pathway mediates calcium release and 
activating protein kinase C (PKC), affecting such processes as cell adhesion and 
gastrulation (Slusarski et al., 1997; Kuhl et al., 2000; Sheldahl et al., 2003).   
The roles of Wnt/"-catenin signaling concerning specification and proliferation 
are largely stage and temporally specific (Yu et al., 2008). Wnt proteins are expressed 
both dorsally and ventrally in cells of the developing spinal cord (Parr et al., 1993; 
Hollyday et al., 1995). In conjunction with other patterning transcription and signaling 
factors, canonical Wnts confer dorsal identities to spinal cord progenitors and contribute 
to signaling gradients in the developing spinal cord through antagonistic regulation of 
Shh activity (Yu et al., 2008; Joksimovic et al., 2009). Specifically, Wnt/TCF signaling is 
a key enhancer of Gli3, a repressor of Shh signaling (Alvarez-Medina et al., 2008). The 
pMN domain, from which motor neurons and most OPCs are generated, is established by 
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the mutually restrictive actions of Pax6 and Nkx2.2, while Pax6 restricts the expansion of 
sFRP2, a secreted inhibitor of canonical Wnt signaling (Lei et al., 2006). In addition to 
their patterning effects, canonical Wnts are necessary for the proliferation of dorsal 
neurons and their stem cell precursors (Chenn and Walsh, 2002; Megason and McMahon, 
2002; Muroyama et al., 2002; Zechner et al., 2003; Ahn et al., 2008), and canonical Wnt 
downregulation is important for the specification of neural stem cells (Kunke et al., 
2009).  
 
The effects of Wnt signaling on oligodendrocytes 
Several recent studies have investigated the direct role of canonical Wnt signaling 
in OL development. Shimizu et al. (2005) initially determined that canonical Wnt 
signaling inhibited the differentiation of OPCs into mature cells in spinal cord explants, 
and Kim et al. (2008) showed similar effects in zebrafish (Shimizu et al., 1997; Kim et 
al., 2008). My studies and those of several others (Fancy et al., 2009; Feigenson et al., 
2009; Ye et al., 2009) showed that canonical Wnt signaling is sufficient to inhibit OPC 
differentiation both in vivo and in vitro. In culture systems, activating the canonical Wnt 
pathway inhibits precursor cells from maturing, even with concurrent application of 
differentiating factors. When canonical Wnt signaling is constitutively activated in vivo, 
delays in both developmental myelination and remyelination after injury are observed 
(Fancy et al., 2009; Feigenson et al., 2009; Ye et al., 2009). In telencephalon-derived 
precursors, Wnt signaling prevents specification of neural precursor cells into OPCs, but 
increases proliferation of already specified OPCs (Langseth et al., 2010). 
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This regulation of maturation is believed to signal through the TCF transcriptional 
complex (Fancy et al., 2009; Fu et al., 2009). TCF is expressed by cells of OL lineage 
embryonically through early postnatal development, at which point it begins to be 
downregulated, but can be reactivated during white matter injury (Fancy et al., 2009). It 
is therefore unlikely to be involved in specification of OPCs, but remains an important 
factor in their growth and maturation. TCF functions as a repressor of canonical Wnt 
signaling genes until it binds with the "-catenin complex, at which point those same 
genes are transcribed. A major switch in OPC lineage occurs when HDACs bind to, and 
subsequently repress, the TCF complex, mediating the switch from precursor to 
myelinating adult cell (He et al., 2007; Ye et al., 2009).  
The method by which canonical Wnt signaling affects OL development is under 
exploration. Canonical Wnt signaling directly activates ID proteins in several other cell 
types (Rockman et al., 2001; Memezawa et al., 2007) and recent studies have showed 
similar effects in OPCs (Ye et al., 2009; Feigenson et al., submitted for publication). This 
may be accompanied by a downregulation of transcription factors that induce 
differentiation, such as Olig2 (Samanta and Kessler, 2004). Canonical Wnt signaling also 
works to control the dorsal boundary of Nkx2.2, a critical transcription factor for OPC 
differentiation (Yu et al., 2008). Taken together, these studies represent a growing body 
of work suggesting an inhibitory role of canonical Wnt signaling in development, but the 
extent to which it is involved remains a target of investigation.  
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BMP Signaling 
One of the major dorsal signaling groups that inhibit OPC differentiation is the 
bone morphogenic protein (BMP) family. The 20 individual BMPs are secreted proteins 
and members of the transforming growth factor-" (TGF") signaling factor family. They 
have many functions throughout development in a variety of systems, affecting cell 
development in relation to patterning, proliferation, specification, differentiation, and 
apoptosis, (Liem et al., 1995; Liem et al., 2000; Wine-Lee et al., 2004; See and Grinspan, 
2009). Canonical signaling is initiated when BMPs bind to a dimerized serine-threonine 
receptor composed of the BMPRI and BMPRII membrane receptors (Fig. 1.4). Upon 
binding, the Type II receptor phosphorylates the Type I receptor, which subsequently 
phosphorylates receptor Smads 1, 5, or 8. This cascade initiates a complex with the co-
Smad, Smad4, allowing it to translocate to the nucleus and induce transcription (Wrana et 
al., 1994; Zhang and Miller, 1996; Kretzschmar et al., 1997). The Type I BMP receptor 
has two sub-classes in OL lineage cells, BMPR1A and BMPR1B, which can compensate 
for one another in dorsal spinal cord patterning (Wine-Lee et al., 2004). BMP signaling 
can activate non-canonical pathways as well, independent of Smad phosphorylation, 
predominantly through activation of STAT proteins (Rajan et al., 2003).  
The role of BMP signaling at various stages in OL lineage has been well studied. 
BMP treatment can induce astrogliogenesis in cultures of OL pre-progenitors and OPCs 
in culture systems (Gross et al., 1996; Mabie et al., 1997; Grinspan et al., 2000a), 
indicating that BMPs can shift the specification and differentiation of multipotent cells 
towards the astrocyte lineage instead of towards the OL lineage. BMP treatment of 
mature cells in vitro does not alter their lineage pattern, but prevents the expression of 
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myelin proteins (See et al., 2004). In vivo, the effects are more complicated. Genetic 
BMP overexpression decreases the number of mature OLs and increases the number of 
astrocytes in mouse and chick models (Mekki-Dauriac et al., 2002; Gomes et al., 2003). 
Genetic ablation of BMP signaling, however, decreases both the number of total 
astrocytes and OLs during development (See et al., 2007), suggesting that 
oligodendrogliogenesis may require a dose dependent amount of BMP signaling.   
BMPs regulate OL development through control of intrinsic transcription factors 
and CNS patterning. BMPs can limit the influence of Shh and its effectors (Bastida et al., 
2009), which are known inducers of OL specification and subsequent differentiation. 
BMP treatment increases ID2/4 in vitro (Cheng et al., 2007); IDs interact with basic 
helix-loop-helix (bHLH) transcription factors and block their ability to bind DNA 
(Norton et al., 1998; Hollnagel et al., 1999). In OPCs, IDs can bind Olig1/2, which 
localizes to cytoplasm the after BMP treatment, inhibiting differentiation (Wang et al., 
2001b; Samanta and Kessler, 2004). 
 
The interactions between the BMP and Wnt signaling pathways 
Members of the Wnt and BMP families are present in the developing CNS. They 
are both present in dorsal spinal cord during embryonic development, and they have 
similar patterning behaviors: Ectopic expression will dorsalize the neural tube, and 
ablation will have ventralizing effects (Nguyen et al., 2000; Muroyama et al., 2002; 
Timmer et al., 2002; Zechner et al., 2007; Alvarez-Medina et al., 2008). These studies 
indicate that in some instances Wnt and BMP signaling can have functionally 
complimentary, redundant, or interacting effects during CNS development. How they 
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may interact during OL development, however, has not been extensively investigated, 
and may be quite complicated based on a number of examples in the literature. 
The relationship between the Wnts and BMPs varies extensively depending on 
context. Wnt signaling acts upstream of the BMP pathway during neurogenesis and 
astrogliogenesis (Kasai et al., 2005), limb mesenchyme development (Hill et al., 2006), 
and tooth development (Liu et al., 2008a). The BMP pathway, however, acts upstream of 
Wnt signaling in neural crest delamination (Burstyn-Cohen et al., 2004), keratinocyte 
development (Yang et al., 2006), and dorsal/ventral patterning (Chesnutt et al., 2004; 
Zechner et al., 2007). In other contexts Wnt and BMP signaling can be directly 
antagonistic, such as in neuroepithelial cell development (Ille et al., 2007), aspects of 
gene regulation in anterior-posterior patterning (Gomez-Skarmeta et al., 2001), muscle 
positioning (Bonafede et al., 2006), intestinal stem cell proliferation (He et al., 2004) and 
osteoblast development (Kamiya et al., 2008b; Kamiya et al., 2008a; Honda et al., 2010).  
Adding further complexity, the interaction between the two pathways is often 
indirect and multifaceted. In some systems, such as during aspects of limb bud and apical 
ectodermal ridge formation, the BMP and Wnt pathways can complexly regulate each 
other through parallel signaling and feedback systems (Soshnikova et al., 2003; 
Villacorte et al., 2010). In myoblast differentiation, "-catenin interacts with Smads to 
suppress BMP activity, while BMP coordinately upregulates "-catenin activated TCF 
transcription. In the development of anterior visceral endoderm, BMPs simultaneously 
upregulate levels of canonical Wnts and the secreted Wnt inhibitor, Dikkopf-1 (Dkk-1, 
Miura et al., 2010). 
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Some of the earliest identified relationships between canonical Wnt and BMP 
signaling involved synergistic activation of downstream transcription factors (Crease et 
al., 1998; Labbe et al., 2000; Nishita et al., 2000; Letamendia et al., 2001; Theil et al., 
2002; Hussein et al., 2003). This occurs because some genes have Smad and TCF binding 
sites in close proximity, such as Emx2 (Theil et al., 2002), Msx2 (Willert et al., 2002; 
Hussein et al., 2003), c-myc (Hu and Rosenblum, 2005), and Xtwin (Labbe et al., 2000; 
Nishita et al., 2000; Letamendia et al., 2001). These genes can be activated independently 
by stimulating either BMP or Wnt signaling, but are significantly more responsive with 
concurrent activation of both pathways. Additionally, Wnt signaling can prolong the 
activity of BMP signaling by inhibiting phosphorylated-Smad degradation (Fuentealba et 
al., 2007), and they can increase neurogenesis, subsequently leading to neuronal 
production of BMPs (Kasai et al., 2005). Given all of the interactions between Wnt and 
BMP signaling in a wide variety of developmental and cellular processes, I hypothesize 
that they interact in OL development as well.  
 
Significance 
OLs are the myelin producing cells of the CNS. Axonal myelination is critical for 
the rapid and efficient transmission of neural signals, and demyelination results in axonal 
damage, impaired cognition, and impaired motor control, characteristics common to a 
variety of disorders. The damage varies depending on the type and extent of the injury, 
but spontaneous recovery can occur after demyelinating events, evidence that the adult 
CNS has the potential to generate new myelin (Shields et al., 1999; Murtie et al., 2005b; 
Patrikios et al., 2006). Adult progenitor cells are actively respond to many of these 
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events, but their ability to differentiate into functionally mature cells varies according to 
age, injury location and duration, size of progenitor pools, and active signaling factors 
(Shields et al., 1999; Chari and Blakemore, 2002; Mason et al., 2004; Tatsumi et al., 
2008; Islam et al., 2009). Treating these disorders will depend on a number of elements, 
especially the manipulation of OPCs and local environments to facilitate cellular 
differentiation, axon recovery, and myelination.  
Part of the challenge in treating such conditions is the complex signaling 
environment of the CNS during injury. Many of the same signals involved in 
developmental systems are involved in regulating injury response, including FGF, 
PDGFA, BMPs, and Wnts (Armstrong et al., 2002; Murtie et al., 2005b; Zhang et al., 
2009; Cate et al., 2010; White et al., 2010). BMPs are upregulated in aspects of CNS 
injury and demyelinating models (Setoguchi et al., 2001; Setoguchi et al., 2004; Ara et 
al., 2008; See and Grinspan, 2009; Cate et al., 2010; Jablonska et al., 2010), and can play 
roles in preventing remyelination and axon regeneration. In parallel, several recent 
studies have also found that members and effectors of the Wnt family are upregulated in 
similar paradigms, and may have similarly inhibitory effects on recovery (Liu et al., 
2008b; Fancy et al., 2009; Miyashita et al., 2009; White et al., 2010).  There is, however, 
evidence that Wnt3a can facilitate spinal cord recovery by enhancing stem cell 
differentiation into neurons (Yin et al., 2008), illustrating the complexity involved in this 
line of in vivo treatment 
If these signaling pathways can be appropriately manipulated, both endogenous 
and transplanted progenitor cells can be directed down specific developmental lineages to 
aid in recovery. This approach would be an end unto itself, but it would also provide 
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insight into the internal mechanisms controlling cellular differentiation. Understanding 
the grand sum of these interactions would be invaluable for combating demyelinating 
events.  
The body of work in my dissertation concerns the canonical Wnt signaling 
pathway, which is active in CNS development and injury. My experiments have shown 
that ectopically activated Wnt signaling will delay the progression of OPCs to mature 
OLs, and that this interaction is dependent on the BMP signaling pathway. These findings 
have direct relevance for understanding the complex environment of signaling factors 
that regulate cell fate and differentiation in OL lineage cells. 
 
Significance 
OLs are the myelin producing cells of the CNS. Axonal myelination is critical for 
the rapid and efficient transmission of neural signals, and demyelination results in axonal 
damage, impaired cognition, and impaired motor control, characteristics common to a 
variety of disorders. The damage varies depending on the type and extent of the injury, 
but spontaneous recovery can occur after demyelinating events, evidence that the adult 
CNS has the potential to generate new myelin (Shields et al., 1999; Murtie et al., 2005b; 
Patrikios et al., 2006). Adult progenitor cells are actively respond to many of these 
events, but their ability to differentiate into functionally mature cells varies according to 
age, injury location and duration, size of progenitor pools, and active signaling factors 
(Shields et al., 1999; Chari and Blakemore, 2002; Mason et al., 2004; Tatsumi et al., 
2008; Islam et al., 2009). Treating these disorders will depend on a number of elements, 
especially the manipulation of OPCs and local environments to facilitate cellular 
differentiation, axon recovery, and myelination.  
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Part of the challenge in treating such conditions is the complex signaling 
environment of the CNS during injury. Many of the same signals involved in 
developmental systems are involved in regulating injury response, including FGF, 
PDGFA, BMPs, and Wnts (Armstrong et al., 2002; Murtie et al., 2005b; Zhang et al., 
2009; Cate et al., 2010; White et al., 2010). BMPs are upregulated in aspects of CNS 
injury and demyelinating models (Setoguchi et al., 2001; Setoguchi et al., 2004; Ara et 
al., 2008; See and Grinspan, 2009; Cate et al., 2010; Jablonska et al., 2010), and can play 
roles in preventing remyelination and axon regeneration. In parallel, several recent 
studies have also found that members and effectors of the Wnt family are upregulated in 
similar paradigms, and may have similarly inhibitory effects on recovery (Liu et al., 
2008b; Fancy et al., 2009; Miyashita et al., 2009; White et al., 2010).  There is, however, 
evidence that Wnt3a can facilitate spinal cord recovery by enhancing stem cell 
differentiation into neurons (Yin et al., 2008), illustrating the complexity involved in this 
line of in vivo treatment 
If these signaling pathways can be appropriately manipulated, both endogenous 
and transplanted progenitor cells can be directed down specific developmental lineages to 
aid in recovery. This approach would be an end unto itself, but it would also provide 
insight into the internal mechanisms controlling cellular differentiation. Understanding 
the grand sum of these interactions would be invaluable for combating demyelinating 
events.  
The body of work in my dissertation concerns the canonical Wnt signaling 
pathway, which is active in CNS development and injury. My experiments have shown 
that ectopically activated Wnt signaling will delay the progression of OPCs to mature 
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OLs, and that this interaction is dependent on the BMP signaling pathway. These findings 
have direct relevance for understanding the complex environment of signaling factors 
that regulate cell fate and differentiation in OL lineage cells. 
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Fig 1.1 Interactions of signaling factors in the developing spinal cord regulate 
oligodendrocyte maturation 
 Patterns of signaling factors are established during spinal cord development after 
the formation of the notochord and floorplate, where Shh is secreted. A gradient of Shh 
induces transcription factors in a concentration dependent manner, originally through 
induction of activating Gli1/2. In contrast, dorsal spinal cord contains signals such as 
members of the BMP and Wnt signaling families, which establish signaling gradients 
contrary to those of Shh. Wnt activates repressive Gli3, limiting the dorsal influence of 
Shh. From these opposing concentrations of signals, transcription factors are expressed in 
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regionally specific areas. They are kept from expanding via mutually repressive dorsal to 
ventral signaling, demarcating areas from which specified populations of cells arise. OLs 
and motor neurons are generated in the pMN domain, identified by expression of Olig1/2 
transcription factors. Motor neurons are generated with concurrent expression of 
Neurogenins, and as development proceeds, Neurogenins are downregulated and Nkx2.2, 
initially expressed near the floorplate in P3, expands dorsally into the pMN. Cells that 
simultaneously express Nkx2.2 and Olig2 are specified as OPCs.  
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Fig 1.2: Oligodendrocytes progress through several stages before reaching maturity 
 Nestin expressing multipotent neuroepithelial cells in the ventricular zone of the 
ventral spinal cord begin to appear around E9 in rodents. Inductive signals, primarily 
Shh, promote their proliferation and specification into OPCs, which begins at E12.5. 
These cells are characterized by bipolar processes and the expression of PDGFR!, A2B5, 
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NG2, Nkx2.2, and Olig1/2. Prohibitive signals in the dorsal spinal cord, such as BMP, 
prevent this progression, instead directing precursor cells to the astrocyte lineage. 
Following concurrent expression of transcription factors Olig2, Sox10, and Nkx2.2, 
OPCs differentiate into mature OLs. At this stage, cells have exited the cell cycle, begin 
to extend multiple processes, and express O4 and GalC. Between the OPC and immature 
OL stage, dorsal inhibitory factors can prevent further differentiation, maintaining cells in 
a precursor state. At the final mature OL stage, cells have extended multiple complex 
processes while expressing myelin proteins, including PLP, MBP, MOG, ASPA, and 
APC. Cells at this stage are competent to myelinate axons. 
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Fig 1.3: Canonical Wnt signals through "-catenin 
 Canonical Wnt signaling initiates a cascade of signaling events that result in "-
catenin translocation into the nucleus. (Left) In the unbound state, Wnt proteins have not 
interacted with the membrane receptors Fz and LRP5/6. This occurs when there are few 
secreted Wnts or many Wnt antagonists present in the extracellular environment. 
Examples of antagonists include extracellular sFRP proteins that bind secreted Wnts, or 
Dkk-1, which binds LRP5/6. Under these circumstances, a destruction complex 
composed of GSK3", APC, and Axin, among other molecules, phosphorylates "-catenin. 
This leads to its ubiquitination and subsequent degradation in the proteosome. Wnt 
binding to Fz and LRP5/6 leads to the phosphorylation of Dvl and subsequent 
phosphorylation of LRP5/6, recruiting Axin away from the destruction complex and 
rendering it inactive. "-catenin can no longer be phosphorylated, accumulates in the 
cytoplasm, and translocates to the nucleus. There, it displaces Groucho and HDACs from 
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the TCF/LEF transcription complex, which is altered from a repressor to an activator of 
Wnt target genes.   
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Fig 1.4: The canonical BMP signaling pathway 
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 BMPs signal by binding to the BMPR type I and II heterodimers. Upon binding, 
the BMPRII receptor phosphorylates the BMPRIA/B receptor. This cascade initiates 
phosphorylation of receptor Smads 1/5/8, allowing them to form a complex with the co-
Smad4. This complex can then translocate into the nucleus and activate transcription of 
BMP target genes. This signaling pathway can be inhibited extracellularly by the action 
of secreted proteins, such as Noggin and Chordin, which bind extracellular BMP 
proteins. Inhibitory Smads 6/7 act intracellularly to prevent the phosphorylation of 
receptor Smads and the formation of the Smad4 complex.  
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Abstract 
 The development of oligodendrocytes, the myelinating cells of the central nervous 
system, is temporally and spatially controlled by local signaling factors acting as inducers 
or inhibitors. Dorsal spinal cord tissue has been shown to contain inhibitors of 
oligodendrogliogenesis, although their identity is not completely known. We have studied 
the actions of one family of dorsal signaling molecules, the Wnts, on oligodendrocyte 
development. Using tissue culture models, we have shown that canonical Wnt activity 
through "-catenin activation inhibits oligodendrocyte maturation, independently of 
precursor proliferation, cell death, or diversion to an alternate cell fate. Mice in which 
Wnt/"-catenin signaling was constitutively activated in cells of the oligodendrocyte 
lineage had equal numbers of oligodendrocyte precursors relative to control littermates, 
but delayed appearance of mature oligodendrocytes, myelin protein, and myelinated 
axons during development, although these differences largely disappeared by adulthood. 
These results indicate that activating the Wnt/"-catenin pathway delays the development 
of myelinating oligodendrocytes.  
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Introduction 
Myelin, the lipid membrane that ensheathes axons, is necessary for the rapid and 
effective conduction of neural signals. In the central nervous system, it is synthesized by 
oligodendrocytes (OLs). These specialized glial cells arise in ventricular zones as 
oligodendrocyte precursors (OPCs) and progress through several stages before 
myelinating axons (Pringle and Richardson, 1993; Ono et al., 1995). During this period, 
OPCs are exposed to a variety of environmental signaling factors that can be inductive or 
inhibitive of developmental processes, including differentiation (Miller, 2002). Although 
much of OL development is well characterized, the factors that affect OL differentiation 
and the mechanisms by which they operate are less well understood.  
In the spinal cord, the majority of OPCs originate in the ventral ventricular zone 
beginning at 12.5 dpc. The specification of these precursors is controlled by floor plate 
signals in the ventral spinal cord, notably sonic hedgehog (Shh), which induces 
expression of transcription factors necessary for the stages of OL development (Lu et al., 
2000; Zhou et al., 2000; Zhou and Anderson, 2002). OPCs then migrate from the 
subventricular zone to populate the spinal cord, eventually contacting axons and 
expressing myelin proteins. Recent evidence suggests, however, that there are 
populations of dorsally generated OLs, although their contribution to the general pool 
may be small and late (Cai et al., 2005; Vallstedt et al., 2005; Kessaris et al., 2006). The 
predominantly ventral origin of OPCs is thought to result, in part, because of specific OL 
inhibitors present in the roof plate and adjacent structures (Wada et al., 2000). These 
dorsal tissue areas contain several families of signaling factors with overlapping 
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expression patterns that may repress multiple aspects of OL development (Wine-Lee et 
al., 2004). 
One of these families, the bone morphogenic proteins (BMP), has been 
extensively studied in this regard. Treatment of OPC cell cultures with BMP4 or BMP4 
overexpression in vivo induces astrogliogenesis at the expense of OL differentiation 
(Grinspan et al., 2000b; Mekki-Dauriac et al., 2002; Gomes et al., 2003; Miller et al., 
2004; See et al., 2004). BMPs, however, may not be the only family of factors that 
dorsalize the neural tube to affect OL development. BMPs interact with other signaling 
molecules, among them the Wnts, to regulate dorsal-ventral patterning and other 
developmental processes (Soshnikova et al., 2003; Wine-Lee et al., 2004; Ille et al., 2007; 
Zechner et al., 2007). One example is upregulating the Wnt signaling pathway in neural 
precursors cells increases the expression of BMPs, which may coordinately regulate OL 
differentiation (Kasai et al., 2005). The extent of their interaction relating to signaling in 
OL development, however, is not well understood.  
In the developing mammalian system, Wnt signaling is involved in regulating 
embryonic patterning, cell proliferation, migration, specification, and differentiation, and 
has stage and context specific effects (Dorsky et al., 1998; Patapoutian and Reichardt, 
2000; Coyle-Rink et al., 2002; Braun et al., 2003; Hirabayashi et al., 2004; Karim et al., 
2004; Kalani et al., 2008). Wnt signaling is active during central nervous system 
development, in dorsal spinal cord from E9.5-E12.5 (Wine-Lee et al., 2004; Shimizu et 
al., 2005), and in the subventricular zone of the developing CNS at E14.5 (Kalani et al., 
2008). In the canonical Wnt pathway, Wnt binds with LRP5/6 to frizzled (Fz) receptors 
which, through a signal cascade, results in the dephosphorylation and thereby 
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accumulation of !-catenin in the cytoplasm (Mi and Johnson, 2005). Ordinarily, "-
catenin is sequestered in a complex with GSK3!, APC, and axin, marking it for 
degradation. Dephosphorylated !-catenin collects in the cytoplasm and translocates to the 
nucleus, where it activates TCF-Lef transcription factors (Wodarz and Nusse, 1998; 
Staal, 2002). GSK3! inhibitors, such as LiCl, prevent phosphorylation of !-catenin, 
allowing nuclear translocation and initiation of the signaling cascade. The role of Wnt 
signaling during OL development has not been extensively investigated. Recent studies 
have demonstrated that Wnt signaling has inhibitory effects on OPC differentiation in 
mouse spinal cord explants and in culture and in zebrafish (Shimizu et al., 2005; Kim et 
al., 2008). We have investigated the role of Wnt/"-catenin signaling on OL maturation in 
primary cultures of OPCs (Grinspan et al., 2000b) and in a mutant mouse in which "-
catenin is constitutively active. 
Using the Cre-Lox system, we created a mutant mouse that expresses 
constitutively active !-catenin in CNP expressing cells. The ubiquitin binding site on the 
!-catenin gene is flanked by LoxP sites, so upon Cre induced recombination, the resulting 
transgene expresses a !-catenin protein that is not targeted for degradation and remains 
perpetually transcriptionally active. CNP is present in cells of the OL lineage and is 
essential for axonal survival; hence its expression is preserved throughout life (Lappe-
Siefke et al., 2003). Using this approach, we can study the effects of constitutively active 
canonical Wnt signaling in all cells of OL lineage. 
In normal rat OPC cultures, the addition of Wnt3a significantly decreases the 
number of immature and mature OLs generated during differentiation. Similarly, cultures 
prepared from Cnp-Cre mice in which "-catenin was constitutively activated show a 
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marked reduction in numbers of immature and mature OLs relative to cultures taken from 
control littermates. Spinal cord sections show significant decreases in mature OLs and 
myelin proteins at postnatal stages, and, although less pronounced, this decrease persists 
until adulthood. Similarly, semi-thin preparations of myelin show fewer myelinated 
axons at postnatal stages, although this effect recovers by adulthood. These findings 
indicate that constitutively activated canonical Wnt signaling delays myelination by 
inhibiting the differentiation of OPCs, and that this signaling pathway is a regulator of 
OL development.  
 
Results 
Wnt3a inhibits oligodendrocyte differentiation via the canonical Wnt signaling pathway 
 To determine whether Wnt3a signaling affects the progression of the OL lineage 
in culture, we generated purified primary OPC cultures from rat and mouse forebrain, 
grew them on 100mm dishes or 12mm coverslips, and then removed growth factors and 
added differentiation medium (DM) when the cells became confluent. After 3 days in 
DM, 20% of the cells had differentiated and could be labeled with antibody to 
galactocerebroside (GalC), an early marker of differentiation (Fig. 2.1A, B). Eighty-six 
percent of the cells labeled with the A2B5 antibody, indicating that some cells remained 
OPCs, and other cells still expressed both markers (Fig. 2.1A, B). Addition of 50 ng/ml 
Wnt3a to the coverslips concurrently with DM, however, resulted in 36% fewer GalC+ 
cells than controls at 3 days (p < 0.05), while the number of A2B5+ cells was comparable 
to controls (Fig. 2.1A, B). This reduction in the numbers of differentiating cells was 
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confirmed by western blots on protein from OPC cultures, which showed less MBP 
expression at 5 days in Wnt3a treated conditions relative to controls (Fig. 2.1C).  
 OPCs are multi-potent and the failure to differentiate could suggest that Wnt3a 
signaling switches cells to a different neural lineage. To determine whether neurons were 
generated by Wnt3a treatment, we labeled with an antibody to Tuj1 and found only 
occasional (less than 1%) TuJ1+ cells in both control and treated cultures (data not 
shown). Because inhibition of differentiation in OLs can be associated with the 
expression of glial fibrillary acidic protein (GFAP) and generation of “type II” astrocytes 
(Raff et al., 1983), we labeled treated cells with an antibody to GFAP after 3 days 
treatment with Wnt3a. Our cultures contain a small percentage (< 5%) GFAP+ type 1 
astrocytes that remain after immunopurification. The number of GFAP+ cells in the 
Wnt3a treated cultures was not significantly different from controls (Fig. 2.1D).  
 To determine whether the decrease in differentiated cells reflected altered 
proliferation of precursors, we labeled cells with BrdU for 3, 6, and 24 hours, but 
observed no differences between the treated and control cells (Fig. 2.1E). To determine 
whether the decrease in differentiated cells reflected increased apoptosis, we performed 
the TUNEL assay for cell death and observed no change in the number of TUNEL+ cells 
(Fig. 2.1F).  
 The canonical Wnt signaling pathway is mediated through "-catenin, but there are 
non-canonical pathways as well (Zhou et al., 2000; Zhou and Anderson, 2002; Veeman et 
al., 2003; Montcouquiol et al., 2006). To determine whether the canonical signaling 
pathway was activated in our system, we labeled OPCs in culture for !-catenin, which, 
when transcriptionally active, translocates to the nucleus. After 6 hours of Wnt3a 
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treatment, !-catenin was observed in the nuclei of cells double labeled with A2B5 (Fig. 
2.2A). An increase in total !-catenin was also observed on western blots of protein from 
OPC cultures treated with Wnt3a, relative to protein from control cultures (Fig. 2.2B). To 
determine whether the inhibitory effect of Wnt3a on OPC differentiation operated via the 
canonical pathway, cultures were treated concurrently with Wnt3a and Dickopf-1 (Dkk-1, 
100 ng/ml), a canonical Wnt signaling inhibitor that prevents signaling through the "-
catenin pathway (Bafico et al., 2001; Semenov et al., 2001), and differentiation was 
rescued (Fig. 2.2C). Additionally, treatment with 10 µM SB216763, a GSK3" inhibitor 
that activates constitutively active "-catenin, also decreased OL differentiation by 32% 
relative to controls (p < 0.055; n = 3). Our results indicate that activating canonical Wnt 
signaling in vitro through "-catenin inhibits the differentiation of OPCs to immature OLs. 
 
Constitutively active "-catenin signaling delays oligodendrocyte development in vivo 
 To determine the effect of Wnt signaling in vivo, we used the LoxP/Cre approach 
to constitutively activate !-catenin signaling in transgenic mice.  In these experiments, we 
use the Cnp-Cre transgenic strain to direct Cre-mediated DNA rearrangements to in 
oligodendroglial lineage.  To ensure that this strain targets specifically cells of OL 
lineage, we crossed the Cnp-Cre mice with Rosa26 reporter mice which express LacZ 
upon Cre mediated recombination (Soriano, 1999). Expression of LacZ therefore, marks 
cells that express Cnp-Cre or in the subsequent lineage of cells that inherit the rearranged 
DNA.  Spinal cord sections from P5 offspring were double immunolabeled with antibody 
directed against "-galactosidase and either PDGFR! or APC, which label OPCs or 
mature OLs, respectively (Fig. 2.3A, B). Cells expressing "-galactosidase were 
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consistently colabeled with both PDGFR! and APC, indicating that Cre-mediated 
rearrangements are found in most cells of OL lineage.  
To activate ß-catenin specifically in the oligodendrocyte lineage, we intercrossed 
Cnp-Cre strain with a pedigree containing the !-catenin
floxedexon3/floxedexon3
 allele. Upon 
Cre-mediated DNA rearrangement, exon 3 of the "-catenin gene is excised, resulting in a 
constitutively active form of ß-catenin.  Robust and highly penetrant Cre-mediated 
rearrangement of this !-catenin
floxedexon3/floxedexon3
 allele has been observed with numerous 
Cre strains (Lappe-Siefke et al., 2003; Rasband et al., 2005; Edgar et al., 2009).  From 
these matings, we would expect half of the resulting offspring to express the activated 
form of !-catenin (referred to as !-Cat-CA mice). Although significantly smaller than 
control littermates, viable mutant animals were born in the expected Mendelian ratios.  
!-Cat-CA mice and littermate controls were sacrificed at specific time points and 
spinal cord sections were analyzed for OL lineage development and myelination. At 
birth, myelin proteins, such as proteolipid protein (PLP) and myelin basic protein (MBP), 
were largely concentrated in ventral spinal cord (Fig. 2.4A, B). At P1, we observed 32% 
fewer PLP+ cells in ventral spinal cord of !-Cat-CA mice than in control littermates (p < 
0.05, Fig. 2.4G). Western blots confirmed this effect, showing a decrease in MBP 
expression from forebrain tissue taken from mutant mice and control littermates (Fig. 
2.4H). 
To address the possibility that the decrease in maturing OLs could reflect an 
alteration in cell fate such that OPCs became astrocytes or neurons, we immunolabeled 
for GFAP and NeuN. In the same areas of ventral spinal cord, there were no significant 
differences in numbers of astrocytes, labeled with GFAP (Fig. 2.4C, D, I) or neurons, 
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labeled with NeuN (data not shown). To examine whether the decrease in mature OLs 
was reflected in altered numbers of precursors, we labeled P1 spinal cord sections with 
antibody to PDGFR! or NG2, both of which stain OPCs (Fig. 2.4E, F). There was no 
difference in numbers of positive cells between the normal and mutant sections (Fig 4. J).  
To determine whether there were any changes in cell proliferation, we labeled 
ventral spinal cord with phospho-histone 3 and Ki67, but did not observe any differences 
between !-Cat-CA mice and control littermates (Supplemental Figure 2.1A-C). Because 
OLs are highly susceptible to cell death in the absence of survival cues, especially as they 
begin to mature, we assayed ventral spinal cord sections with TUNEL to observe if the 
decrease in differentiated OLs resulted from increased cell death. We did not observe any 
differences in TUNEL labeling between !-Cat-CA mice and control littermates 
(Supplemental Figure 2.1D). 
 At P7, we observed the greatest difference in the number of cells expressing 
myelin proteins between normal and !-Cat-CA mice (Fig. 2.5A, B). We observed 38% 
fewer cells labeling with antibody to PLP in P7 !-Cat-CA mice compared to control 
littermates in ventral spinal cord (p < 0.05; Fig. 2.5G). In the same areas, mice at this 
stage do not have significant differences in staining of PDGFR!, NG2, GFAP, NeuN, 
and cleaved-caspase 3 (data not shown), or in labeling with phospho-histone 3, Ki67, or 
TUNEL (Supplemental Figure 2.1A-D). Western blots performed on protein taken from 
forebrain of P7 mice showed a decrease in expression of MBP in !-Cat-CA mice relative 
to control littermates (Fig 5. H).  
 After myelination has progressed for two weeks or more, it becomes difficult to 
label individual cells labeled with antibody to PLP because of the overlapping 
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arrangement of OLs and their processes. To label OLs at this age, we used anti-
aspartoacylase (ASPA), which specifically targets OL cell bodies (Hershfield et al., 
2006). At P21, !-Cat-CA mice have 19% fewer ASPA+ cells in white matter of ventral 
spinal cord than control littermates (p < 0.05, Fig. 2.5C, D, I). The number of ASPA+ 
OLs in ventral and dorsal regions decreased equally between mutants and control 
littermates, indicating that the !-catenin mutation affects OLs in both regions of the 
spinal cord in a similar manner.  At 10 weeks, !-Cat-CA mice have 13% fewer ASPA 
positive cells in white matter of ventral spinal cord compared to control littermates (p < 
0.05, Fig. 2.5E, F, J). At both of these time points, there is no significant differences 
between !-Cat-CA mice and control littermates in the number of cells labeling with 
antibody to PDGFR!, NG2, GFAP, NeuN, phospho-histone 3, and anti-cleaved-caspase 
3 (data not shown). These results indicate that constitutively activated canonical Wnt 
signaling in cells of OL lineage inhibits or delays OL maturation, but that this delay is 
overcome in adulthood. 
 
Semi thin sections demonstrate a decrease in myelinated axons during development 
following constitutively active signaling by "-catenin. 
 To characterize the effect of activating the canonical Wnt signaling pathway on 
myelination, we counted myelinated axons in semi thin sections from spinal cord and 
sciatic nerves of !-Cat-CA and control pups (P7, Fig. 2.6A-F) and adult mice (Fig. 2.6G-
L). In comparable sections of P7 ventral spinal cord, we observed a 44% decrease in 
myelinated axons in !-Cat-CA mice when compared to control littermates (p < 0.05, Fig. 
2.6M). Cross sections of tibial sciatic nerve had a 27% reduction in myelinated axons in 
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!-Cat-CA compared to control littermates; this difference only trended towards 
significance (p < 0.07, Fig. 2.6M). In contrast, there were no discernable differences in 
the number of myelinated axons in adult optic nerve (data not shown), ventral spinal 
cord, or sciatic nerve (Fig. 2.6M). These results further indicate that there is a delay in 
myelinating cell development in !-Cat-CA mice relative to control littermates. Since CNP 
expression in the nervous system is limited to OLs and Schwann cells (Lappe-Siefke et 
al., 2003; Rasband et al., 2005; Edgar et al., 2009), these are likely to be cell-autonomous 
effects. 
 
Cultures of OPCs from !-Cat-CA mice contain fewer differentiated oligodendrocytes 
than controls 
 To determine if the effects of the constitutively activated "-catenin mutation were 
cell autonomous, we generated primary cultures of OPCs from !-Cat-CA mice, grew 
them in dishes, and differentiated them as described previously, comparing them to 
cultures taken from control littermates. After 3 days in DM, there were 60% fewer cells 
labeled with GalC in mutant cultures compared to controls (p < 0.05), indicating a large 
reduction in differentiating cells (Fig. 2.7A, B). 
 Because this reduction in immature OLs could have been caused by a change in 
the number of precursors, we labeled cells with A2B5 and did not observe significant 
differences (Fig 7. A, B). Similarly, there were no significant changes in the number of 
GFAP, BrdU, or TUNEL labeled cells, indicating that the number of astrocytes, 
proliferating cells, and cells undergoing apoptosis, respectively, were unchanged (Fig. 
2.7C-E). These results indicate that constitutively activated canonical Wnt signaling 
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inhibits differentiation in vitro in a cell autonomous manner, and that this is a direct result 
of inhibition of differentiation and does not result from a change in the number of 
precursors, astrocytes, proliferating cells, or cells undergoing apoptosis.  
 
Discussion 
 We have investigated the role of canonical Wnt signaling during OL development 
both in vitro, using cultures from normal rats and from mice in which a dominant stable 
form of !-catenin is active, and in vivo, examining spinal cords from these same mutant 
mice. We showed a significant inhibition of OPC differentiation in cultures with 
activated canonical Wnt signaling. In spinal cord sections, we observed a decrease in 
numbers of OLs and myelin protein early in postnatal development of !-Cat-CA mutant 
mice, relative to control littermates. This difference, however, became progressively less 
pronounced as the mice reached adulthood. Similarly, we observed fewer myelinated 
axons in the CNS and PNS of mutant pups compared to controls, but the difference 
largely disappeared in adults.  
 During spinal cord development, OPCs are generated from E12.5 through birth in 
ventral progenitor zones. After specification, they migrate into other areas of spinal cord, 
mature, and, upon contact with axons, begin the myelination process. Throughout this 
period, they are exposed to a variety of internal and external signals that regulate their 
proliferation, specification, and differentiation. Dorsal regions are the latest to be 
populated by OPCs and are thought to contain inhibitors of OPC specification and 
differentiation (Wada et al., 2000). 
 39 
 Canonical Wnt signaling plays a variety of roles in the developing nervous 
system. Members of the Wnt family that signal through the canonical Wnt pathway, 
notably Wnt1 and Wnt3a, are found in the developing dorsal spinal cord during the onset 
of neural and glial specification (Hollyday et al., 1995; Megason and McMahon, 2002; 
Wine-Lee et al., 2004; Shimizu et al., 2005). Canonical Wnt signaling through the 
stabilization of "-catenin is involved in neural precursor proliferation in both spinal cord 
(Megason and McMahon, 2002; Chenn and Walsh, 2003) and brain (Gulacsi and 
Anderson, 2008), while also helping to pattern developing spinal cord (Muroyama et al., 
2002; Zechner et al., 2007). Wnt3a is known to inhibit Shh signaling to regulate the 
spatial and temporal specification of neurons and glial cells throughout neural tube (Lei 
et al., 2006), spinal cord (Yu et al., 2008), and hindbrain development (Joksimovic et al., 
2009). Using a cell autonomous approach, we have shown that canonical Wnt signaling 
inhibits and delays OL differentiation. Our data agrees with that of Shimizu et al. (2005) 
in mouse explants and Kim et al. (2008) in zebrafish.  In zebrafish, however, the Wnt 
receptor Fz8a is required for the proliferation and organization of radial glial cells, which 
indirectly controls OPC specification (Shimizu et al., 2005; Kim et al., 2008). Following 
specification, canonical Wnt signaling could be preventing premature OPC differentiation 
to help control the temporal and spatial patterning of myelination in the developing spinal 
cord.  
 How does canonical Wnt signaling control OL differentiation? A lack of mature 
OLs can result from a decrease in the size of the progenitor pool, increased apoptosis 
among cells of OL lineage, a change in specification of OPCs, or the prevention of OPCs 
from undergoing differentiation into mature adult cells. Canonical Wnt signaling could 
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limit the number of precursors available, thereby decreasing the total potential amount of 
adult OLs. Our data show this is unlikely, as canonical Wnt signaling does not decrease 
the total pool of precursors, as seen by A2B5 labeling in vitro and PDGFR! and NG2 
labeling in vivo. Proliferation among precursors could be another factor: decreased 
proliferation could limit the total pool size of the OL population. Our data show, 
however, no change in markers of cell proliferation, as Wnt3a treated OPCs in vitro do 
not have significant differences in BrdU labeling relative to controls and proliferation 
appears to be unchanged in the !-Cat-CA mouse, as measured by Ki67 and phospho-
histone 3 labeling. The pool of OPCs could also be reduced by increasing the number of 
cells that undergo fate switching to astrocytes or neurons, at the expense of OLs. Our 
results show, however, no change in the number of cells labeled with GFAP or Tuj1. 
Finally, OLs could be decreased by apoptosis of OPCs, or more likely immature OLs, but 
we have shown no increase in TUNEL labeling in vitro or in vivo.  
Taken together, our results suggest the possibility that canonical Wnt signaling 
prevents cells already committed to the OL lineage from undergoing the maturation stages 
needed to become myelin-producing OLs. In this model, cells in the precursor stage would 
remain progenitors without increasing their rate of proliferation, apoptosis, or adoption of 
other cell fates. This has been seen in other genetically altered mice in which transcription 
factors or receptors involved in differentiation have been disregulated, thus inhibiting 
differentiation. Examples include elimination of signaling through BMP type 1 receptors, 
genetic deletions of the transcription factors Olig1, Nkx2.2, and Sox10, and increased Sox4 
expression (Qi et al., 2001; Lu et al., 2002; Stolt et al., 2002; See et al., 2004; Potzner et al., 
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2007). In all of these genetic models, differentiation is inhibited without a concurrent change 
in precursor number. 
Myelination in the !-Cat-CA mice eventually reaches relatively normal levels, 
showing a small deficit (12%) in OLs and normal numbers of myelinating axons in the adult. 
Mechanisms for this could include a constant slower rate of precursor differentiation until 
nearly full myelination is achieved, or a decrease in the importance of "-catenin signaling for 
inhibition of OL differentiation in the adult, thus making it more permissive. In addition, 
more immature OLs are produced in normal development than are needed for myelination 
and are pruned by apoptosis (Barres et al., 1992a). In our mutant mouse, if not all OLs were 
inhibited from differentiating by "-catenin activation, less cell death in the differentiating 
population would slowly restore the number of mature OLs to normal levels. 
The interactions between elements downstream of "-catenin in the canonical Wnt 
signaling pathway and factors known to be involved in OL differentiation, which might 
account for the lack of OL maturation, have not been directly explored. There is, however, 
precedence for their potential interactions. Tcf4, a downstream transcription factor of active 
"-catenin, is known to repress the expression of the transcription factor Nkx2.2 during 
development of the ventral spinal cord (Lei et al., 2006). Nkx2.2 is one of several 
transcription factors, along with Olig1/2 and Sox10, which are necessary for OL 
differentiation. Direct interactions between "-catenin, downstream effectors, and these 
factors need to be pursued.  
It is possible that stabilizing !-catenin alters the interaction of OPCs with their 
environment in the spinal cord, making it difficult to identify the cell autonomous effects 
of Wnt signaling OL lineage cells. For this reason, we cultured cells from mutant and 
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control mice and analyzed their differentiation capacity after 3 days in DM. Our 
observations mimicked the application of exogenous Wnt3a to control cultures. While 
some cells expressed GalC in both mutant and control cultures, there were far fewer in 
cells from mutant cultures. These findings support the idea that canonical Wnt signaling 
partially inhibits or delays OPC differentiation, while not completely preventing it.  
The later appearance of OLs in dorsal regions is an essential part of spinal cord 
patterning. Inhibitory signals in these areas likely play important roles in preventing 
ventrally generated OPCs from migrating dorsally and subsequently differentiating. 
Recent studies have found that there may be dorsally generated, albeit significantly 
smaller, populations of OPCs, although their contribution to the total OL pool is difficult 
to determine and may be small (Cai et al., 2005; Vallstedt et al., 2005; Kessaris et al., 
2006). While no clear differences between these OPC populations have been observed, it 
stands to reason that their responses to environmental cues could vary, allowing for 
distinct temporal, spatial, and functional patterns. Because Wnt signaling greatly reduces 
the proportion of differentiated cells at certain time points, and appears to prevent 
differentiation in some cells and not others, it is possible that there are differences in 
threshold responses within OPC populations. This could contribute to the varied 
responses of some populations of OPCs to the gradient of signaling factors established in 
the spinal cord, helping to control their temporal and spatial development. We likely 
observed a universal reduction in lieu of regional differences in the !-Cat-CA mouse 
because "-catenin is artificially activated in all OLs. 
Understanding the inductive and repressive signals that guide OL development is 
important in generating strategies to more effectively manipulate OL specification, 
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growth, survival, and maturation, to promote regeneration and remyelination following 
CNS disease or injury. We have shown that activated canonical Wnt signaling is 
sufficient to inhibit the differentiation of OLs in vivo and in vitro, and that this effect is 
transitory in the developing CNS. 
  
Methods 
Cell culture generation and treatment 
All experiments were performed in accordance with the guidelines set forth by the 
Children’s Hospital of Philadelphia Institutional Animal Care and Use Committee. To 
generate cultures of purified OPCs from newborn rats, a mixed population of cells was 
harvested from Sprague-Dawley rats and seeded on 100 mm Petri dishes in serum-
containing medium as previously described (See et al., 2004). After 24 hours, the cell 
cultures were switched to a serum free growth medium, containing Neurobasal medium 
(Invitrogen) with B27 supplement (1:50; Life Technologies), 10 ng/ml basic fibroblast 
growth factor (R&D Systems, Minneapolis, MN), 2 ng/ml platelet-derived growth factor 
(R & D), and 1 ng/ml neurotrophin-3 (Peprotech, Rocky Hill, NJ).  
Cultures were purified by immunopanning 6 to 8 days after isolation as previously 
described (Grinspan et al., 2000b). Briefly, the cells were sequentially seeded on two 
changes of dishes coated with antibody to RAN-2 to remove type 1 astrocytes, meningeal 
cells, and microglia (Barres et al., 1992a), and then onto  dishes coated with the A2B5 
antibody to collect OPCs. Following trypsinization, the cells were seeded in one 75 sq cm 
flask in the serum free growth medium described above. Within three days, these cells 
were confluent and could be subcultured into polylysine-coated flasks, 12mm polylysine–
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coated coverslips for immunofluorescence, or 100mm polylysine-coated Petri dishes for 
western blotting. These cells could be passaged 3-4 times.  
To differentiate precursors into immature OLs, growth medium was removed 
from cultures, and cells were fed with “differentiation medium” (DM), consisting of 50% 
DMEM, 50% Ham’s F12 with 50 µg/ml transferrin, 5 µg/ml putresine, 3 ng/ml 
progesterone, 2.6 ng/ml selenium, 12.5 µg/ml insulin, 0.4 µg/ml T4, 0.3% glucose, 2mM 
glutamine, 10 ng/ml and biotin. Signaling molecules were added to some cultures, 
including Wnt3a (50 ng/ml, R & D), Dkk-1 (100 ng/ml, R & D), and SB216763 (10 µM, 
Biomol International), and cells were immunolabeled after 3 days.  
 To establish cultures of mouse OLs, a mixed population of cells was isolated from 
forebrains of normal and CNP-Cre "-catenin constitutively active (!-Cat-CA) mice using 
the same methods and media as described above for rat OL isolation. Individual mouse 
brains were cultured separately until mice were genotyped by PCR of tail DNA, at which 
point cultures from mice of identical genotypes were then combined. Cultures were 
purified using a gentle modified washdown procedure. Four ml of Hanks Buffered Salt 
Solution without Mg+ and Ca+ was drawn up into a Pasteur pipette and was vigorously 
ejected at the cell monolayer at an angle. Small, round process-bearing cells (OPCs) 
detached, leaving a population of cells adherent to the plastic (GFAP+ astrocytes). The 
plate was tilted and the non-adherent cells plus the Hank’s medium were drawn up into 
the pipette and the procedure was repeated several times. The detached cells were 
collected in the Hank’s medium, triturated several times with the Pasteur pipette, and 
centrifuged at 100g for 5 minutes. The pellet, at 90-95% OPCs, was plated on polylysine-
coated vessels. 
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Immunofluorescence 
Cells on coverslips were processed for detection of specific antigens as described 
previously (Grinspan and Franceschini, 1995; See et al., 2004). Antibody pairs used for 
cell cultures were A2B5 (undiluted, hybridoma supernatant, ATCC, (Eisenbarth et al., 
1979) with goat anti-mouse IgM, anti-Galactocerebroside (GalC, R-mAb, hybridoma 
supernatant (Ranscht et al., 1982), with goat anti-mouse IgG3, anti-PLP (AA3, 
hybridoma supernatant, gift of Dr. Alex Gow, Wayne State), anti-GFAP (hybridoma 
supernatant, gift of Virginia Lee, University of Pennsylvania) with goat-anti rat IgG, anti-
Tuj1 (1:50, Chemicon/Millipore, Billerica, MA ) with goat anti-mouse IgG, and anti-"-
catenin (1:1000, Transduction laboratories) with goat-anti mouse IgG1. To quantify cell 
proliferation, cells were treated with a pulse of 10 µM BrdU. Three, 6, or 24 hours later, 
cells were fixed with 70% ethanol in 50 mM glycine buffer for 20 minutes on ice, labeled 
with anti-BrdU antibody (1:10, Roche Applied Science), followed by anti-mouse-
fluorescein IgG. To determine cell death, coverslips were labeled with anti-cleaved 
caspase antibody (1:200, Cell Signaling) followed by goat anti-rabbit IgG. The TUNEL 
assay to determine apoptosis was also performed as previously described (Grinspan et al., 
1998).  
To count cells expressing antigens in culture, antigen+ and DAPI+ cells were 
counted in 10 fields in each of 2 coverslips from at least 3 separate preparations of cells 
using a Leica DM6000B fluorescence microscope at 63x magnification. Approximately 
1000 total cells were counted per condition.  
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Western Blotting 
Tissue sections from P1, P7, P21, and adult mouse spinal cord and brain were 
dissected, sonicated for 30s in cold lysis buffer (containing 25 mM Tris, pH 7.6, 1mM 
MgCl2, 1 mM EDTA, 1% TritonX-100, 1% SDS, 1 mM PMSF, 50 !g/ml antipain, 2 
!g/ml aprotinin, 1 !g/ml leupeptin, 1 !g/ml pepstatin A), centrifuged, and the 
supernatants preserved. For cells in culture, cells were harvested in lysis buffer with a cell 
scraper (Corning Inc), passaged 10x through a 22g syringe, rotated on ice for 30 minutes, 
and spun at 14,000g for 15 minutes. Amount of protein in each sample was determined 
by the BCA method (Pierce Chemical, Rockford, IL). Samples were be denatured by 
boiling in sample buffer containing "–mercaptoethanol, separated on 15% or 8% 
acrylamide gels, and transferred to immobilon-P membranes (Millipore). Membranes 
were incubated with appropriate primary antibodies (MBP, 1:500, and "-catenin, 1:1000) 
followed by the appropriate horseradish peroxidase-conjugated anti-rat IgG secondary 
antibody (1:100), and imaged using ECL reagents (Amersham, Piscataway, NJ) and 
hyperfilm (Amersham). Blots were stripped and reprobed with GAPDH (1:2,500, 
Chemicon International) as a loading control for protein quantification.  
 
Generation of Cnp-Cre !-catenin constitutively active mice 
Constitutively activated !-catenin (!-Cat-CA) mice were generated by crossing 
heterozygous Cnp-Cre mice (obtained from Dr. Klaus Nave, Max Planck Institute, 
Germany, (Lappe-Siefke et al., 2003) with !-catenin
floxedexon3/floxedexon3
 mice (obtained 
from Dr. Mark Taketo, Kyoto University, Japan). Half of the offspring were 
heterozygous for CNP-Cre and floxed !-catenin, the other half were heterozygous for 
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floxed !-catenin, showed no phenotype, and used as controls. PCR analyses of tail 
genomic DNA were used to identify all mouse genotypes. !-Cat-CA mice survive to 
adulthood but are smaller than control littermates.  
 
Immunohistochemistry 
To prepare sections of normal and mutant spinal cords, mice were sacrificed at 
P1, P7, P21, and adulthood according to established protocols (See et al., 2007). Mice at 
P1 and P7 were decapitated, spinal cord sections were removed and fixed in 4% 
paraformaldehyde for 1 hr, placed in 30% sucrose overnight, and embedded in OCT 
(Sakura Finetek). Adult and P21 mice were perfused with 0.9% saline and 4% 
paraformaldehyde, then spinal cord sections were removed, fixed in 4% 
paraformaldehyde overnight, washed in phospho-buffered saline (PBS), placed in 30% 
sucrose overnight, and embedded in OCT. Frozen sections were cut on a Leica cryostat at 
12!m. To label OL lineage cells and astrocytes, slides were washed PBS, incubated in 
block with 20% fetal bovine serum, 2% bovine serum albumin, and 0.1% triton in PBS 
for 20 minutes to 1 hour, washed in PBS, incubated overnight at 4°C in primary antibody, 
washed in PBS, and then incubated in the appropriate secondary antibody for 30 minutes 
(all secondaries were diluted 1:100 and purchased from Jackson Immunoresearch 
Laboratories), washed in PBS, and then mounted on slides with mounting medium 
containing DAPI (Vector Laboratories).  
The antibody pairs used to label mature OLs in vivo were anti-PLP (1:2) with goat 
anti-rat IgG, anti-MBP (1:2, rat hybridoma supernatant, gift of Virginia Lee, University 
of Pennsylvania) with goat anti-rat IgG, and anti-aspartoacylase (ASPA, dilution, gift of 
 48 
Dr James Garbern, Wayne State University) with goat anti-rabbit IgG, and anti-CC1 
(1:20, Calbiochem) with goat anti-mouse IgG. Antibody pairs used to label OPCs were 
anti-PDGFR! (1:250, BD Biosciences Pharmigen) with goat anti-rat IgG and anti-NG2 
(1:100, Chemicon) with goat anti-rabbit IgG. Astrocytes were labeled with anti-GFAP 
(1:100) with goat- anti-rat IgG, and neurons were labeled with anti-NeuN (1:100, 
Chemicon) with goat anti-mouse IgG.  
To characterize changes in cell proliferation between the control and mutant 
animals, we employed both the mitosis marker phosphorylated-histone H3 (PH3, 1:250, 
Upstate technology) and antibody to the proliferation protein Ki-67 (1:00, Vector labs), 
as described above, both with goat anti-rabbit IgG (1:100).  
Cell death was measured using an anti-cleaved-caspase 3 antibody (1:200, Cell 
signaling) or the TUNEL method as previously described. Detection of cell death was 
combined with immunophenoptyping of OLs using the NG2 antibody. 
To count cells from frozen sections of all mice, normal and mutant animals from 
at least three litters were used. For P1 mice, digital images were taken at from three 
cervical spinal cord sections per animal, counting 6 40x fields of white matter per section. 
For P7 animals, digital images were taken at 40x from 4 white matter and 4 grey matter 
sections. For adult animals, composite images were accumulated at 10x to count all cells 
in the white matter of hemisections.  
 
Semi thin sections 
 Adult mice and P7 mice were sacrificed and processed for semi-thin sections 
according to established protocols (Arroyo et al., 1998; Scherer et al., 1998). Three 
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control and mutant mice were anesthetized at each age, perfused with PBS followed by 
2% paraformaldehyde and 2% gluteraldehyde in 0.1M phosphate buffer. The spinal cord, 
sciatic nerves, and optic nerves were removed and placed in fixative overnight. They 
were post fixed in 4% OsO4 in 0.1M phosphate buffer for 2 hours, rinsed in 0.1M 
phosphate buffer, and dehydrated in ascending concentrations of ethanol. Tissue was then 
embedded in ascending concentrations of epoxy and semi-thin sections were stained with 
toluidine blue. Images were recorded at 20x, 40x, and 63x magnification. For each 
animal, myelinated axons were counted in 2 ROIs of 50 x 150µm (in P7 mice) or 100 x 
250µm (adult mice) in ventral spinal cord, and in an entire cross section of sciatic nerve.  
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Figure 2.1: Wnt signaling inhibits OPC differentiation in vitro and does not promote 
the generation of astrocytes, nor alter cell death or proliferation.  
 Rat OPC cultures were placed in differentiation medium with 50 ng/ml Wnt3a 
and processed for immunofluorescence. (A, B) Following 3 days of treatment, cells were 
labeled with the A2B5 antibody to identify OPCs and antibody to GalC to identify 
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immature or mature OLs. The antibody positive cells and DAPI positive nuclei were 
counted and expressed as percent of control. Cultures treated with Wnt3a showed a 40% 
reduction in GalC labeled cells compared to controls after 3 days in DM (n = 8, p < 0.05), 
while there was no statistically significant change in the number of A2B5 labeled cells (n 
= 5). (C) Western blots performed on protein from cells cultured with DM or DM plus 
Wnt3a for 5 days were probed with antibody to MBP. GAPDH is used as a loading 
control. Wnt3a treated cells showed a decrease in MBP expression relative to controls. 
(D) Cultures treated with Wnt3a for 3 days showed no statistically significant alteration 
from controls in number of GFAP+ astrocytes (n = 9). (E) Proliferation was unchanged 
between treated cultures and controls as measured by cells labeling with BrdU after 3 (n 
= 8), 6 (n = 3), and 24 hours (n = 3). (F) The number of apoptotic cells was not altered in 
the Wnt3a treated cultures after 3 days as measured by the TUNEL assay (n = 3). 
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Figure 2.2: Wnt3a Treatment inhibits oligodendrocyte differentiation through 
activation of the canonical "-catenin signaling pathway.  
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 (A) Rat OPC cultures were double labeled with antibodies to A2B5 and "-catenin 
6 hours after treatment with Wnt3a. "-catenin labeling appeared in the nuclei of A2B5+, 
Wnt3a-treated cells, but not controls (indicated by the white arrows). (B) Western blots 
were performed on protein from rat OPC cultures 24 hours after Wnt3a treatment, using 
antibodies to "-catenin and GAPDH as the loading control. Protein taken from cells 
treated with Wnt3a showed an increase in "-catenin staining relative to controls (n = 3). 
(C) Cultures were placed in differentiation medium and treated with Wnt3a or Wnt3a 
plus the canonical Wnt signaling inhibitor Dkk-1. Cells treated with Wnt3a alone showed 
a 38% reduction in GalC staining relative to controls (p < 0.05, n = 3), whereas cells 
treated with Wnt3a and Dkk-1 did not have statistically different numbers of GalC+ cells 
compared to controls. 
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Figure 2.3: Cnp-Cre is expressed in both OPCs and mature oligodendrocytes.  
 Cnp-Cre mice were mated with Rosa26 mice. "-galactosidase expression in cells 
of these animals indicates somatic recombination of the Rosa26 gene. Animals were 
sacrificed at P5 and spinal cords were sectioned. (A) Photomicrographs taken at 40x 
magnification showing PDGFR!+ OPCs also labeling with antibody to "-galactosidase. 
Inset is at 63x magnification; white arrows indicate double-labeled cells. (B) 
Photomicrographs taken at 40x magnification depicting cells double labeling with APC, 
which identifies mature OLs, and "-galactosidase. Inset is at 63x magnification; white 
arrows indicate double-labeled cells. 
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Figure 2.4: P1 !-Cat-CA mice have fewer oligodendrocytes and less myelin protein 
than control littermates, but the same numbers of OPCs.  
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 Spinal cords were removed from P1 control and !-Cat-CA mice and prepared for 
cryosectioning and labeling. Cell counts were performed at 40x magnification in 6 fields 
of white matter, on 3 spinal cord sections per animal from each of 6 control and mutant 
animals from 3 litters. (A, B) Photomicrographs depicting ventral cervical spinal cord in 
!-Cat-CA mice and control littermates labeled with DAPI and antibody to PLP at 10x 
magnification, with 40x magnification insets. (C, D) Photomicrographs depicting equal 
numbers of GFAP+ cells in spinal cord sections of !-Cat-CA mice and control 
littermates. (E, F) Photomicrographs depicting equal numbers of cells labeling with DAPI 
and antibody to NG2 in !-Cat-CA mice and control littermates. (G) Counts of PLP+ cells 
per section showed a 32% decrease in OLs in !-Cat-CA mice relative to controls (p < 
0.05, n = 6). (H) Western blots were performed on protein taken from forebrain from P1 
mice, and indicated a decrease in MBP expression in !-Cat-CA mice relative to controls, 
using GAPDH as a loading control (n = 3). (I) Counts of GFAP+ cells per section showed 
no significant difference between mutant mice and controls (n = 5). (J) There were no 
significant differences in the numbers of OPCs between mutant and control spinal cords 
using both antibody to NG2 (n = 3) and PDGFR! (n = 6). 
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Figure 2.5: !-Cat-CA mice show a decrease in myelin protein expression that 
becomes less severe with age.  
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 !-Cat-CA and normal mice were sacrificed at P7, P21 and 10 weeks, and spinal 
cords were prepared for sectioning and immunolabeling. (A, B) Photomicrographs of 
spinal cord sections of P7 !-Cat-CA mice and control littermates labeled with DAPI and 
antibody to PLP, demonstrating decreased labeling in both the white and grey matter of 
the mutant cord sections. (C, D) Photomicrographs of spinal cord sections of P7 !-Cat-
CA mice and control littermates labeled with DAPI and antibody to ASPA, which labels 
OL cell bodies, demonstrating fewer OLs labeling with ASPA in the white matter. (E, F) 
Photomicrographs of adult !-Cat-CA mice and control littermates showing labeling for 
ASPA and DAPI. (G) To perform cell counts at P7, PLP+ cells in 8 identical fields were 
counted at 40x magnification in 3 sections of ventral spinal cord per animal in 6 animals 
from 3 liters. !-Cat-CA mice had 38% fewer PLP+ cells than control littermates (p < 
0.05, n = 6). (H) Western blots were performed on protein taken from forebrain of P7 
mice, and indicated a decrease in MBP expression in !-Cat-CA mice relative to controls, 
using GAPDH as a loading control (n = 3). (I) At P21, cell counts were performed on the 
white matter of 3 composite hemisections per animal in 6 animals per 3 litters. There 
were 19% fewer ASPA+ cells in !-Cat-CA mice compared to control littermates (p < 
0.05, n = 6). (J) In adults, cell counts were also performed on the white matter of 3 
composite hemisections per animal in 3 animals in 6 liters. There were 12% fewer 
ASPA+ cells in !-Cat-CA mice compared to control littermates (p < 0.05, n = 8). 
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Figure 2.6: !-Cat-CA mice have fewer myelinated axons than control littermates at 
P7, but not at adulthood. 
 !-Cat-CA and normal mice were sacrificed at P7 or adulthood, then spinal cord 
and sciatic nerve were removed and prepared for semi-thin sections as described in the 
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methods. Images were taken at 10x and 40x magnification, and myelinated axons were 
counted in 2 regions of interest of 50 x 150µm (at P7) or 100 x 250µm (in adults) in 
ventral spinal cord, or in complete cross sections of sciatic nerve. (A, B) Images taken at 
10x and 40x magnification of ventral spinal cord demonstrating 44% more myelinated 
axons (p < 0.05, n = 3) in normal mice than in !-Cat-CA littermates (D, E). (C) Images 
taken at 40x magnification of tibeal nerve demonstrating 27% more myelinated axons (p 
< 0.07, n = 3) in normal mice than in !-Cat-CA mice littermates (F). (G, H) Images taken 
at 10x and 40x magnification of ventral spinal cord showing similar numbers of 
myelinated axons in adult normal mice and !-Cat-CA littermates (J, K). (I) Images taken 
at 40x magnification of sciatic nerve showing similar numbers of myelinated axons in 
normal mice and !-Cat-CA littermates (L). (M) Graph showing counts of the number of 
myelinated axons in ventral spinal cord and tibeal nerve of P7 mice and ventral spinal 
cord and sciatic nerve of adult mice.  
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 Figure 2.7: OPCs from !-Cat-CA mice differentiate poorly in culture.  
OPC cultures were generated from forebrain of normal and !-Cat-CA mice. 
Cultures were then placed in DM and were immunolabeled after 3 days. (A) 
Photomicrographs of cultures after 3 days in DM. Cells were labeled with antibodies to 
GalC and A2B5. (B) Cells from !-Cat-CA cultures had 60% fewer GalC+ cells relative to 
control cultures after 3 days in DM (p < 0.05, n = 5), but maintained similar levels of 
DAPI and A2B5 (n = 5). (C) After 3 days in DM, there was no significant difference in 
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the number of GFAP labeled cells. (D) After 3 and 6 hours, there was no significant 
difference in the number of BrdU labeled cells in mutant cultures relative to controls (n = 
3). (E) Mutant cultures did not have significantly different numbers of TUNEL labeled 
cells relative to controls (n = 3).  
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 Supplemental Figure 2.1: Spinal cord sections from !-Cat-CA mice and control 
mice did not contain statistically different numbers of proliferating cells or cells 
undergoing apoptosis.  
 !-Cat-CA mice and normal littermates were sacrificed at P1 and P7, processed for 
sectioning, and labeled with markers for OPCs, proliferation, and apoptosis. (A) 
Photomicrographs of ventral spinal cord sections from !-Cat-CA mice and control 
littermates at P1 and P7. Sections were labeled with PDGFR!, Ki67, and DAPI, and 
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taken at 63x magnification. White arrows indicate cells colabeling with PDGFR! and 
Ki67. (B) Cell counts show no statistical difference in the number of Ki67+ cells from 
spinal cords of !-Cat-CA mice and control littermates at P1 and P7 (n=3). (C) There was 
also no statistically significant differences in the number of PH3+ cells in spinal cord 
sections taken from !-Cat-CA mice and control littermates at P1 (n=3). (D) There was no 
statistical difference in the number of TUNEL+ cells in spinal cord sections taken from 
!-Cat-CA mice and control littermates at P1 and P7 (n=4).  
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Abstract 
 We examine the relationship between the canonical Wnt and BMP pathways 
during oligodendrocyte development in vitro. The regulation of oligodendrocyte 
development, from precursor to mature myelinating cell, is controlled by a variety of 
inhibitory and inductive signaling factors. The dorsal spinal cord contains signals that 
inhibit oligodendrocyte development, including members of the Wnt and BMP signaling 
pathways. Wnts and BMPs have overlapping temporal activity and similar inhibitory 
effects on oligodendrocyte differentiation. In addition, both pathways feature prominently 
in many developmental processes and during demyelinating events, and they are known 
to interact in complex inductive, inhibitive, and synergistic manners in many developing 
systems. The interaction between BMP and Wnt signaling in oligodendrocyte 
development, however, has not been extensively explored. We use pharmacological and 
genetic paradigms to show that both Wnt3a and BMP4 will inhibit oligodendrocyte 
differentiation in vitro. We also show that when the canonical BMP signaling pathway is 
blocked, neither Wnt3a nor BMP4 have inhibitory effects on oligodendrocyte 
differentiation. In contrast, abrogating the Wnt signaling pathway does not alter the 
actions of BMP4 treatment. Our results indicate that the BMP signaling pathway is 
necessary for the canonical Wnt signaling pathway to exert its effects on oligodendrocyte 
development, but not vice versa, suggesting that Wnt signals upstream of BMP.  
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Introduction 
 
 Myelin is an essential physiological structure, allowing for the rapid and effective 
conductance of neural signals. Demyelination, which occurs in disorders such as multiple 
sclerosis, severely impairs neuronal communication, resulting in functional deficits and 
axonal degeneration (Trapp et al., 1998; Lappe-Siefke et al., 2003; Edgar and Garbern, 
2004). Because several factors involved in regulating myelination during development 
are also involved in demyelinating disorders, understanding their actions is crucial to 
designing treatments or therapies (Setoguchi et al., 2001; Armstrong et al., 2002; Liu et 
al., 2008b; Zhang et al., 2009; Cate et al., 2010).  
 Oligodendrocytes (OLs) are the myelinating cells of the central nervous system 
(CNS). OLs are generated through a series of specific developmental stages (Pringle and 
Richardson, 1993; Ono et al., 1995), during which they are exposed to a range of 
signaling factors that can be inductive or inhibitory, extracellular or intracellular (Miller, 
2002). OL precursor cells (OPCs) originate in ventricular zones at E12.5 in the rodent 
CNS and migrate dorsally and radially, expressing markers such as A2B5, NG2, and 
PDGFR!. Once differentiation begins, OPCs progress to immature OLs, generating 
processes and expressing galactocerebroside (GalC). After contacting neurons, OPCs will 
begin to extend processes, express myelin proteins, including proteolipid protein (PLP), 
myelin basic protein (MBP), and 2’-3’ cyclic nucleotide 3’-phosphodiesterase (CNP), 
then myelinate axons (Grinspan, 2002; Miller, 2002). While the signals that influence this 
development are beginning to be characterized, the extent of their interactions remains to 
be fully explored.  
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 Initially, signals in the ventral spinal cord, especially sonic hedgehog (Shh), 
induce expression of transcription factors essential for OL specification and development, 
including Olig1 and Olig2 (Lu et al., 2000; Zhou et al., 2000; Zhou and Anderson, 2002). 
In contrast, signals emanating from the roofplate in dorsal spinal cord can inhibit this 
development (Wada et al., 2000), possibly to control the exact times when these cells 
reach and myelinate dorsal regions. There are, however, dorsal populations of OPCs 
whose generation is Shh independent, although their overall contributions appear to be 
limited and their distinct functions are unknown (Cai et al., 2005; Kasai et al., 2005; 
Vallstedt et al., 2005; Kessaris et al., 2006).  
 Two families of dorsal signaling factors, the bone morphogenic proteins (BMPs) 
and the Wnts, have been shown to exert inhibitory effects on OPC differentiation.  BMPs 
are members of the TGF" signaling family, and they have many roles in the developing 
nervous system involving embryonic patterning, cell proliferation, specification, 
differentiation, and apoptosis (Liem et al., 1995; Mehler et al., 1997; Liem et al., 2000; 
Wine-Lee et al., 2004; See and Grinspan, 2009 for review). BMP has been more 
extensively investigated with regard to OL development, exerting time and stage specific 
effects. BMPs drastically inhibit OPC differentiation into mature OLs, instead promoting 
astrogliogenesis (Grinspan et al., 2000a; Miller et al., 2004; Samanta and Kessler, 2004; 
See et al., 2004; Cheng et al., 2007).  
 The Wnts are involved in many of the same roles as BMPs in the nervous system, 
including embryonic patterning, cell specification, proliferation, migration, and 
differentiation (Dorsky et al., 1998; Coyle-Rink et al., 2002; Braun et al., 2003; 
Hirabayashi et al., 2004; Karim et al., 2004; Kalani et al., 2008; Ulloa and Marti, 2010 
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for review). Recent studies have investigated the influence of canonical Wnt signaling on 
OL development, both in vitro and in vivo, indicating that the Wnts and BMPs have 
similar effects. In spinal cord explants and OPC cultures, ectopic Wnt3a application 
inhibits the differentiation of OPCs into mature cells (Shimizu et al., 2005; Kim et al., 
2008; Fancy et al., 2009; Feigenson et al., 2009; Ye et al., 2009). Constitutively-activated 
Wnt signaling in cells of OL lineage results in an early developmental decrease in mature 
OLs. This effect diminishes as the mice age, however, suggesting that the importance of 
Wnt signaling may vary over the course of OL development (Fancy et al., 2009; 
Feigenson et al., 2009). 
 The interaction of BMPs and Wnts is well documented in a variety of different 
systems, their expression is spatially and temporally similar, and they are functionally 
involved in many of the same processes. Their relationship, however, varies based on 
tissue and developmental timeline: depending on context, they can directly or indirectly 
be inductive, antagonistic, or synergistic (Soshnikova et al., 2003; Guo and Wang, 2009; 
Itasaki and Hoppler, 2010 for review). There is evidence that Wnt signaling prevents 
oligodendroglial specification at the neural stem cell stage by upregulating BMPs through 
neurogenesis (Kasai et al., 2005), but how these two pathways may interact in OL 
development has not been explored in detail.  An understanding of the interaction of 
these pathways is an important avenue for developing treatments and therapies for 
demyelinating events. BMPs are upregulated in CNS injury and models of demyelinating 
disease and can inhibit remyelination (Setoguchi et al., 2001; Setoguchi et al., 2004; See 
and Grinspan, 2009; Cate et al., 2010; Jablonska et al., 2010). In parallel, several recent 
studies have also found that members and effectors of the Wnt family are upregulated in 
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similar paradigms, and may have similar inhibitory effects on recovery (Liu et al., 2008b; 
Fancy et al., 2009; Miyashita et al., 2009; White et al., 2010).  
 Because Wnts and BMPs have similar sites of origin and effects on OLs during 
development and demyelinating events, we hypothesized that these two signaling factors 
mutually regulate OL development.  To explore this interaction, we have employed 
effectors and antagonists of both canonical Wnt and BMP signaling on both mutant and 
normal OPC cultures. We find that while both BMP4 and Wnt3a inhibit the 
differentiation of OPCs, when the BMP pathway is blocked - by either chemical or 
genetic means - the effects of both Wnt3a and BMP4 are abrogated. In contrast, the effect 
of BMP4 on OPC differentiation is not altered when the canonical Wnt signaling 
pathway is blocked. Our results indicate that the BMP pathway is necessary for canonical 
Wnt signaling to inhibit OPC differentiation.  
 
Results 
Wnt and BMP inhibit oligodendrocyte differentiation 
 To observe the effects of Wnt3a and BMP on OL development in vitro, we 
examined highly purified primary cultures of OPCs from mouse or rat brain. OPCs were 
grown to confluency on coverslips or dishes, subsequently, growth factors were removed 
and differentiation medium (DM) was added with or without BMP4 (50ng/ml) or Wnt3a 
(50ng/ml).  After 3 days in DM, cells were immunostained with antibodies against GalC 
(a marker of early differentiation) and A2B5 (which labels OPCs). In control conditions, 
26% of rat cells expressed GalC, and 67% labeled with A2B5, as observed in previous 
studies (Feigenson et al., 2009). In contrast, BMP4 treatment almost completely 
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eliminated GalC labeling while maintaining comparable levels of A2B5 labeling (Fig. 
3.1A, C). Wnt3a treatment reduced GalC labeling by 33% (p < 0.05), in keeping with the 
30-40% decrease we have observed previously (Feigenson et al., 2009), and also did not 
have a significant effect on the amount of cells labeling with A2B5 (Fig. 3.1A, C).  
 To determine whether BMP4 or Wnt3a affected the number of astrocytes, we 
immunolabeled cells with antibodies directed against glial fibrillary acidic protein 
(GFAP). Control cultures and cultures treated with Wnt3a contained fewer than 5% 
astrocytes, while in BMP4 treated cultures the number of astrocytes increased 6.5-fold (p 
< 0.05, Fig. 3.1B, D). We have previously shown that neither BMP4 nor Wnt3a 
significantly affected the number of cells undergoing apoptosis, proliferation, or 
differentiation into neurons (Grinspan et al., 2000a; Feigenson et al., 2009). Thus, BMP4 
completely inhibited OPC differentiation and induced astrogliogenesis, while Wnt3a 
partially inhibited OPC differentiation without promoting astrocyte differentiation. 
  
A BMP inhibitor blocks the effects of both BMP4 and Wnt3a signaling but a Wnt 
inhibitor blocks only Wnt3a signaling. 
 To determine whether there is a relationship between the Wnt and BMP signaling 
pathways, pharmacological inhibitors of both pathways were added to our treatment 
paradigm. Noggin (500ng/ml), an inhibitor of canonical BMP signaling, was added to 
OPC cultures along with DM, 50ng/ml BMP4, or 50ng/ml Wnt3a. Noggin treatment 
alone did not alter the number of GalC+ cells relative to control conditions. Noggin 
added with BMP4 completely blocked the effect of BMP4, and the number of GalC+ 
cells was not significantly different from DM treatment alone (Fig. 3.2A). Similarly, 
 72 
when Noggin was added along with Wnt3a, the number of GalC+ cells was the same as 
in the untreated control condition, indicating that blocking the BMP signaling pathway 
blocks the inhibitory actions of BMP4 and Wnt3a on OPC differentiation in vitro (Fig. 
3.2A). 
 To determine whether blocking the canonical Wnt signaling pathway could block 
BMP signaling, we treated OPC cultures with Dikkopf-1 (Dkk-1), an inhibitor of 
canonical Wnt signaling. Dkk-1 treatment (100ng/ml) alone did not alter the number of 
GalC+ cells relative to control conditions. When used concurrently with Wnt3a, however, 
Dkk-1 blocked the inhibitory effect of Wnt3a. In contrast, BMP4 completely inhibited 
GalC expression in cells even when treated concurrently with Dkk-1 (Fig. 3.2B), 
indicating that blocking the canonical Wnt signaling pathway does not block the BMP 
signaling pathway in vitro. These results suggest that BMP4 does not signal upstream of 
the canonical Wnt pathway, and that the BMP pathway is not dependent on the Wnt 
signaling pathway. 
 
Genetic ablation of the BMP signaling pathway blocks the effects of BMP4 and Wnt3a 
 We next used a genetic model to help determine the relationship between BMP4 
and Wnt3a and confirm our pharmacological results. We cultured OPCs from single 
BMPR1 double receptor knockout mice (Bmpr1 DKO) in which both BMPR1A and 
BMPR1B have been functionally inactivated in the neural tube by E10.5 using the Bcre-
32 transgenic allele (Wine-Lee et al., 2004; See et al., 2007). When the two type I 
membrane receptors, 1A and 1B, are both deleted, BMP signaling is effectively 
eliminated (Wine-Lee et al., 2004). The BMP signaling pathway is described in detail in 
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Chapter 1. OPCs cultured from the animals are able to differentiate, do not translocate 
Smad to the nucleus, and do not respond to BMP treatment (See et al., 2007).  
 We generated cultures from these double knockout animals as well as from single 
knockouts (Bmpr1b KO, Bmpr1a KO), and normal littermates. We then treated these 
cultures with DM alone or DM containing BMP4 or Wnt3a. OPCs in the Bmpr1 DKO 
cultures differentiated to the extent of the normal cells even in the presence of BMP4, as 
we have previously shown (See et al., 2007). When Bmpr1 DKO OPC cultures were 
treated with Wnt3a, the number of GalC+ cells was not significantly different from 
control conditions (Fig. 3.3A). BMP4 completely eliminated GalC expression in normal 
mouse OPC cultures after 3 days in DM, and Wnt3a reduced the number of GalC+ cells 
by 41%. The number of A2B5+ cells did not vary from control conditions, replicating our 
previous findings in control cultures. These results were further replicated in OPC 
cultures from Bmpr1a KO and Bmpr1b KO mice (Fig. 3.3A), indicating that when the 
BMP signaling pathway is completely abrogated, the canonical Wnt signaling pathway is 
similarly prevented from inhibiting OPC differentiation. Furthermore, when either 
Bmpr1a or Bmpr1b is individually deleted, the other type I receptor can compensate to 
maintain the integrity of the BMP signaling pathway and allow it to influence OL 
development. 
 
Genetic inhibition of the canonical Wnt signaling pathway blocks the effect of Wnt3a, 
but not that of BMP4, on oligodendrocyte differentiation 
 To observe the effectiveness of canonical Wnt signaling and canonical BMP 
signaling on OL development when the Wnt signaling pathway has been effectively 
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eliminated, we employed mutant mice with a conditional knockout of the nuclear effector 
of canonical Wnt signaling, "-catenin (!-Cat-Null). Cnp-Cre mice were bred to a line 
containing floxed sites surrounding exons 3-6 on the "-catenin gene (Huelsken et al., 
2001; Lappe-Siefke et al., 2003; Feigenson et al., 2009). Cre mediated recombination 
results in no functional "-catenin protein, preventing the activation of canonical Wnt 
signaling.  The Wnt pathway is described in detail in Chapter 1. In these mutant mice, the 
Wnt signaling pathway is inhibited in all cells of OL lineage by preventing active "-
catenin from being produced.  
 OPC cultures were generated from mutants and normal littermates at P1 and 
treated with DM with or without BMP4 or Wnt3a. Wnt3a did not change the number of 
GalC-expressing cells relative to DM in the !-Cat-Null OPC cultures, indicating that 
canonical Wnt signaling was effectively eliminated from OPCs (Fig. 3.3B). In contrast, 
BMP4 completely eliminated expression of GalC in treated cells. These results indicate 
that blocking the canonical Wnt signaling pathway prevents the inhibitory effect of 
Wnt3a on OL development, but not that of BMP4, and that the BMP signaling pathway is 
not upstream of the Wnt signaling pathway or dependent on the Wnt signaling pathway in 
this system. 
 
BMP4, but not Wnt3a, increases phosphorylated Smad levels 
 To see if Wnt3a directly upregulates the canonical BMP signaling pathway, we 
treated cultured OPCs with BMP4 and Wnt3a and looked for increases of phosphorylated 
Smad 1/5/8. When cultures were treated with BMP4, phosphorylated-Smad levels 
increased after 30 minutes post treatment, as observed by Western blots (Fig. 3.4A). In 
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contrast, Wnt3a did not noticeably increase Smad levels after the same amount of time or 
at longer time points, up to 48 hours post treatment (data not shown), demonstrating that 
Wnt3a does not directly upregulate BMP signaling.  
 
BMP4 and Wnt3a do not decrease OPC differentiation in a combinatorial manner 
 To determine whether the effects of BMP4 and Wnt3a were additive, we treated 
OPCs with DM containing 50ng/ml Wnt3a and 10ng/ml BMP4, both of which 
individually reduce the number of GalC+ cells by approximately 40% relative to control 
conditions. We also treated cells with each growth factor individually and with 50ng/ml 
BMP4 as a positive control. There were no significant decreases in GalC expression, 
however, in the combined treatment condition when compared to individual treatments 
with 10ng/ml BMP4 or 50ng/ml Wnt3a (Fig. 3.5). This is consistent with the 
interpretation that the same downstream pathway is used by both signaling factors to 
inhibit OL maturation. 
 
Wnt3a and BMP4 target Id2 and Olig2 
 We used quantitative real-time PCR to determine the effects Wnt and BMP 
treatment on OPC development. Treating cultures with Wnt3a or BMP4 decreased Mbp 
transcript levels after 48 hours, mirroring our previous results (Fig. 3.6A). ID proteins are 
known inhibitors of differentiation, and previous studies have revealed that they are 
targets of BMP and Wnt signaling (Samanta and Kessler, 2004; Ye et al., 2009). When 
assaying for Id2 mRNA, both Wnt3a and BMP4 significantly increased transcript levels 
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(Fig. 3.6B). These results indicate that Wnt3a and BMP4 can target a key effector of OL 
differentiation. 
 ID2 prevents the nuclear localization of Olig2 after stimulation with BMP4, thus 
inhibiting BMP signaling (Samanta and Kessler, 2004). We examined the localization of 
Olig2 after treatment with either BMP4 or Wnt3a. After 2 days of treatment, we observed 
a significant decrease in the total number of cells in which Olig2 was clearly visible 
colocalized with cell nuclei in both BMP4 and Wnt3a treated cultures. There was a 55% 
reduction in Olig2 and DAPI colabeling in BMP4 treated cultures and a 19% reduction in 
Wnt3a treated cultures relative to controls (p < 0.05, Fig. 3.7A, B). These results further 
indicate that BMP4 and Wnt3a are targeting common factors in OPC differentiation. 
 
Discussion 
We have analyzed the relationship between canonical Wnt and BMP signaling in 
OL development, and our results indicate that both pathways rely on a fully functional 
BMP signaling pathway. In primary OPC cultures, BMP4 by itself almost completely 
eliminates OPC differentiation and significantly increases the number of astrocytes. 
Wnt3a by itself decreases OPC differentiation by 30-40% without a corresponding 
increase in astrocyte generation. Blocking the BMP signaling pathway, however, 
prevents the effects of both factors. In contrast, blocking the canonical Wnt signaling 
pathway was able to counter the effect of Wnt3a on OPC differentiation, but not that of 
BMP4.  
 The BMP and Wnt pathways have many contextually and temporally dependent 
interactions throughout development (Itasaki and Hoppler, 2010). In the developing 
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spinal cord, overexpression of either signaling factor alone induces a dorsalized 
phenotype, whereas their removal produces ventralized phenotypes, indicating that both 
signals may have functionally similar, interacting, or redundant effects (Nguyen et al., 
2000; Muroyama et al., 2002; Timmer et al., 2002; Zechner et al., 2007; Alvarez-Medina 
et al., 2008). In some developmental systems, the BMP pathway upregulates or acts 
upstream of Wnt signaling, such as in neural crest delamination (Burstyn-Cohen et al., 
2004), keratinocyte development (Yang et al., 2006), and dorsal/ventral patterning 
(Zechner et al., 2007). Conversely, Wnt signaling can act upstream or upregulate the 
BMP pathway, such as during neurogenesis and astrogliogenesis (Kasai et al., 2005), 
limb mesenchyme development (Hill et al., 2006), and tooth development (Liu et al., 
2008a). The downstream effectors of both signaling pathways can also interact in 
synergistic manners to regulate transcription (Labbe et al., 2000; Nishita et al., 2000; 
Letamendia et al., 2001; Theil et al., 2002; Hussein et al., 2003), and canonical Wnt 
signaling can prolong the activity of the BMP pathway (Fuentealba et al., 2007). In other 
contexts, Wnt and BMP signaling can be directly antagonistic, such as in neuroepithelial 
cell development (Ille et al., 2007), aspects of neural development (Gomez-Skarmeta et 
al., 2001), muscle positioning (Bonafede et al., 2006), and osteoblast development 
(Kamiya et al., 2008b; Kamiya et al., 2008a; Honda et al., 2010). In some systems, such 
as during aspects of limb bud and apical ectodermal ridge formation, the BMP and Wnt 
pathways can complexly regulate each other through parallel signaling and feedback 
systems (Soshnikova et al., 2003; Villacorte et al., 2010). 
 Our results clearly demonstrate that the BMP signaling pathway is essential for 
the Wnt signaling pathway to inhibit OPC differentiation. Treatment of cultures with 
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Wnt3a does not upregulate phosphorylated Smad levels, however, indicating that Wnt 
signaling does not directly upregulate canonical BMP signaling. The possibility remains, 
however, that Wnt signaling may directly activate the BMP signaling pathway, but at 
levels below detection in Smad assays. Some targets of Smads have TCF/LEF binding 
sites in close proximity, indicating that the two pathways have synergistic activity among 
their downstream effectors, including Emx2 (Theil et al., 2002), Msx2 (Willert et al., 
2002; Hussein et al., 2003), c-myc (Hu and Rosenblum, 2005), and Xtwin (Labbe et al., 
2000; Nishita et al., 2000; Letamendia et al., 2001). In some of these instances, activation 
of either pathway results in downstream activity, but the activity is significantly increased 
upon concurrent activation of both BMP and Wnt signaling. In our system, BMP and Wnt 
activity could independently activate signaling, but blocking BMP would completely 
prevent both pathways from having any effect. Furthermore, while we investigated the 
canonical BMP and Wnt signaling pathways, both systems have non-canonical pathways 
that are active in development. Wnt treatment could directly upregulate a non-canonical 
arm of the BMP signaling pathway, which would not necessarily be observed by Smad 
phosphorylation. 
 While both BMP4 and Wnt3a treatment inhibit OPC differentiation and maintain 
similar levels of A2B5+ cells, only BMP4 directly increases the number of astrocytes in 
culture. It has been shown that BMP4 may activate various pathways in cells of 
multipotent neural precursor cells, and that its effects on astrocyte induction may result 
from non-canonical pathways (Rajan et al., 2003). It is also possible that there is a lower 
threshold required to induce astrogliogenesis with canonical BMP signaling than with 
canonical Wnt signaling.  
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To find at what level BMP4 and Wnt3a may be inhibiting OPC differentiation, we 
performed Real-Time Quantitative PCR and assayed for Id2 transcript levels. Both BMP4 
and Wnt3a consistently reduced transcript levels of Mbp, complementing our IHC results, 
and also increased levels of Id2, in keeping with earlier studies (Samanta and Kessler, 
2004; Ye et al., 2009). IDs are actively involved in preventing OPC differentiation and 
OL myelination, largely by preventing nuclear localization of Olig proteins to keep the 
timing of differentiation precise and regulated (Kondo and Raff, 2000; Wang et al., 
2001a; Samanta and Kessler, 2004; Gokhan et al., 2005; Marin-Husstege et al., 2006; 
Cheng et al., 2007). We found that both Wnt3a and BMP4 reduced the number of cells 
colabeled with Olig2 in the nucleus, indicating that both factors were actively preventing 
the nuclear activity and differentiating capabilities of Olig2, possibly via ID2 induction. 
 The BMP and Wnt signaling pathways may also interact during epigenetic 
regulation of OL differentiation. Recent studies have shown that histone deacetylases 
(HDACs) compete with activated "-catenin to bind with TCF4. Bound to "-catenin, 
TCF4 acts as a transcriptional repressor of OL differentiation by upregulating such 
factors as ID2/4. Bound to HDACs, TCF acts as a transcriptional repressor, inhibiting the 
activity of ID2/4 and upregulating myelin-promoting genes such as Mbp (Marin-Husstege 
et al., 2002; Shen et al., 2005; He et al., 2007; Ye et al., 2009). Our experiments indicate 
that canonical Wnt signaling depends on the BMP pathway to inhibit OL development; it 
is possible that the TCF transcriptional complex requires inherent Smad elements or other 
downstream effectors of BMP signaling to interact with IDs or other inhibitory elements.  
 Understanding what signals regulate the timing mechanisms OL maturation will 
facilitate the development of therapies for myelin disorders. BMP upregulation has been 
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well documented in many types of CNS disease and demyelinating paradigms (See and 
Grinspan, 2009). Furthermore, several recent studies demonstrate that Wnt signaling is 
active during white matter injury as well, including aspects of axonal regeneration (Liu et 
al., 2008b; Miyashita et al., 2009), NG2+ cell proliferation (Orre et al., 2009; White et al., 
2010), and remyelination (Fancy et al., 2009). BMPs and Wnts interact in many intricate 
ways during development, and it is likely they have similar interactions during CNS 
injury and recovery. It is, therefore, important to understand how these pathways function 
independently and in relationship to one another. We have shown that the BMP pathway 
is required for canonical Wnt signaling to inhibit OPC differentiation in cell culture 
paradigms. Further experiments should investigate this interaction during remyelination 
events and CNS injury models.  
 
Experimental Methods 
Cell culture generation and treatment 
 All experiments were performed in accordance with the guidelines set forth by the 
Children’s Hospital of Philadelphia Institutional Animal Care and Use Committee. To 
generate purified OPC cultures from newborn Sprague-Dawley rats or mixed background 
mice, forebrain cells were harvested and seeded on 100mm Petri dishes in serum 
containing medium as previously described (See et al., 2004; Feigenson et al., 2009). 
After 24 hours, cultures were switched to serum free growth medium containing 
Neurobasal medium (Invitrogen) with B27 supplement (1:50 Life technologies), 10ng/ml 
basic fibroblast growth factor (R & D Systems, Minneapolis, MN), 2ng/ml platelet-
derived growth factor (R & D), and 1ng/ml neurotrophin-3 (Peprotech, Rocky Hill, NJ).  
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 Rat cultures were purified 6 to 8 days after plating by immunopanning as 
previously described (Grinspan et al., 2000a). Cells were successively seeded onto two 
sets of dishes coated with Ran-2 antibody to bind type-1 astrocytes, meningeal cells, and 
microglia. Cells were then put on dishes plated with A2B5 antibody (undiluted, 
hybridoma supernatant, ATCC, Rockville, MD, (Eisenbarth et al., 1979)) to bind the 
OPCs. When cells reached confluency, they were subcultured into polylysine-coated 
flasks, 12 mm polylysine coated coverslips, 100 mm polylysine coated Petri dishes, or 50 
mm polylysine coated Petri dishes. Cells could be passaged 3-4 times. Cultures were 
considered purified if they contained fewer than 5% astrocytes. 
 To culture mouse OPCs, cells were harvested from the forebrains of individual 
animals using the same methods and media as previously above. Individual mouse brains 
were cultured singularly until genotypes were identified by PCR of tail DNA. At this 
stage, identically genotyped cultures were combined. OPCs were purified using a gentle 
modified washdown procedure as previously described (Feigenson et al., 2009). Briefly, 
4 ml of Hanks Buffered Salt Solution without Mg+ and Ca+ was drawn into a Pasteur 
pipette, and then forcefully released on the cell monolayer at an angle. OPCs would 
detach, leaving any astrocytes adherent to the plate. OPCs and the Hanks medium were 
then drawn up into the pipette and the procedure could be repeated several times until 
enough cells were collected. The detached OPCs were collected in the Hank’s medium, 
triturated several times with the Pasteur pipette, and centrifuged at 100 g for 5 minutes. 
The pellet was then plated onto a polylysine-coated flask. Cultures were considered 
purified if they contained fewer than 5% astrocytes. 
 When OPCs were differentiated into mature OLs, growth medium was removed, 
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and cell cultures were fed with differentiation medium (DM), consisting of 50% DMEM 
and 50% Ham’s F12, with 50µg/ml transferrin, 5µg/ml putresine, 3ng/ml progesterone, 
2.5ng/ml selenium, 12.5µg/ml insulin, 0.4µg/ml T4, 0.3% glucose, 2 mM glutamine, and 
10ng/ml biotin. Cells were allowed to differentiate for 3 days to examine markers of 
immature OLs or 5 days to look at markers of mature OLs. Treatment conditions 
involved application of signaling factors to some cultures; these were 50ng/ml Wnt3a (R 
& D), 50ng/ml or 10ng/ml BMP4 (R & D), 100ng/ml Dkk-1 (R & D), and 500ng/ml 
Noggin (R & D). 
 
Immunofluorescence 
 Immunostaining and preparation of coverslip-plated cells were performed as 
previously described (Grinspan and Franceschini, 1995; Feigenson et al., 2009). 
Antibody pairs used to detect surface antibodies were anti-A2B5 with goat anti-mouse 
IgM, and anti-Galactocerebroside (RmAb GalC, undiluted, hybridoma supernatant, 
(Ranscht et al., 1982)) with goat-anti-mouse IgG3. Internal antibodies included anti-
GFAP (undiluted, hybridoma supernatant, gift of Dr. Virginia Lee, University of 
Pennsylvania) with goat anti-rat IgG, and anti-Tuj1 (1:50, Chemicon/Millipore, Billerica, 
MA) with goat anti-mouse IgG. To label Olig2 (1:500, Millipore, paired with goat anti-
rabbit IgG), cells were blocked for 10 minutes in 0.3% triton after fixing with 4% 
paraformaldehyde. To quantify apoptosis, the TUNEL assay was used as previously 
described (Grinspan et al., 1998). To label cell proliferation, cells were treated with BrdU 
and cell counts were performed as previously described (Feigenson et al., 2009). For all 
cell counts, positively labeled cells and DAPI+ cells were counted in 10 fields in each of 
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2 coverslips from each of at least 3 separate in vitro preparations, using a Leica 
DM6000B fluorescence microscope at 63x magnification. Approximately 3000 cells 
were counted per experimental data point. 
 
Western Blots 
 Rat cells were collected for Western blot analysis as previously described 
(Feigenson et al., 2009). Cells were treated with 50ng/ml BMP4 or Wnt3a and collected 
after 30 minutes, 3 hours, or 48 hours. Membranes were incubated with Phosphorylated-
Smad (1:3000, Cell Signaling) followed by horseradish peroxidase-conjugated anti-rat 
IgG secondary antibody (1:100), and imaged using ECL reagents (Amersham, 
Piscataway, NJ) and hyperfilm (Amersham). Blots were stripped and reprobed with 
GAPDH (1:2,500, Chemicon International) as a loading control for protein 
quantification. Secondary antibodies were purchased from Jackson Laboratories. 
 
Generation of mutant mice 
 The Bmpr1 double knockout mice (Bmpr1 DKO) were generated as previously 
described (Wine-Lee et al., 2004; See et al., 2007). Lines include a classical BMPR1A 
knockout (Mishina et al., 1995), a BMPR1A conditional knockout mouse (Ahn et al., 
2001; Mishina et al., 2002), a BMPR1B classical knockout mouse (gift from Dr. Karen 
Lyons, UCLA (Yi et al., 2000), and a Bcre-32 transgenic mouse. The generation of these 
mice has been previously described (Wine-Lee et al., 2004; See et al., 2007). Normal 
littermates have one functional allele of both BMPR1 receptors and do not exhibit any 
phenotype. All mice were sacrificed at P1 and OPC cultures were successfully harvested. 
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 !-Cat-Null mice were made available by crossing !-cateninfloxedexon3-6/floxedexon3-6 
mice (made available by Dr. Walter Birchmeier, Max Delbruck Centrum, Germany) with 
CNP-Cre mice, obtained from Dr. Klaus Nave, Max Planck Institute, Germany. 
Generation of !-catenin
floxedexon3-6/floxedexon3-6 
mice has been described previously 
(Huelsken et al., 2001), as has the generation of CNP-Cre mice (Lappe-Siefke et al., 
2003). Offspring were established by mating !-catenin
floxedexon3-6/floxedexon3-6
; +/+ mice with 
!-catenin
floxedexon3-6/+
; CNP/+ mice. !-catenin loss of function mice had the genotype !-
catenin
floxedexon3-6/floxedexon3-6
; CNP/+. 
 
Real Time PCR 
 OPC cultures were grown on 50 mm dishes and harvested after 6 or 48 hours post 
treatment with 50ng/ml Wnt3a or 50ng/ml BMP4, with or without 500ng/ml Noggin. 
Cells were extracted with Trizol (Molecular Research Center, Inc., Cincinnati, OH). 
Complementary DNA (cDNA) was reverse transcribed from 2-5µg RNA per treatment 
group using Superscript III First Strand Synthesis Kit for RT-PCR (Invitrogen 
#18080044) Primers used were GAPDH, MBP, and ID2 (IDT Technologies). 
Quantitative Real-Time PCR was performed using SYBR Green (Applied Biosystems) 
with the MXPro 3000P. Quantification was determined using the SYBR Green with 
Dissociation Curve method, as per the protocol of the manufacturer. Threshold values of 
fluorescence, Ct values, were calculated at least three times per cycle, and values relative 
to control conditions were used to determine treatment differences. Samples were 
measured in triplicate for each experiment.  
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Image Acquisition 
 All images were acquired using a Leica DM6000B fluorescence microscope. All 
images were mounted using Vectashield (Vector). Images were acquired with a Leica 
DFC360 Fx camera, using Leica Application Suite 2.1.0 software. Images were evenly 
enhanced using Adobe Photoshop (Adobe Systems, Mountain View, CA).  
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Figure 3.1: BMP4 and Wnt3a treatment inhibit oligodendrocyte differentiation 
Cultures of rat OPCs were grown to confluence, switched to DM, alone or with 
BMP4 or Wnt3a, and then immunostained for GalC, GFAP, and A2B5. (A) After 3 days 
 87 
in DM, many control OPCs expressed GalC and A2B5. BMP4 treated OPCs expressed 
A2B5 at comparable levels to controls conditions, but almost no cells expressed GalC (p 
< 0.01). Wnt3a treated cells had comparable levels of A2B5 expressing cells relative to 
control conditions, but a 33% reduction in the number of cells expressing GalC (p < 
0.05). (B) Control cultures had occasional labeling of GFAP+ cells, whereas 6.5 times as 
many cells in the BMP4 treatment condition were positively labeled with GFAP antibody 
(p < 0.01). Wnt3a treatment did not noticeably change the number of GFAP+ cells 
relative to control conditions. (C, D) Bar graphs quantify the number of cells labeled with 
specific antibodies, measured relative to control conditions, n = 9. Images shown were 
taken at 20x magnification. 
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Figure 3.2: Pharmacological inhibition of the BMP pathway blocks the effects of 
Wnt3a and BMP4 on oligodendrocyte differentiation 
OPC cultures were placed in DM, alone or with BMP4 or Wnt3a. Noggin or Dkk-
1 was added to similarly treated cells. (A) BMP4 treatment eliminated GalC expression 
(p < 0.01), but the addition of Noggin concurrently with BMP4 rescued this effect. 
Similarly, Wnt3a treatment reduced the number of GalC+ cells by 39% relative to 
controls (p < 0.05), but concurrent Noggin treatment rescued this effect (n = 7). (B) Dkk-
1 addition abrogated the effect of Wnt3a on the number of GalC+ cells (p < 0.01), did not 
alter the BMP4 mediated elimination of GalC expressing cells (p < 0.05, n = 3).  
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Figure 3.3: Oligodendrocyte precursor cells from mice lacking the BMP type I 
receptor do not respond to BMP4 or Wnt3a treatment 
OPC cultures were generated from Bmpr1 DKO, Bmpr1a KO, Bmpr1b KO, and 
normal mice, grown, and placed in DM. (A) After DM treatment, OPCs from all 3 types 
of mutant mice exhibited similar numbers of GalC+ cells relative to controls. BMP4 
treatment almost completely eliminated GalC+ cells in Bmpr1a KO, Bmpr1b KO, and 
normal mouse OPCs (p < 0.01), but not in OPC cultures from Bmpr1 DKO mice. 
Similarly, Wnt3a expression decreased GalC+ cells in cultures from Bmpr1a KO, 
Bmpr1b KO, and normal mice (p < 0.05), but not in those from Bmpr1 DKO mice. (B) 
OPC cultures generated from !-Cat-Null mice and normal littermates were treated with 
BMP4 or Wnt3a. BMP4 almost completely reduced the number of GalC+ cells in both 
types of cultures (p < 0.01). Wnt3a reduced the number of GalC+ cells by 57% in control 
cultures, but did this effect was not observed in the mutant cultures (p < 0.05, n = 3).  
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Figure 3.4: BMP4, but not Wnt3a, increases levels of phosphorylated Smad 1/5/8 
 Rat cells were treated with Wnt3a or BMP4, and cells were harvested for protein 
at 30 minutes and 3 hours. Phosphorylated Smad bands are visible in BMP4 treated 
conditions but not in Wnt3a or control conditions. GAPDH was used as a loading control  
(n = 3). 
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Figure 3.5: Combined treatment with BMP4 and Wnt3a does not inhibit precursor 
differentiation greater than individual treatment with BMP4 or Wnt3a 
 Rat OPCs were cultured and then placed in DM with BMP4 (50ng/ml), BMP4 
(10ng/ml), Wnt3a (50ng/ml), or Wnt3a (50ng/ml) and BMP4 (10ng/ml). BMP4 
(50ng/ml) decreased GalC+ cells by 92% relative to control conditions (p < 0.05), BMP4 
(10ng/ml) decreased OPC differentiation by 35% (p < 0.05), Wnt3a 50ng/ml decreased 
OPC differentiation by 38% (p < 0.05), and Wnt3a (50ng/ml) combined with BMP4 
(10ng/ml) decreased OPC differentiation by 44% (p < 0.05). The difference between the 
combined addition of BMP4 and Wnt3a was not significantly different from the 
application of either treatment factor individually (n = 3). 
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Figure 3.6: BMP4 and Wnt3a regulate Id2 and Mbp transcript levels 
Rat OPCs treated with Wnt3a or BMP4 and assayed for Q-PCR. (A) After 
treatment for 48 hours, levels of Mbp mRNA were calculated compared to untreated 
control OPCs. DM treated cells had a 7-fold increase in Mbp expression over that of 
untreated cells and BMP4 treated cells (p < 0.05). This expression was  also 2.33 fold 
more than that of Wnt3a treated cells (p < 0.05, n = 4). (B) After treatment for 6 hours, 
levels of Id2 mRNA were calculated compared to untreated control OPCs. BMP4 and 
Wnt3a treatment increased Id2 transcript expression 4.7 fold and 2.2 fold, respectively (p 
< 0.05, n = 7).  
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Figure 3.7: BMP4 and Wnt3a decrease levels of Olig2 
 Mouse OPCs were treated with Wnt3a or BMP4. (A) Two days after treatment, 
cells were labeled for Olig2 and A2B5. (B) Bar graphs quantify the number of Olig2+ 
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cells in each condition relative to control. BMP4 decreased the number of nuclei 
colabeled with Olig2 by 55% (p < 0.01, n = 5). Wnt3a decreased the number of nuclei 
colabeled with Olig2 by 19% (p < 0.05, n = 5). Images shown were taken at 40x 
magnification. 
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Chapter 4 
 
Discussion 
My experiments have shown that canonical Wnt signaling inhibits the maturation 
of OPCs, causing developmental delays in axonal myelination in vivo (Chapter 2). In 
contrast, I have also shown that "-catenin inactivation does not significantly regulate 
OPC maturation in vivo (Appendix). Furthermore, I have shown that the inhibitory effects 
of canonical Wnt signaling are dependent on a functioning BMP pathway (Chapter 3). 
These results add insight into signaling systems that regulate OL development and also 
identify a potential role of Wnt signaling following demyelinating injury. 
Canonical Wnt signaling is a significant factor during OL differentiation. When 
treating cultured OPCs with Wnt3a, there is a 30-40% reduction in the number of 
differentiating cells relative to control conditions. This is not accompanied by a change in 
the number of precursors, astrocytes, proliferating cells, or cells undergoing apoptosis, 
indicating that Wnt/"-catenin signaling is specifically preventing precursor cells from 
undergoing the steps required to become mature cells (Fig. 2.1A-F). These results are 
consistent with those of other recent studies. Wnt3a treatment significantly, but not 
completely, inhibited OPC differentiation in OPC cultures and in spinal cord explants 
(Shimizu et al., 2005). Similarly, transfection of cultured neural progenitor cells with a 
dominant active form of "-catenin prevented the appearance of fully mature OLs without 
affecting the number of precursors (Ye et al., 2009). 
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The mechanisms responsible for these effects could be explained through 
epigenetic regulation. OLs must exit the cell cycle to differentiate and additionally 
require myelin genes to be activated, a process mediated by HDACs (Marin-Husstege et 
al., 2002; He et al., 2007). Canonical Wnts compete with HDACs to bind TCF, 
upregulating inhibitory transcription factors, such as ID2/4, at the expense of inductive 
ones, such as Olig1/2. In this fashion, cells are maintained in precursor states while their 
proliferative capabilities are unaffected. When cells are not bound with canonical Wnts, 
TCF forms a complex with HDACs and Groucho to repress the transcription of Ids, 
permitting differentiation. Future experiments will include ID2/4 knockdown using 
transfected siRNA into OPC cultures: If Wnt3a limits OPC differentiation by restricting 
Olig proteins to the cytoplasm via ID induction, there should be no inhibitory effect of 
Wnt3a treatment on transfected OPC cultures. Similarly, transfecting OPCs with 
constitutively active Olig2 should be able to rescue differentiation in Wnt3a treated 
cultures. 
Driving constitutively active canonical Wnt signaling in OPCs in vivo replicated 
the in vitro effects (Fig 2.4-2.6). These !-Cat-CA mutant mice were viable, but displayed 
significantly fewer OLs and less myelin at early ages than normal littermates, although 
this largely recovered as mice reached adulthood (Fig 4.1). This recovery could occur 
because OLs are developing at a slower overall rate or because the importance of 
canonical Wnt signaling in OL development is reduced as the mice age. In the mutants, 
fewer overall mature OLs were produced at early time points, but normal amounts of 
myelin could be achieved if OLs undergo relatively fewer apoptosis events. In normal 
mice, more OLs are produced than are needed, and apoptosis functionally limits the final 
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number. I did not observe any changes in the number of cells labeled with TUNEL, a 
marker of apoptosis, but it is possible that this occurs at levels below detection or at time 
points that were not observed. A more likely reason is the reduced importance of 
canonical Wnt signaling: Levels of TCF are active throughout CNS development in cells 
of OL lineage, but their expression decreases after P21 (Fancy et al., 2009). This would 
lead to a scenario wherein constitutively active "-catenin limits the progression of 
precursors to mature cells through the actions of TCF, but as TCF itself is removed from 
the signaling environment those cells can begin differentiating, albeit comparatively later 
than their normal counterparts. 
These results indicate that Wnt/"-catenin signaling is sufficient to disrupt or delay 
myelination in vitro and in vivo, but what occurs when canonical Wnt signaling is 
eliminated? Blocking Wnt signaling pharmacologically prevents its effects in vitro, and 
cells show no abnormal differentiation effects, implying Wnt activity is not required for 
normal aspects of OPC differentiation (Fig 3.2). In vivo, a "-catenin a loss of function 
mutation targeted to the Cnp promoter does not alter OL cell numbers or noticeably 
impair white matter development, suggesting canonical Wnt signaling is not necessary to 
regulate OL development in vivo (Fig 3.3). Although mutants experience high embryonic 
and adult lethality, this effect is probably not a result of abnormal OL development. 
While "-catenin does factor into the multiple aspects of cellular processes outside of TCF 
signaling, including cell adhesion and migration, it is possible that other signals can 
compensate at this stage of specification (Huelsken et al., 2000). Similarly, as multiple 
signals intricately regulate OL development, removing the impeding effects of Wnt/"-
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catenin signaling may not result in ectopic or premature differentiation if other signals, 
such as Notch or the BMPs, can compensate. 
Wnt signaling, however, is upregulated during spinal cord injury, and can 
exacerbate white matter damage in demyelinating models (Fancy et al., 2009, Appendix). 
While loss of function canonical Wnt signaling may not alter embryonic development, it 
could affect remyelination. I attempted to test this using a cuprizone white matter injury 
model on both "-catenin loss of function and "-catenin gain of function mutant mice. The 
lethality rates, however, were too high to feasibly perform experiments in the loss of 
function conditions. Future experiments could involve crossing the floxed loss of 
function mutant mouse to an inducible Cre targeted to similar promoters active in cells of 
OL lineage. These mutations could then be activated in adult mice, removing from the 
equation any developmentally lethal effects. Cells lacking "-catenin may be able to 
remyelinate or differentiate into mature cells more easily if they cannot respond to 
upregulated levels of Wnt during injury. This would be observed after cuprizone 
treatment if mutant mice had fewer or less severe white matter lesions, increased numbers 
of mature OLs in lesioned areas, smaller inflammatory responses, or shorter recovery 
periods. 
My results are important in context with two other recent studies in which Wnt 
signaling was disrupted in cells of OL lineage in vivo. Fancy et al. (2009) used an Olig2-
Cre mouse line to drive constitutively active Wnt signaling in OLs and observed a 
postnatal hypomyelination effect that disappeared as animals reached adulthood, very 
similar to the phenotypes of my "-Cat-Ca mutants (Fig 2.5A-J). These animals also 
experienced significantly less remyelination following lysolecithin induced injury than 
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wild type littermates, despite similar numbers of precursors recruited to lesion sites, 
suggesting Wnt signaling impairs the differentiation of adult OPCs in vivo. The mutant 
mice had a more exacerbated white matter deficit compared to my mutant animals, 
however: They observed greater than 60% reduction in PLP+ cells at P9, compared to the 
39% reduction I observed at P7. This most likely results from the earlier activation of the 
Olig2 promoter in neural precursor cells compared to the CNP promoter, which is 
activated in OPCs, leading to more cells expressing the "-catenin mutation (Fancy et al., 
2009).  
Ye et al. (2009) also drove a constitutively activated "-catenin signaling mutation 
in cells of OL lineage using an Olig1-Cre mouse line. They observed a significant loss of 
myelin gene expression up to P14 in these mutants, but did not track them to adulthood to 
observe if the phenotype recovered. The more exaggerated hypomeylination phenotype 
compared to my mutant animals is most likely again because the Olig1 promoter is active 
before the CNP promoter in OL lineage. They also targeted the same loss of function 
"-catenin mutation that I employed to the Olig1-Cre, observing ectopic expression of 
Olig2 and PDGFR! compared to wild type littermates at E12.75, but did not examine 
later time points (Ye et al., 2009). These results are significant, because my !-Cat-Null 
mice did not have a myelin phenotype at P1, although it is possible that they had an 
embryonic phenotype that normalized by birth (Fig. Appendix 1.A-C). Future 
experiments in my lab should investigate whether there is an embryonic phenotype in 
mutant animals. These results support to the theory that endogenous Wnts prevent ectopic 
or premature differentiation of OLs in dorsal spinal cord. Ye et al. also investigated the 
phenotype of a TCF7L2 (TCF4) knockout mouse and observed a complete loss of Plp 
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and Mbp expression at E17.5, indicating proper OL development requires TCF4, the 
downstream transcriptional effector of canonical Wnt signaling. These animals died at 
P1, however, preventing further study of their adult phenotypes. Taken together, this 
recent data highlight the importance of the Wnt signaling pathway during OL 
development in vivo. 
A further goal of my dissertation was to examine whether canonical Wnt 
signaling interacts with other dorsal signals, and I specifically examined the BMP 
signaling pathway because of its similar expression patterns and effects in embryonic 
development (Chapter 3). Genetic and pharmacological inhibition of canonical BMP 
signaling not only blocked the effects of BMP4 treatment on OPC cultures, but also that 
of Wnt3a. In contrast, pharmacological and genetic inhibition of the canonical Wnt 
signaling pathway effectively blocked the effects of Wnt3a on OPC cultures, but not that 
of BMP4. This suggests that canonical Wnt signaling requires the BMP pathway to 
inhibit OPC differentiation, although it is still unknown at what levels the pathways 
interact (Fig 4.2). The most direct possibility would be if Wnt/"-catenin signaling directly 
upregulates BMP activity. Wnt3a treatment, however, does not increase levels of 
phosphorylated-Smad, the downstream effector of BMP signaling, suggesting this is not 
the manner in which the pathways cooperate (Fig. 3.5). 
The next step will therefore be to determine at what specific level the BMP and 
canonical Wnt pathways interact. There are many examples in the literature of the 
canonical Wnt and BMP pathways interacting, discussed in detail in Chapter 3. There are 
also examples of how the Wnt pathway can influence the BMP pathway without overtly 
upregulating BMP ligand or phosphorylated-Smad. These include mutual regulation of 
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downstream genes (Nishita et al., 2000; Letamendia et al., 2001), synergistic regulation 
of transcriptional complexes (Labbe et al., 2000), and maintenance of the BMP signal 
(Fuentealba et al., 2007).  
There are several different experiments that would offer significant insight into 
the relationship between the BMP and Wnt signaling pathways. Performing microarrays 
from primary OPC cultures would be the first. After treatment with BMP4, Wnt3a, or a 
combination of the two factors, the regulation of a number of genes could be analyzed. 
Instead of looking at genes important for OL differentiation, I would look at effectors of 
the signaling pathways. This assay would be able to examine multiple components of 
both pathways at early and late time points. If Wnt3a signals through the BMP pathway 
without directly upregulating ligands or phosphorylated-Smad levels, there could instead 
be increased expression of BMP target genes or decreased expression of BMP inhibitors, 
such as Smurf1, Noggin, or Chordin. If the pathways interact in a synergistic manner, 
commonly regulated genes would have increased expression when both pathways are 
activated simultaneously as opposed to individually. Additional experiments would 
include sequence analysis to determine if TCF and phosphorylated-Smad regulatory sites 
are located in close proximity on co-regulated genes involved with OL differentiation and 
myelination. Furthermore, chromatin immunoprecipitation experiments could determine 
whether Smad and TCF bind to the same target genes, and Co-IPs could be performed to 
observe whether Smad and TCF directly form regulatory complexes in cells of OL 
lineage.  
Another way to determine the specific nature of BMP and Wnt signaling would 
be to combine the pedigree of BMP signaling mutant mice with canonical Wnt signaling 
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mutant mice. If constitutively-activated canonical Wnt signaling mice are crossed with 
Bmp1r DKO mice, the abrogated BMP pathway should be able to rescue the 
developmental delay in myelination caused by dominant active "-catenin expression. 
However, the BMP mutant mice die early in embryonic development as a result of the 
Brn-32 Cre being universally expressed in the neural tube (Wine-Lee et al., 2004). For 
this experiment to be viable, the breeding scheme would have to be reassigned to an OL 
lineage specific Cre. A similar experiment that would require fewer breeding generations 
would be to cross the Wnt signaling mutant mice with a Noggin overexpressing mutant 
mouse (Chalazonitis et al., 2004). These mice overexpress Noggin in neurons, leading to 
ectopic levels in extracellular regions of the CNS. Blockade of the BMP signaling 
pathway by Noggin should rescue the myelination delays induced by "-catenin gain of 
function mutants in vivo.  
My dissertation has added to the current understanding of the role of canonical 
Wnt signaling in OL development. I have shown how Wnt signaling interacts in vitro and 
in vivo to delay OL maturation, and how this process relies on the BMP signaling 
pathway in vitro. These results indicate how Wnts are involved in cellular development, 
OL differentiation, and recovery from demyelinating events. Future studies should 
examine the biochemical relationship between canonical Wnt and BMP signaling and 
how this relationship could be manipulated when treating white matter injury.  
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Fig 4.1: Model of OL development in "-catenin mutant mice 
 The time course of spinal cord development is described for three types of mice: 
Wild type (top row), loss of function Wnt signaling mutant mice (!-Cat-Null, middle 
row), and gain of function Wnt signaling mutant mice (!-Cat-CA, bottom row). All 
mutations are activated by the Cnp promoter early in OL lineage. In wild type and !-Cat-
Null mice, OPCs develop normally in ventral spinal cord, migrating outward and 
beginning to mature towards the late embryonic stage. Extensive myelination begins at 
early postnatal stages and is completed by adulthood, at which point OLs are spread 
throughout the spinal cord, including the grey matter. In !-Cat-CA mice, OPCs are 
generated in ventral spinal cord and migrate outward in similar proportions and at similar 
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time points to their wild type littermates. Far fewer OPCs, however, differentiate into 
mature cells at late embryonic and early postnatal stages, although they are sporadically 
observed. While mutant mice still have fewer mature OLs when they reach 3 months of 
age, myelination levels are comparable to those of wild type littermates.  
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Fig 4.2: A model by which canonical Wnt and BMP signaling regulated OL 
development 
 TCF4 exists in two regulatory states, complexed with either HDAC1/2 or "-
catenin. When bound with Groucho and HDACs, TCF represses Wnt target genes, such 
as the OL differentiation inhibitors, ID2/4. These transcription factors are thus prevented 
from binding Olig1/2. In this scenario, Olig1/2 can translocate to the nucleus, promoting 
the transcription factors Nkx2.2 and Sox10, in turn allowing them to transcribe myelin 
genes, such as Mbp and Plp. Upon Wnt stimulation, HDACs and Groucho are replaced in 
the TCF4 transcription complex by "-catenin, altering its state from transcriptional 
repressor to transcriptional activator. The resulting upregulation of IDs inhibits 
differentiation by restricting Olig1/2 to the cytoplasm. BMPs, through the actions of 
phosphorylated-Smad, independently upregulate ID2/4 levels and inhibit differentiation. 
It is possible, however, that the TCF4 activating complex requires effectors of the 
endogenous BMP signaling pathway to induce transcription.   
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Appendix 
 
The role of Wnt signaling during white matter injury 
 
This section contains unpublished experiments that will be included in future publications 
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Abstract 
 Oligodendrocytes (OLs), the myelinating cells of the central nervous system 
(CNS), undergo defined stages during development before they mature into adult cells. 
Their development is regulated by a variety of intracellular and extracellular signaling 
factors that balance levels of proliferation, migration, and differentiation. I have shown 
that activation of members of one of these families of dorsal signals, Wnts, inhibits OL 
differentiation in vitro and in vivo. I next investigated what functional effects canonical 
Wnt signaling may have on OLs during development or demyelinating injury. I generated 
loss of function "-catenin signaling mutant mice and examined their development in vivo. 
Mutant animals did not have significant differences in myelination compared to normal 
littermates. I next generated loss of function and gain of function "-catenin signaling 
mutant mice and placed them on a cuprizone diet to induce demyelination of the corpus 
callosum. I found that the loss of function mutant mice had normal myelin phenotypes in 
control conditions. Preliminary results from cuprizone treated mice indicate that 
activation of Wnt/"-catenin signaling exacerbates white matter injury. Additional mutants 
will be necessary to infer significance and to determine whether blocking canonical Wnt 
signaling ameliorates the effects of injury.  
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Introduction 
 My thesis has investigated the role of canonical Wnt signaling in vitro and in vivo. 
Results indicated that Wnt/"-catenin signaling is sufficient to prevent differentiation in 
primary culture, and that it delays or prevents OL maturation in mice. Having shown that 
canonical Wnt signaling was sufficient to inhibit or delay myelination in vivo, the next 
step was to observe if it was also necessary. !-Cat-Null mice were generated as described 
in Chapter 3. These mice have a loss of function mutation driven by the Cnp promoter, 
which is active in cells of OL lineage. Mice were sacrificed in a developmental time 
course and spinal cord white matter was examined, but the number of mature OLs and 
amount of PLP expression was not significantly different from that of normal littermates. 
These findings suggest that a loss of function Wnt signaling mutation targeted to cells of 
OL lineage does not regulate their maturation in vivo.  
 While a functional requirement for canonical Wnt signaling in OL development 
was not observed, this pathway could still regulate adult cells during different processes. 
Several studies have shown evidence that dorsal signaling factors in the developing 
neural tube, such as BMP and Wnt3a, are upregulated during injury (Liu et al., 2008b; 
Fancy et al., 2009; Miyashita et al., 2009; White et al., 2010). The cuprizone model of 
inducing chronic white matter injury was employed to determine whether eliminating 
functioning "-catenin in OLs could alter injury response in vivo. At 6 weeks of age, mice 
were placed on a diet of normal food combined with 0.3% cuprizone (oxalic acid bis-
(cyclohexylidenehydrazide) for a period of 6 weeks to induce demyelinating lesions, 
according to established protocols (Armstrong et al., 2002; Murtie et al., 2005a). 
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Cuprizone is a copper chelating agent that, when ingested over a period of time, results in 
chronic loss of OLs and myelin in specific regions of the brain, notably the corpus 
callosum (Benetti et al., 2010). 
 The experimental paradigm used on normal animals produced results consistent 
with the literature. Fewer OLs were observed in corpus callosa after chronic cuprizone 
treatment, while inflammatory responses and astrogliogenesis were marked by increased 
numbers of microglia and astrocytes. Initial studies on !-Cat-CA mice showed that injury 
was exacerbated when canonical Wnt signaling is constitutively active. Both gain of 
function and loss of function mutant mice, however, did not survive the treatment periods 
with the same frequency as wild type littermates. While the results are promising, to draw 
conclusions about the role of Wnt signaling will necessitate generating more mutant 
mice. 
 
Results and Discussion 
 A loss of function "-catenin mutation was targeted to the Cnp promoter and the 
mice (!-Cat-Null) were generated according to a breeding scheme described in Chapter 
3. OPC cultures were taken from these mice at birth, grown, placed in DM, and treated 
with Wnt3a. After 3 days, the percentage of GalC+ cells in culture was similar to 
untreated conditions, indicating that canonical Wnt activity had been functionally 
eliminated (Fig. 3.3). Mice were viable at P1 and adulthood, but were not born at 
expected Mendelian ratios, indicating a high rate of prenatal lethality. Mutant mice and 
wild type littermates that survived were sacrificed at P1 and P21, cryosectioned, and 
assayed for markers of myelination. At P1, mutant mice had similar numbers of PLP+ 
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cells relative to wild type littermates (Fig. Appendix.1A, B). At P21, mutant mice had 
similar numbers of ASPA+ cells relative to wild type littermates, suggesting that 
developmental myelination was unimpaired (Fig. Appendix.1A, C).  
 While eliminating canonical Wnt signaling in different aspects of the neural 
system can have dramatic effects (McMahon et al., 1992; Ikeya et al., 1997; Brault et al., 
2001; Ye et al., 2009), it does not appear necessary for OL development when targeted to 
specified OPCs. There could be several different reasons for this effect. The lack of "-
catenin in adherens junctions can be compensated with other proteins, negating potential 
migratory or cell-to-cell adhesion consequences (Huelsken et al., 2000). Similarly, Wnts 
can have non-canonical roles in OL development that are unaffected by functional 
elimination of "-catenin. Furthermore, canonical Wnt signaling appears to influence cells 
that have exited the cell cycle and prevent their differentiation. It is possible that when 
canonical Wnt signaling is removed other dorsal inhibitory signals, such as Notch or 
BMP, can compensate in this regard.  
 These findings indicate that canonical Wnt signaling is not necessary to delay or 
inhibit myelin formation in vivo. They do not, however, preclude a cell autonomous 
effect of eliminating canonical Wnt signaling in OLs during post-developmental events. 
Wnt signaling is regulated during demyelinating injury, and it is possible that eliminating 
"-catenin can alter cellular responses to injury or recovery. Therefore, it is important to 
examine the functional role of Wnt/"-catenin signaling during white matter injury. 
 After 6 weeks of cuprizone treatment, mice were either sacrificed or placed on 
normal food for an additional 3 weeks and then sacrificed. Treated mice were compared 
to untreated control littermates. After 6 weeks of cuprizone ingestion, corpus callosa of 
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treated animals had significantly decreased numbers of ASPA+ cells (Fig. Appendix.2A-
D, G), and Olig2+ cells (Fig. Appendix.3A-D, G), and PLP expression (Fig. 
Appendix.4A-F), indicating a decrease in cells of OL lineage. These same regions had 
increased numbers of GFAP+ (Fig.Appendix.5A-D, G) and Iba1+ cells (Fig. 
Appendix.6A-D, G), indicating that reactive astrocytes and microglia were increased 
simultaneously increased. Some mice were allowed to recover after 3 weeks on normal 
food, allowing time to evaluate how much natural remyelination occurs after injury. 
These animals had increased numbers of ASPA+ cells (Fig 2E, F, G), Olig2+ cells (Fig. 
Appendix.3E, F, G), and PLP labeling (Fig. Appendix.4E, F) compared to mice from the 
6 week treatment period. The number of GFAP+ cells remained the same in the recovery 
conditions compared to animals sacrificed at 6 weeks (Fig 5E, F, G), although the 
number of Iba+ cells appeared to decrease (Fig. Appendix.6E, F, G), indicating that a 
reactive response is somewhat maintained. 
 With the cuprizone treatment paradigm employed, the next step was to observe 
whether gain of function or loss of function canonical Wnt signaling affected the injury 
response. !-Cat-CA mice and normal littermates were generated as previously described 
(Chapter 1); however, many !-Cat-CA mice did not survive the 6 week cuprizone 
treatment period. Three mutants survived the treatment period and were sacrificed, but 
the corpus callosa were almost completely degenerated and the cells could not be counted 
in two of the mutants. Preliminary results from the one mutant in which cells could be 
counted showed increased degeneration of the corpus callosum when labeling for PLP 
and Olig2 compared to normal littermates (Fig. Appendix.7A-I). !-Cat-Null mice were 
generated as previously described (Chapter 2), but 75% fewer mutants were born than 
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expected according to Mendelian ratios, and none survived the 6 week treatment period. 
These results indicate that canonical Wnt signaling may increase demyelination during 
injury, but it will require more mutant animals to draw substantial conclusions. In 
summary, cuprizone treatment induced white matter damage in selected regions of the 
corpus callosa in treated animals, with an observable recovery when mice were switched 
back to normal food. This replicates findings observed in the literature (Crawford et al., 
2009; Xie et al., 2010).  Preliminary analysis of !-Cat-CA mice treated with cuprizone 
indicate that canonical Wnt signaling impairs natural recovery of demyelination or 
intensifies the injury itself, in keeping with recent studies (Fancy et al., 2009). 
 Future experiments would involve generating sufficient numbers of Wnt signaling 
mutant mice, both gain of function and loss of function, to obtain significant results. This 
will help determine whether blocking canonical Wnt signaling in cells of OL lineage 
prevents or attenuates white matter damage during injury. If this were the case, Wnt 
signaling could be exacerbating the initial injury by decreasing survival of OLs and 
axons. !-Cat-Null mice should then have more cells labeled with markers of mature OLs 
after 6 weeks of cuprizone treatment compared to control littermates. In contrast, !-Cat-
CA mice should have significantly fewer mature OLs in the same areas. Wnt/"-catenin 
signaling could also be inhibiting the ability of precursors to proliferate in or migrate to 
the areas of injury. If this were the case, !-Cat-Null mice may have demyelinating lesions 
after initial cuprizone treatment, but more OPCs would be observed in the regions of 
interest after 6 weeks of treatment and after the 3 week recovery, whereas !-Cat-CA mice 
should have fewer. Canonical Wnt signaling could also be impairing the ability of OPCs 
to differentiate into mature, myelinating cells once they reach injured regions. If this were 
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the case, !-Cat-Null mutant mice should have similar levels of precursors in regions of 
interest compared to control littermates after cuprizone treatment, but after the 3 week 
recovery, they should have more myelinating OLs. !-Cat-CA should have fewer 
myelinating OLs at the same time points.  
 
Methods 
Animals and cuprizone treatment 
 Mutant mice were generated as described previously (!-Cat-CA, Chapter 2; !-
Cat-Null, Chapter 3). For spinal cord anatomy, viable mice were sacrificed along with 
wild type littermates at P1 and P21, perfused with 4% paraformaldehyde, and processed 
for cryosectioning and immunolabeling as previously described (Chapter 1).  
For cuprizone treatment, mice were genotyped and at 6 weeks of age transferred from a 
normal diet to one containing 0.3% cuprizone [oxalic bis(cyclohexylidenehydrazide); 
Adrich, St. Louis, MI] mixed into milled chow (Harlan Teklad). Mice were kept on the 
diet for 6 weeks and then sacrificed, perfused with 4% paraformaldehyde, and processed 
for cryosectioning as previously described (Chapter 1). A cohort of mice was removed 
from the cuprizone diet after 6 weeks, and maintained on a diet of normal chow for 3 
weeks, at which point they were sacrificed.  
 
Immunohistochemistry 
 Sections were processed at 12µm and labeled with various antibodies. To label 
sections, slides were washed in PBS and incubated in block for 20 minutes with 20% 
fetal bovine serum, 2% bovine serum albumin, and 0.1% triton in PBS, incubated 
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overnight at 4° C in primary antibody, washed in PBS, and incubated in the appropriate 
secondary antibody, diluted 1:100 in PBS.  All secondary antibodies were purchased 
from Jackson Immunoresearch Laboratories. Sections were then washed in PBS and 
mounted using mounting medium containing DAPI (Vector Laboratories). 
 Antibody pairs used to label mature OLs in vivo were anti-PLP (1:2, AA3, 
hybridoma supernatant, gift of Dr. Alex Gow, Wayne State) with goat anti-rat IgG and 
anti-ASPA (1:3000, gift of Dr James Garben, Wayne State) with goat anti-rabbit IgG. 
Anti-GFAP (1:2, hybridoma supernatant, gift of Virginia Lee, University of 
Pennsylvania) with goat anti-rat IgG was used to label astrocytes. Iba1 (1:1000, Wako) 
with goat anti-rabbit IgG was used to label microglia. To label precursors, slides were 
baked at 37 °C for 20 minutes and then autoclaved at 105 °C for 10 minutes before 
labeling with Olig2 (1:1000, Millipore) with goat anti-rabbit IgG.  
To count spinal cord cells from frozen sections at P1, digital images were taken 
from 3 cervical spinal cord sections per animal, counting PLP+ cells in 6 40x fields of 
white matter per section. Two mutant and control animals were processed from each of 2 
separate litters. For P21 animals, composite images were accumulated at 10x 
magnification to count all ASPA+ cells in the white matter of hemisections. One mutant 
and control animal was used from each of three separate litters. To quantify cells in 
corpus callosum, 4 200µm x 200µm ROIs were taken at 20x magnification for in each of 
3 sections per animal. Rostral corpus callosum was selected as regions of the corpus 
callosum anterior to the appearance of the lateral ventricles and caudal corpus callosum 
was selected as regions of the corpus callosum beginning dorsal to the first appearance of 
the hippocampus. Two litters were used for cuprizone experiments, from the first, 6 wild 
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type mice were placed on the cuprizone diet for 6 weeks with 2 fed normal diets for the 
same duration. After treatment, two mice were switched back to normal food for an 
additional 3 weeks, while the rest were sacrificed. In the second litter, 2 wild type mice 
were placed on a cuprizone diet, with one placed on normal food for the same duration. 
Three !-Cat-CA mice were placed on the cuprizone diet, with two fed normal diets for 
the same duration. 
  All images were acquired using a Leica DM6000B fluorescence microscope, 
using a Leica DFC360 Fx camera and Leica Application Suite 2.1.0 software. 
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Fig. Appendix.1: !-Cat-Null mice have normal myelin phenotypes 
  "-Cat-Null mice and wild type littermates were sacrificed at P1 and P21 and 
assayed for markers of myelination. (A) The number of PLP+ cells is similar at P1 (top 
row) in both mutant mice and wild type littermates. The number of ASPA+ OLs was 
similar at P21 (bottom row) in both mutant mice and wild type littermates. (B) 
Quantification of PLP+ cells at P1 indicated no significant difference between mutant and 
normal mice. (C) Quantification of ASPA+ cells at P21 indicated no significant 
difference between mutant and normal mice. All images were taken at 10x magnification. 
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Fig. Appendix.2: ASPA+ cells decrease after cuprizone treatment 
 Mice were fed cuprizone for a period of 6 weeks and then sacrificed or placed on 
normal chow 3 weeks before being sacrificed. Immunolabeling of ASPA+ cells in 
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anterior corpus callosa (A) and posterior corpus callosa (B) of wild type mice fed normal 
diets. ASPA+ cells were decreased by 55% (p < 0.05) in cuprizone treated mice in 
anterior corpus callosa (C) and by 67% (p < 0.05) in posterior corpus callosa (D). Mice 
allowed to recover for three weeks had similar numbers of ASPA+ cells in both anterior 
(E) and posterior corpus callosa (F) compared to untreated controls. (G) Quantification of 
ASPA+ cells in anterior and posterior corpus callosa. Controls n = 2; Cuprizone 6 weeks, 
n = 4; Three week recovery, n = 2. All images were taken at 10x magnification.  
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Fig Appendix.3: Olig2+ cells decrease after cuprizone treatment 
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 Mice were fed cuprizone for a period of 6 weeks and then sacrificed or placed on 
normal chow 3 weeks before being sacrificed. Immunolabeling of Olig2+ cells in anterior 
(A) and posterior corpus callosa (B) of wild type mice fed normal diets. In cuprizone 
treated animals, Olig2+ cells were decreased in both anterior (C) and posterior corpus 
callosa (D), with 28% fewer Olig2+ cells in anterior corpus callosa (p < 0.01) and 35% 
fewer in posterior corpus callosa (p < 0.01). In mice allowed to recover following 3 
weeks of cuprizone treatment, anterior corpus callosa had similar numbers of Olig2+ 
cells compared to treatment conditions (E), although these levels were not significantly 
different from non treatment control animals. In posterior corpus callosa (F), the number 
of Olig2+ cells appeared to return to untreated levels (p < 0.05). (G) Quantification of 
Olig2+ cells in anterior and posterior corpus callosa. Controls, n = 2; Cuprizone 6 weeks, 
n = 4; Three week recovery, n = 3. All images were taken at 10x magnification. 
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Fig Appendix.4: PLP labeling decreases in cuprizone treated mice 
 Mice were fed cuprizone for a period of 6 weeks and then sacrificed or placed on 
normal chow 3 weeks before being sacrificed. Immunolabeling of PLP+ cells in anterior 
(A) and posterior corpus callosa (B) of wild type mice fed normal diets. In mice treated 
with cuprizone for 6 weeks, PLP expression in anterior corpus callosa (C) appeared 
similar to untreated controls, while posterior corpus callosa (D) appeared to have less 
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PLP expression. Mice that were allowed to recover for 3 weeks appeared to recover PLP 
expression in both anterior (E) and posterior (F) corpus callosa. Images were taken at 10x 
magnification. 
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Fig. Appendix.5: GFAP+ cells increase after cuprizone treatment and are 
maintained through recovery 
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 Mice were fed cuprizone for a period of 6 weeks and then sacrificed or placed on 
normal chow 3 weeks before being sacrificed. Immunolabeling of GFAP+ cells in 
anterior (A) and posterior corpus callosa (B) of wild type mice fed normal diets. GFAP+ 
cells were increased in both anterior (C) and posterior corpus callosa (D), with a 2.25 fold 
increase in GFAP labeled cells in cuprizone treated animals when compared to untreated 
control animals in posterior corpus callosa (p < 0.01). The difference in anterior corpus 
callosa trended towards significance. GFAP+ cells remained higher in the corpus callosa 
of mice allowed to recover for 3 weeks after cuprizone treatment in anterior corpus 
callosum (E) and posterior corpus callosum, in which condition the effect was significant 
(p < 0.05). (G) Quantification of GFAP counted cells in anterior and posterior corpus 
callosa. Controls, n = 2; Cuprizone 6 weeks, n = 4; Three week recovery, n = 3. Images 
are taken at 10x magnification. 
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Fig. Appendix.6: Iba+ cells increase after cuprizone treatment, but return to control 
levels after recovery 
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 Mice were fed cuprizone for a period of 6 weeks and then sacrificed or placed on 
normal chow 3 weeks before being sacrificed. Immunolabeling of Iba+ cells, representing 
microglia, in the anterior (A) and posterior (B) corpus callosa of wild type mice fed 
normal diets. In the corpus callosa of mice treated with cuprizone for 6 weeks, Iba+ cells 
were increased 1.7 fold (p < 0.05) in anterior corpus callosa (C) and 2 fold (p < 0.05) in 
posterior corpus callosa (D). Mice allowed to recover for 3 weeks post cuprizone 
treatment showed similar numbers of Iba+ cells compared to control littermates in both 
anterior (E) and posterior (F) corpus callosum (p < 0.05). (G) Quantification of the 
number of Iba+ cells. Untreated controls, n = 2; Cuprizone 6 weeks, n = 3; Three week 
recovery, n = 3. Images were taken at 10x magnification.  
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Fig. Appendix.7: !-Cat-CA mice have increased white matter damage after 
cuprizone treatment relative to wild type littermates 
 !-Cat-CA mice and wild type littermates were fed cuprizone for a period of 6 
weeks and then sacrificed or allowed to recover for 3 weeks before being sacrificed. (A-
C) Rostral corpus callosum of a wild type mouse fed a normal diet and labeled for PLP, 
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Olig2, and DAPI. (D-F) Rostral corpus callosum of a wild type mouse treated with 
cuprizone for 6 weeks; a loss of PLP and Olig2 can be observed. (G-I) Rostral corpus 
callosum of a !-Cat-CA mouse fed a normal diet; myelination appears similar to that of 
wild type mice. (J-L) Rostral corpus callosum of one !-Cat-CA mice treated with 
cuprizone for 6 weeks; extensive loss of PLP and Olig2 can be observed relative to its 
control littermate. All images were taken at 10x magnification. 
 
 
 
 
 
 
 
 129 
References 
 
Ahn K, Mishina Y, Hanks MC, Behringer RR, Crenshaw EB, 3rd (2001) BMPR-IA 
signaling is required for the formation of the apical ectodermal ridge and dorsal-
ventral patterning of the limb. Development 128:4449-4461. 
Ahn SM, Byun K, Kim D, Lee K, Yoo JS, Kim SU, Jho EH, Simpson RJ, Lee B (2008) 
Olig2-induced neural stem cell differentiation involves downregulation of Wnt 
signaling and induction of Dickkopf-1 expression. PLoS One 3:e3917. 
Alvarez-Medina R, Cayuso J, Okubo T, Takada S, Marti E (2008) Wnt canonical 
pathway restricts graded Shh/Gli patterning activity through the regulation of Gli3 
expression. Development 135:237-247. 
Ara J, See J, Mamontov P, Hahn A, Bannerman P, Pleasure D, Grinspan JB (2008) Bone 
morphogenetic proteins 4, 6, and 7 are up-regulated in mouse spinal cord during 
experimental autoimmune encephalomyelitis. J Neurosci Res 86:125-135. 
Arce L, Yokoyama NN, Waterman ML (2006) Diversity of LEF/TCF action in 
development and disease. Oncogene 25:7492-7504. 
Armstrong RC, Le TQ, Frost EE, Borke RC, Vana AC (2002) Absence of fibroblast 
growth factor 2 promotes oligodendroglial repopulation of demyelinated white 
matter. J Neurosci 22:8574-8585. 
Arroyo EJ, Bermingham JR, Jr., Rosenfeld MG, Scherer SS (1998) Promyelinating 
Schwann cells express Tst-1/SCIP/Oct-6. J Neurosci 18:7891-7902. 
Bafico A, Liu G, Yaniv A, Gazit A, Aaronson SA (2001) Novel mechanism of Wnt 
signalling inhibition mediated by Dickkopf-1 interaction with LRP6/Arrow. Nat 
Cell Biol 3:683-686. 
Barley K, Dracheva S, Byne W (2009) Subcortical oligodendrocyte- and astrocyte-
associated gene expression in subjects with schizophrenia, major depression and 
bipolar disorder. Schizophr Res 112:54-64. 
Barres BA, Raff MC (1994) Control of oligodendrocyte number in the developing rat 
optic nerve. Neuron 12:935-942. 
Barres BA, Lazar MA, Raff MC (1994) A novel role for thyroid hormone, 
glucocorticoids and retinoic acid in timing oligodendrocyte development. 
Development 120:1097-1108. 
Barres BA, Raff MC, Gaese F, Bartke I, Dechant G, Barde YA (1994a) A crucial role for 
neurotrophin-3 in oligodendrocyte development. Nature 367:371-375. 
Barres BA, Hart I, Coles HSR, Burne JF, Voyvodic JT, Richardson WD, Raff MC 
(1992a) Cell death and the control of cell survival in the oligodendrocyte lineage. 
Cell 70:31-47. 
Bastida MF, Sheth R, Ros MA (2009) A BMP-Shh negative-feedback loop restricts Shh 
expression during limb development. Development 136:3779-3789. 
Battiste J, Helms AW, Kim EJ, Savage TK, Lagace DC, Mandyam CD, Eisch AJ, 
Miyoshi G, Johnson JE (2007) Ascl1 defines sequentially generated lineage-
restricted neuronal and oligodendrocyte precursor cells in the spinal cord. 
Development 134:285-293. 
Behrens J, von Kries JP, Kuhl M, Bruhn L, Wedlich D, Grosschedl R, Birchmeier W 
(1996) Functional interaction of beta-catenin with the transcription factor LEF-1. 
Nature 382:638-642. 
 130 
Benetti F, Ventura M, Salmini B, Ceola S, Carbonera D, Mammi S, Zitolo A, D'Angelo 
P, Urso E, Maffia M, Salvato B, Spisni E (2010) Cuprizone neurotoxicity, copper 
deficiency and neurodegeneration. Neurotoxicology 31:509-517. 
Billon N, Jolicoeur C, Tokumoto Y, Vennstrom B, Raff M (2002) Normal timing of 
oligodendrocyte development depends on thyroid hormone receptor alpha 1 
(TRalpha1). Embo J 21:6452-6460. 
Bonafede A, Kohler T, Rodriguez-Niedenfuhr M, Brand-Saberi B (2006) BMPs restrict 
the position of premuscle masses in the limb buds by influencing Tcf4 expression. 
Dev Biol 299:330-344. 
Bonner J, Gribble SL, Veien ES, Nikolaus OB, Weidinger G, Dorsky RI (2008) 
Proliferation and patterning are mediated independently in the dorsal spinal cord 
downstream of canonical Wnt signaling. Dev Biol 313:398-407. 
Brault V, Moore R, Kutsch S, Ishibashi M, Rowitch DH, McMahon AP, Sommer L, 
Boussadia O, Kemler R (2001) Inactivation of the beta-catenin gene by Wnt1-
Cre-mediated deletion results in dramatic brain malformation and failure of 
craniofacial development. Development 128:1253-1264. 
Braun MM, Etheridge A, Bernard A, Robertson CP, Roelink H (2003) Wnt signaling is 
required at distinct stages of development for the induction of the posterior 
forebrain. Development 130:5579-5587. 
Bunge RP (1968) Glial cells and the central myelin sheath. Physiol Rev 48:197-251. 
Burstyn-Cohen T, Stanleigh J, Sela-Donenfeld D, Kalcheim C (2004) Canonical Wnt 
activity regulates trunk neural crest delamination linking BMP/noggin signaling 
with G1/S transition. Development 131:5327-5339. 
Cai J, Qi Y, Hu X, Tan M, Liu Z, Zhang J, Li Q, Sander M, Qiu M (2005) Generation of 
oligodendrocyte precursor cells from mouse dorsal spinal cord independent of 
Nkx6 regulation and Shh signaling. Neuron 45:41-53. 
Cameron-Curry P, LeDouarin NM (1995) Oligodendrocyte precursors originate from 
both the dorsal and ventral parts of the spinal cord. Neuron 15:1299-1310. 
Cate HS, Sabo JK, Merlo D, Kemper D, Aumann TD, Robinson J, Merson TD, Emery B, 
Perreau VM, Kilpatrick TJ (2010) Modulation of bone morphogenic protein 
signalling alters numbers of astrocytes and oligodendroglia in the subventricular 
zone during cuprizone-induced demyelination. J Neurochem. 
Cavallo RA, Cox RT, Moline MM, Roose J, Polevoy GA, Clevers H, Peifer M, Bejsovec 
A (1998) Drosophila Tcf and Groucho interact to repress Wingless signalling 
activity. Nature 395:604-608. 
Chalazonitis A, D'Autreaux F, Guha U, Pham TD, Faure C, Chen JJ, Roman D, Kan L, 
Rothman TP, Kessler JA, Gershon MD (2004) Bone morphogenetic protein-2 and 
-4 limit the number of enteric neurons but promote development of a TrkC-
expressing neurotrophin-3-dependent subset. J Neurosci 24:4266-4282. 
Chan JR, Watkins TA, Cosgaya JM, Zhang C, Chen L, Reichardt LF, Shooter EM, 
Barres BA (2004) NGF controls axonal receptivity to myelination by Schwann 
cells or oligodendrocytes. Neuron 43:183-191. 
Chari DM, Blakemore WF (2002) Efficient recolonisation of progenitor-depleted areas of 
the CNS by adult oligodendrocyte progenitor cells. Glia 37:307-313. 
 131 
Cheng X, Wang Y, He Q, Qiu M, Whittemore SR, Cao Q (2007) Bone morphogenetic 
protein signaling and olig1/2 interact to regulate the differentiation and maturation 
of adult oligodendrocyte precursor cells. Stem Cells 25:3204-3214. 
Chenn A, Walsh CA (2002) Regulation of cerebral cortical size by control of cell cycle 
exit in neural precursors. Science 297:365-369. 
Chenn A, Walsh CA (2003) Increased neuronal production, enlarged forebrains and 
cytoarchitectural distortions in beta-catenin overexpressing transgenic mice. 
Cereb Cortex 13:599-606. 
Chesnutt C, Burrus LW, Brown AM, Niswander L (2004) Coordinate regulation of 
neural tube patterning and proliferation by TGFbeta and WNT activity. Dev Biol 
274:334-347. 
Choi SC, Han JK (2002) Xenopus Cdc42 regulates convergent extension movements 
during gastrulation through Wnt/Ca2+ signaling pathway. Dev Biol 244:342-357. 
Colognato H, Baron, W., Avellana-Adalid, V., Relvas, J.B., Baron Von-Evercooren, A., 
Georges-Labouesse, E.,  Ffrench-Constant, C. (2002) CNS integrins switch 
growth factor signalling to promote target-dependent survival. Nature Cell- 
Biology. 
Coyle-Rink J, Del Valle L, Sweet T, Khalili K, Amini S (2002) Developmental 
expression of Wnt signaling factors in mouse brain. Cancer Biol Ther 1:640-645. 
Crawford DK, Mangiardi M, Xia X, Lopez-Valdes HE, Tiwari-Woodruff SK (2009) 
Functional recovery of callosal axons following demyelination: a critical window. 
Neuroscience 164:1407-1421. 
Crease DJ, Dyson S, Gurdon JB (1998) Cooperation between the activin and Wnt 
pathways in the spatial control of organizer gene expression. Proc Natl Acad Sci 
U S A 95:4398-4403. 
Davidson G, Wu W, Shen J, Bilic J, Fenger U, Stannek P, Glinka A, Niehrs C (2005) 
Casein kinase 1 gamma couples Wnt receptor activation to cytoplasmic signal 
transduction. Nature 438:867-872. 
Djiane A, Riou J, Umbhauer M, Boucaut J, Shi D (2000) Role of frizzled 7 in the 
regulation of convergent extension movements during gastrulation in Xenopus 
laevis. Development 127:3091-3100. 
Dorsky RI, Moon RT, Raible DW (1998) Control of neural crest cell fate by the Wnt 
signalling pathway. Nature 396:370-373. 
Echelard Y, Epstein DJ, St-Jacques B, Shen L, Mohler J, McMahon JA, McMahon AP 
(1993) Sonic hedgehog, a member of a family of putative signaling molecules, is 
implicated in the regulation of CNS polarity. Cell 75:1417-1430. 
Edgar JM, Garbern J (2004) The myelinated axon is dependent on the myelinating cell 
for support and maintenance: molecules involved. J Neurosci Res 76:593-598. 
Edgar JM, McLaughlin M, Werner HB, McCulloch MC, Barrie JA, Brown A, Faichney 
AB, Snaidero N, Nave KA, Griffiths IR (2009) Early ultrastructural defects of 
axons and axon-glia junctions in mice lacking expression of Cnp1. Glia. 
Eisenbarth G, Walsh F, Nirenberg M (1979) Monoclonal antibody to a plasma membrane 
antigen of neurons. Proc Nat'l Acad Sci USA 76:4913-4917. 
Fancy SP, Baranzini SE, Zhao C, Yuk DI, Irvine KA, Kaing S, Sanai N, Franklin RJ, 
Rowitch DH (2009) Dysregulation of the Wnt pathway inhibits timely 
myelination and remyelination in the mammalian CNS. Genes Dev 23:1571-1585. 
 132 
Feigenson K, Reid M, See J, Crenshaw EB, 3rd, Grinspan JB (2009) Wnt signaling is 
sufficient to perturb oligodendrocyte maturation. Mol Cell Neurosci 42:255-265. 
Finzsch M, Stolt CC, Lommes P, Wegner M (2008) Sox9 and Sox10 influence survival 
and migration of oligodendrocyte precursors in the spinal cord by regulating 
PDGF receptor alpha expression. Development 135:637-646. 
Fu H, Cai J, Clevers H, Fast E, Gray S, Greenberg R, Jain MK, Ma Q, Qiu M, Rowitch 
DH, Taylor CM, Stiles CD (2009) A genome-wide screen for spatially restricted 
expression patterns identifies transcription factors that regulate glial development. 
J Neurosci 29:11399-11408. 
Fuentealba LC, Eivers E, Ikeda A, Hurtado C, Kuroda H, Pera EM, De Robertis EM 
(2007) Integrating patterning signals: Wnt/GSK3 regulates the duration of the 
BMP/Smad1 signal. Cell 131:980-993. 
Genoud S, Lappe-Siefke, C., Goebbels, S., Radtke, F., Aguet, M., Scherer, S. S., Suter, 
U., Nave, K-A., Mantei, N. (2002) Notch1 control of oligodendrocyte 
differentiation in the spinal cord. J Cell Biol 158:709-718. 
Gokhan S, Marin-Husstege M, Yung SY, Fontanez D, Casaccia-Bonnefil P, Mehler MF 
(2005) Combinatorial profiles of oligodendrocyte-selective classes of 
transcriptional regulators differentially modulate myelin basic protein gene 
expression. J Neurosci 25:8311-8321. 
Gomes WA, Mehler MF, Kessler JA (2003) Transgenic overexpression of BMP4 
increases astroglial and decreases oligodendroglial lineage commitment. 
Developmental Biology 255:164-177. 
Gomez-Skarmeta J, de La Calle-Mustienes E, Modolell J (2001) The Wnt-activated 
Xiro1 gene encodes a repressor that is essential for neural development and 
downregulates Bmp4. Development 128:551-560. 
Grinspan J (2002) Cells and signaling in oligodendrocyte development. J Neuropathol 
Exp Neurol 61:297-306. 
Grinspan JB, Franceschini B (1995) PDGF is a survival factor for PSA-NCAM+ 
oligodendroglial pre-progenitor cells. J Neurosci Res 41:540-551. 
Grinspan JB, Coulalglou M, Beesley JS, Carpio DF, Scherer SS (1998) Maturation-
dependent apoptotic cell death of oligodendrocytes in myelin-deficient rats. J 
Neurosci Res 54:623-634. 
Grinspan JB, Edell E, Carpio DF, Beesley JS, Lavy L, Pleasure D, Golden JA (2000a) 
Stage-specific effects of bone morphogenetic protein on the oligodendrocyte 
lineage. J Neurobiol 43:1-17. 
Grinspan JB, Edell E, Carpio DF, Beesley JS, Lavy L, Pleasure D, Golden JA (2000b) 
Stage-specific effects of bone morphogenetic proteins on the oligodendrocyte 
lineage. J Neurobiol 43:1-17. 
Gross RE, Mehler MF, Mabie PC, Zang Z, Santschi L, Kessler JA (1996) Bone 
Morphogenic proteins promote astroglial lineage commitment by mammalian 
subventricular zone progenitor cells. Neuron 17:595-606. 
Gulacsi AA, Anderson SA (2008) Beta-catenin-mediated Wnt signaling regulates 
neurogenesis in the ventral telencephalon. Nat Neurosci 11:1383-1391. 
Guo X, Wang XF (2009) Signaling cross-talk between TGF-beta/BMP and other 
pathways. Cell Res 19:71-88. 
 133 
Habas R, Kato Y, He X (2001) Wnt/Frizzled activation of Rho regulates vertebrate 
gastrulation and requires a novel Formin homology protein Daam1. Cell 107:843-
854. 
Habas R, Dawid IB, He X (2003) Coactivation of Rac and Rho by Wnt/Frizzled signaling 
is required for vertebrate gastrulation. Genes Dev 17:295-309. 
He XC, Zhang J, Tong WG, Tawfik O, Ross J, Scoville DH, Tian Q, Zeng X, He X, 
Wiedemann LM, Mishina Y, Li L (2004) BMP signaling inhibits intestinal stem 
cell self-renewal through suppression of Wnt-beta-catenin signaling. Nat Genet 
36:1117-1121. 
He Y, Dupree J, Wang J, Sandoval J, Li J, Liu H, Shi Y, Nave KA, Casaccia-Bonnefil P 
(2007) The transcription factor Yin Yang 1 is essential for oligodendrocyte 
progenitor differentiation. Neuron 55:217-230. 
Herbert MR, Ziegler DA, Deutsch CK, O'Brien LM, Lange N, Bakardjiev A, Hodgson J, 
Adrien KT, Steele S, Makris N, Kennedy D, Harris GJ, Caviness VS, Jr. (2003) 
Dissociations of cerebral cortex, subcortical and cerebral white matter volumes in 
autistic boys. Brain 126:1182-1192. 
Hershfield JR, Madhavarao CN, Moffett JR, Benjamins JA, Garbern JY, Namboodiri A 
(2006) Aspartoacylase is a regulated nuclear-cytoplasmic enzyme. Faseb J 
20:2139-2141. 
Hill TP, Taketo MM, Birchmeier W, Hartmann C (2006) Multiple roles of mesenchymal 
beta-catenin during murine limb patterning. Development 133:1219-1229. 
Hirabayashi Y, Itoh Y, Tabata H, Nakajima K, Akiyama T, Masuyama N, Gotoh Y 
(2004) The Wnt/beta-catenin pathway directs neuronal differentiation of cortical 
neural precursor cells. Development 131:2791-2801. 
Hoffmans R, Stadeli R, Basler K (2005) Pygopus and legless provide essential 
transcriptional coactivator functions to armadillo/beta-catenin. Curr Biol 15:1207-
1211. 
Hollnagel A, Oehlmann V, Heymer J, Ruther U, Nordheim A (1999) Id genes are direct 
targets of bone morphogenetic protein induction in embryonic stem cells. J Biol 
Chem 274:19838-19845. 
Hollyday M, McMahon JA, McMahon AP (1995) Wnt expression patterns in chick 
embryo nervous system. Mech Dev 52:9-25. 
Honda T, Yamamoto H, Ishii A, Inui M (2010) PDZRN3 negatively regulates BMP-2-
induced osteoblast differentiation through inhibition of Wnt signaling. Mol Biol 
Cell 21:3269-3277. 
Hu MC, Rosenblum ND (2005) Smad1, beta-catenin and Tcf4 associate in a molecular 
complex with the Myc promoter in dysplastic renal tissue and cooperate to control 
Myc transcription. Development 132:215-225. 
Huelsken J, Vogel R, Erdmann B, Cotsarelis G, Birchmeier W (2001) beta-Catenin 
controls hair follicle morphogenesis and stem cell differentiation in the skin. Cell 
105:533-545. 
Huelsken J, Vogel R, Brinkmann V, Erdmann B, Birchmeier C, Birchmeier W (2000) 
Requirement for beta-catenin in anterior-posterior axis formation in mice. J Cell 
Biol 148:567-578. 
 134 
Hussein SM, Duff EK, Sirard C (2003) Smad4 and beta-catenin co-activators 
functionally interact with lymphoid-enhancing factor to regulate graded 
expression of Msx2. J Biol Chem 278:48805-48814. 
Ibarrola N, Mayer-Proschel M, Rodriquez-Pena A, Noble M (1996) Evidence for the 
existence of at least two timing mechanisms that contribute to oligodendrocyte 
generation in vitro. Developmental Biology 180:1-21. 
Ikeya M, Lee SM, Johnson JE, McMahon AP, Takada S (1997) Wnt signalling required 
for expansion of neural crest and CNS progenitors. Nature 389:966-970. 
Ille F, Atanasoski S, Falk S, Ittner LM, Marki D, Buchmann-Moller S, Wurdak H, Suter 
U, Taketo MM, Sommer L (2007) Wnt/BMP signal integration regulates the 
balance between proliferation and differentiation of neuroepithelial cells in the 
dorsal spinal cord. Dev Biol 304:394-408. 
Islam MS, Tatsumi K, Okuda H, Shiosaka S, Wanaka A (2009) Olig2-expressing 
progenitor cells preferentially differentiate into oligodendrocytes in cuprizone-
induced demyelinated lesions. Neurochem Int 54:192-198. 
Itasaki N, Hoppler S (2010) Crosstalk between Wnt and bone morphogenic protein 
signaling: a turbulent relationship. Dev Dyn 239:16-33. 
Itoh K, Krupnik VE, Sokol SY (1998) Axis determination in Xenopus involves 
biochemical interactions of axin, glycogen synthase kinase 3 and beta-catenin. 
Curr Biol 8:591-594. 
Jablonska B, Aguirre A, Raymond M, Szabo G, Kitabatake Y, Sailor KA, Ming GL, 
Song H, Gallo V (2010) Chordin-induced lineage plasticity of adult SVZ 
neuroblasts after demyelination. Nat Neurosci 13:541-550. 
Joksimovic M, Yun BA, Kittappa R, Anderegg AM, Chang WW, Taketo MM, McKay 
RD, Awatramani RB (2009) Wnt antagonism of Shh facilitates midbrain floor 
plate neurogenesis. Nat Neurosci 12:125-131. 
Kalani MY, Cheshier SH, Cord BJ, Bababeygy SR, Vogel H, Weissman IL, Palmer TD, 
Nusse R (2008) Wnt-mediated self-renewal of neural stem/progenitor cells. Proc 
Natl Acad Sci U S A 105:16970-16975. 
Kamiya N, Ye L, Kobayashi T, Mochida Y, Yamauchi M, Kronenberg HM, Feng JQ, 
Mishina Y (2008a) BMP signaling negatively regulates bone mass through 
sclerostin by inhibiting the canonical Wnt pathway. Development 135:3801-3811. 
Kamiya N, Ye L, Kobayashi T, Lucas DJ, Mochida Y, Yamauchi M, Kronenberg HM, 
Feng JQ, Mishina Y (2008b) Disruption of BMP signaling in osteoblasts through 
type IA receptor (BMPRIA) increases bone mass. J Bone Miner Res 23:2007-
2017. 
Karim R, Tse G, Putti T, Scolyer R, Lee S (2004) The significance of the Wnt pathway in 
the pathology of human cancers. Pathology 36:120-128. 
Kasai M, Satoh K, Akiyama T (2005) Wnt signaling regulates the sequential onset of 
neurogenesis and gliogenesis via induction of BMPs. Genes Cells 10:777-783. 
Kessaris N, Pringle N, Richardson WD (2001) Ventral neurogenesis and the neuron-glial 
switch. Neuron 31:677-680. 
Kessaris N, Fogarty M, Iannarelli P, Grist M, Wegner M, Richardson WD (2006) 
Competing waves of oligodendrocytes in the forebrain and postnatal elimination 
of an embryonic lineage. Nat Neurosci 9:173-179. 
 135 
Kim HJ, Sugimori M, Nakafuku M, Svendsen CN (2007) Control of neurogenesis and 
tyrosine hydroxylase expression in neural progenitor cells through bHLH proteins 
and Nurr1. Exp Neurol 203:394-405. 
Kim S, Kim SH, Kim H, Chung AY, Cha YI, Kim CH, Huh TL, Park HC (2008) Frizzled 
8a function is required for oligodendrocyte development in the zebrafish spinal 
cord. Dev Dyn 237:3324-3331. 
Kishida M, Koyama S, Kishida S, Matsubara K, Nakashima S, Higano K, Takada R, 
Takada S, Kikuchi A (1999) Axin prevents Wnt-3a-induced accumulation of beta-
catenin. Oncogene 18:979-985. 
Kondo T, Raff M (2000) The Id4 HLH protein and the timing of oligodendrocyte 
differentiation. Embo J 19:1998-2007. 
Kramps T, Peter O, Brunner E, Nellen D, Froesch B, Chatterjee S, Murone M, Zullig S, 
Basler K (2002) Wnt/wingless signaling requires BCL9/legless-mediated 
recruitment of pygopus to the nuclear beta-catenin-TCF complex. Cell 109:47-60. 
Kremer D, Heinen A, Jadasz J, Gottle P, Zimmermann K, Zickler P, Jander S, Hartung 
HP, Kury P (2009) p57kip2 is dynamically regulated in experimental autoimmune 
encephalomyelitis and interferes with oligodendroglial maturation. Proc Natl 
Acad Sci U S A 106:9087-9092. 
Kretzschmar M, Doody J, Massague J (1997) Opposing BMP and EGF signalling 
pathways converge on the TGF-beta family mediator Smad1. Nature 389:618-
622. 
Kuhl M, Sheldahl LC, Malbon CC, Moon RT (2000) Ca(2+)/calmodulin-dependent 
protein kinase II is stimulated by Wnt and Frizzled homologs and promotes 
ventral cell fates in Xenopus. J Biol Chem 275:12701-12711. 
Kunke D, Bryja V, Mygland L, Arenas E, Krauss S (2009) Inhibition of canonical Wnt 
signaling promotes gliogenesis in P0-NSCs. Biochem Biophys Res Commun 
386:628-633. 
Kuspert M, Hammer A, Bosl MR, Wegner M (2010) Olig2 regulates Sox10 expression in 
oligodendrocyte precursors through an evolutionary conserved distal enhancer. 
Nucleic Acids Res. 
Labbe E, Letamendia A, Attisano L (2000) Association of Smads with lymphoid 
enhancer binding factor 1/T cell-specific factor mediates cooperative signaling by 
the transforming growth factor-beta and wnt pathways. Proc Natl Acad Sci U S A 
97:8358-8363. 
Lajtha A, Toth J, Fujimoto K, Agrawal HC (1977) Turnover of myelin proteins in mouse 
brain in vivo. Biochem J 164:323-329. 
Langseth AJ, Munji RN, Choe Y, Huynh T, Pozniak CD, Pleasure SJ (2010) Wnts 
influence the timing and efficiency of oligodendrocyte precursor cell generation 
in the telencephalon. J Neurosci 30:13367-13372. 
Lappe-Siefke C, Goebbels S, Gravel M, Nicksch E, Lee J, Braun PE, Griffiths IR, Nave 
KA (2003) Disruption of Cnp1 uncouples oligodendroglial functions in axonal 
support and myelination.[see comment]. Nature Genetics 33:366-374. 
Lee X, Yang Z, Shao Z, Rosenberg SS, Levesque M, Pepinsky RB, Qiu M, Miller RH, 
Chan JR, Mi S (2007) NGF regulates the expression of axonal LINGO-1 to inhibit 
oligodendrocyte differentiation and myelination. J Neurosci 27:220-225. 
 136 
Lei Q, Jeong Y, Misra K, Li S, Zelman AK, Epstein DJ, Matise MP (2006) Wnt signaling 
inhibitors regulate the transcriptional response to morphogenetic Shh-Gli 
signaling in the neural tube. Dev Cell 11:325-337. 
Lemke G (1996) Neuregulins in Development. Molecular and Cellular Neuroscience 
7:247-262. 
Letamendia A, Labbe E, Attisano L (2001) Transcriptional regulation by Smads: 
crosstalk between the TGF-beta and Wnt pathways. J Bone Joint Surg Am 83-A 
Suppl 1:S31-39. 
Li H, Lu Y, Smith HK, Richardson WD (2007) Olig1 and Sox10 interact synergistically 
to drive myelin basic protein transcription in oligodendrocytes. J Neurosci 
27:14375-14382. 
Liem KF, Jr., Jessell TM, Briscoe J (2000) Regulation of the neural patterning activity of 
sonic hedgehog by secreted BMP inhibitors expressed by notochord and somites. 
Development 127:4855-4866. 
Liem KF, Jr., Tremml G, Roelink H, Jessell TM (1995) Dorsal differentiation of neural 
plate cells induced by BMP-mediated signals from epidermal ectoderm. Cell 
82:969-979. 
Ligon KL, Fancy SP, Franklin RJ, Rowitch DH (2006) Olig gene function in CNS 
development and disease. Glia 54:1-10. 
Liu A, Li J, Marin-Husstege M, Kageyama R, Fan Y, Gelinas C, Casaccia-Bonnefil P 
(2006) A molecular insight of Hes5-dependent inhibition of myelin gene 
expression: old partners and new players. Embo J 25:4833-4842. 
Liu C, Li Y, Semenov M, Han C, Baeg GH, Tan Y, Zhang Z, Lin X, He X (2002) 
Control of beta-catenin phosphorylation/degradation by a dual-kinase mechanism. 
Cell 108:837-847. 
Liu F, Chu EY, Watt B, Zhang Y, Gallant NM, Andl T, Yang SH, Lu MM, Piccolo S, 
Schmidt-Ullrich R, Taketo MM, Morrisey EE, Atit R, Dlugosz AA, Millar SE 
(2008a) Wnt/beta-catenin signaling directs multiple stages of tooth 
morphogenesis. Dev Biol 313:210-224. 
Liu Y, Wang X, Lu CC, Kerman R, Steward O, Xu XM, Zou Y (2008b) Repulsive Wnt 
signaling inhibits axon regeneration after CNS injury. J Neurosci 28:8376-8382. 
Lu QR, Sun T, Zhu Z, Ma N, Garcia M, Stiles CD, Rowitch DH (2002) Common 
developmental requirement for Olig function indicates a motor 
neuron/oligodendrocyte connection. Cell 109:75-86. 
Lu QR, Yuk D-I, Alberta JA, Zhu Z, Pawlitzky I, Chan J, McMahon AP, Stiles CD, 
Rowitch DH (2000) Sonic hedgehog-regulated oligodendrocyte lineage genes 
encoding bHLH proteins in the mamalian central nervous system. Neuron 25:317-
329. 
Lubetzki C, Demerens C, Anglade P, Villarroya H, Frankfurter A, Lee VM, Zalc B 
(1993) Even in culture, oligodendrocytes myelinate solely axons. Proc Natl Acad 
Sci U S A 90:6820-6824. 
Lyssiotis CA, Walker J, Wu C, Kondo T, Schultz PG, Wu X (2007) Inhibition of histone 
deacetylase activity induces developmental plasticity in oligodendrocyte 
precursor cells. Proc Natl Acad Sci U S A 104:14982-14987. 
 137 
Mabie PC, Mehler MF, Marmur R, Papavasiliou A, Song Q, Kessler JA (1997) Bone 
morphogenic proteins induce astroglial differentiation of oligodendroglial-
astroglial progenitor cells. Journal of Neuroscience 17:4112-4120. 
Mahon K, Burdick KE, Szeszko PR (2010) A role for white matter abnormalities in the 
pathophysiology of bipolar disorder. Neurosci Biobehav Rev 34:533-554. 
Maier CE, Miller RH (1997) Notocord is essential of oligodendrocyte development in 
Xenopus spinal cord. Journal of Neuroscience Research 47:361-371. 
Maire CL, Buchet D, Kerninon C, Deboux C, Baron-Van Evercooren A, Nait-Oumesmar 
B (2009) Directing human neural stem/precursor cells into oligodendrocytes by 
overexpression of Olig2 transcription factor. J Neurosci Res 87:3438-3446. 
Marin-Husstege M, Muggironi M, Liu A, Casaccia-Bonnefil P (2002) Histone 
deacetylase activity is necessary for oligodendrocyte lineage progression. J 
Neurosci 22:10333-10345. 
Marin-Husstege M, He Y, Li J, Kondo T, Sablitzky F, Casaccia-Bonnefil P (2006) 
Multiple roles of Id4 in developmental myelination: predicted outcomes and 
unexpected findings. Glia 54:285-296. 
Mason JL, Toews A, Hostettler JD, Morell P, Suzuki K, Goldman JE, Matsushima GK 
(2004) Oligodendrocytes and progenitors become progressively depleted within 
chronically demyelinated lesions. Am J Pathol 164:1673-1682. 
McMahon AP, Joyner AL, Bradley A, McMahon JA (1992) The midbrain-hindbrain 
phenotype of Wnt-1-/Wnt-1- mice results from stepwise deletion of engrailed-
expressing cells by 9.5 days postcoitum. Cell 69:581-595. 
Megason SG, McMahon AP (2002) A mitogen gradient of dorsal midline Wnts organizes 
growth in the CNS. Development 129:2087-2098. 
Mehler MF, Mabie PC, Zhang D, Kessler JA (1997) Bone morphogenetic protein in the 
nervous system. Trends Neurosci 20:309-317. 
Mekki-Dauriac S, Agius E, Kan P, Cochard P (2002) Bone morphogenetic proteins 
negatively control oligodendrocyte precursor specification in the chick spinal 
cord. Development 129:5117-5130. 
Memezawa A, Takada I, Takeyama K, Igarashi M, Ito S, Aiba S, Kato S, Kouzmenko AP 
(2007) Id2 gene-targeted crosstalk between Wnt and retinoid signaling regulates 
proliferation in human keratinocytes. Oncogene 26:5038-5045. 
Mi K, Johnson GV (2005) Role of the intracellular domains of LRP5 and LRP6 in 
activating the Wnt canonical pathway. J Cell Biochem 95:328-338. 
Mi S, Miller RH, Lee X, Scott ML, Shulag-Morskaya S, Shao Z, Chang J, Thill G, 
Levesque M, Zhang M, Hession C, Sah D, Trapp B, He Z, Jung V, McCoy JM, 
Pepinsky RB (2005) LINGO-1 negatively regulates myelination by 
oligodendrocytes. Nat Neurosci 8:745-751. 
Mieszczanek J, de la Roche M, Bienz M (2008) A role of Pygopus as an anti-repressor in 
facilitating Wnt-dependent transcription. Proc Natl Acad Sci U S A 105:19324-
19329. 
Miller RH (2002) Regulation of oligodendrocyte development in the vertebrate CNS. 
Prog Neurobiol 67:451-467. 
Miller RH, Dinsio K, Wang R, Geertman R, Maier CE, Hall AK (2004) Patterning of 
spinal cord oligodendrocyte development by dorsally derived BMP4. J Neurosci 
Res 76:9-19. 
 138 
Mishina Y, Suzuki A, Ueno N, Behringer RR (1995) BMPr encodes a type I bone 
morphogenetic protein receptor that is essential for gastrulation during mouse 
embryogenesis. Genes and Development 9:3027-3037. 
Mishina Y, Hanks MC, Miura S, Tallquist MD, Behringer RR (2002) Generation of 
Bmpr/Alk3 conditional knockout mice. Genesis 32:69-72. 
Miura S, Singh AP, Mishina Y (2010) Bmpr1a is required for proper migration of the 
AVE through regulation of Dkk1 expression in the pre-streak mouse embryo. Dev 
Biol 341:246-254. 
Miyashita T, Koda M, Kitajo K, Yamazaki M, Takahashi K, Kikuchi A, Yamashita T 
(2009) Wnt-Ryk signaling mediates axon growth inhibition and limits functional 
recovery after spinal cord injury. J Neurotrauma 26:955-964. 
Mizuguchi R, Sugimori M, Takebayashi H, Kosako H, Nagao M, Yoshida S, Nabeshima 
Y, Shimamura K, Nakafuku M (2001) Combinatorial roles of olig2 and 
neurogenin2 in the coordinated induction of pan-neuronal and subtype-specific 
properties of motoneurons. Neuron 31:757-771. 
Molenaar M, van de Wetering M, Oosterwegel M, Peterson-Maduro J, Godsave S, 
Korinek V, Roose J, Destree O, Clevers H (1996) XTcf-3 transcription factor 
mediates beta-catenin-induced axis formation in Xenopus embryos. Cell 86:391-
399. 
Montcouquiol M, Crenshaw EB, 3rd, Kelley MW (2006) Noncanonical Wnt signaling 
and neural polarity. Annu Rev Neurosci 29:363-386. 
Muroyama Y, Fujihara M, Ikeya M, Kondoh H, Takada S (2002) Wnt signaling plays an 
essential role in neuronal specification of the dorsal spinal cord. Genes Dev 
16:548-553. 
Murtie JC, Zhou YX, Le TQ, Armstrong RC (2005a) In vivo analysis of oligodendrocyte 
lineage development in postnatal FGF2 null mice. Glia 49:542-554. 
Murtie JC, Zhou YX, Le TQ, Vana AC, Armstrong RC (2005b) PDGF and FGF2 
pathways regulate distinct oligodendrocyte lineage responses in experimental 
demyelination with spontaneous remyelination. Neurobiol Dis 19:171-182. 
Nguyen VH, Trout J, Connors SA, Andermann P, Weinberg E, Mullins MC (2000) 
Dorsal and intermediate neuronal cell types of the spinal cord are established by a 
BMP signaling pathway. Development 127:1209-1220. 
Nishita M, Hashimoto MK, Ogata S, Laurent MN, Ueno N, Shibuya H, Cho KW (2000) 
Interaction between Wnt and TGF-beta signalling pathways during formation of 
Spemann's organizer. Nature 403:781-785. 
Noble M, Murray K, Stroobant P, Waterfield MD, Riddle P (1988) Platelet-derived 
growth factor promotes division and motility and inhibits premature 
differentiation of the oligodendrocyte type-2 astrocyte progenitor cell. Nature 
333:560-562. 
Noll E, Miller RH (1994) Regulation of oligodendrocyte differentiation: a role for 
retinoic acid in the spinal cord. Development 120:649-660. 
Norton JD, Deed RW, Craggs G, Sablitzky F (1998) Id helix-loop-helix proteins in cell 
growth and differentiation. Trends Cell Biol 8:58-65. 
Ono K, Bansal R, Payne J, Rutishauser U, Miller RH (1995) Early development and 
dispersal of oligodendrocyte precursors in the embryonic chick spinal cord. 
Development 121:1743-1754. 
 139 
Orentas DM, Miller RH (1996) The origin of spinal cord oligodendrocyte is dependent on 
local influences from the spinal cord. Developmental Biology 177:43-53. 
Orentas DM, Hayes JE, Dyer KL, Miller RH (1999) Sonic hedgehog signaling is required 
during the appearance of spinal cord oligodendrocyte precursors. Development 
126:2419-2429. 
Orre K, Wennstrom M, Tingstrom A (2009) Chronic lithium treatment decreases NG2 
cell proliferation in rat dentate hilus, amygdala and corpus callosum. Prog 
Neuropsychopharmacol Biol Psychiatry 33:503-510. 
Park HC, Appel B (2003) Delta-Notch signaling regulates oligodendrocyte specification. 
Development 130:3747-3755. 
Parker DS, Ni YY, Chang JL, Li J, Cadigan KM (2008) Wingless signaling induces 
widespread chromatin remodeling of target loci. Mol Cell Biol 28:1815-1828. 
Parr BA, Shea MJ, Vassileva G, McMahon AP (1993) Mouse Wnt genes exhibit discrete 
domains of expression in the early embryonic CNS and limb buds. Development 
119:247-261. 
Parras CM, Galli R, Britz O, Soares S, Galichet C, Battiste J, Johnson JE, Nakafuku M, 
Vescovi A, Guillemot F (2004) Mash1 specifies neurons and oligodendrocytes in 
the postnatal brain. Embo J 23:4495-4505. 
Patapoutian A, Reichardt LF (2000) Roles of Wnt proteins in neural development and 
maintenance. Curr Opin Neurobiol 10:392-399. 
Patrikios P, Stadelmann C, Kutzelnigg A, Rauschka H, Schmidbauer M, Laursen H, 
Sorensen PS, Bruck W, Lucchinetti C, Lassmann H (2006) Remyelination is 
extensive in a subset of multiple sclerosis patients. Brain 129:3165-3172. 
Peters JM, McKay RM, McKay JP, Graff JM (1999) Casein kinase I transduces Wnt 
signals. Nature 401:345-350. 
Piaton G, Gould RM, Lubetzki C (2010) Axon-oligodendrocyte interactions during 
developmental myelination, demyelination and repair. J Neurochem 114:1243-
1260. 
Potzner MR, Griffel C, Lutjen-Drecoll E, Bosl MR, Wegner M, Sock E (2007) Prolonged 
Sox4 expression in oligodendrocytes interferes with normal myelination in the 
central nervous system. Mol Cell Biol 27:5316-5326. 
Pringle NP, Richardson WD (1993) a singularity of PDGFalpha receptor expression in 
the dorsoventral axis of the neural tube may define the origin of the 
oligodendrocyte lineage. Development 117:525-533. 
Pringle NP, Mudhar HS, Collarini EJ, Richardson WD (1992) PDGF receptors in the rat 
CNS: during late neurogenesis, PDGF alpha-receptor expression appears to be 
restricted to glial cells of the oligodendrocyte lineage. Development 115:535-551. 
Pringle NP, Yu W-P, Guthrie S, Poelink H, Lumsden A, Peterson A, Richardson WD 
(1996) Determination of neuroepithelial cell fate:Induction of the oligoendrocyte 
lineage by ventral midline cells and sonic hedgehog. Developmental Biology 
177:30-42. 
Qi Y, Cai J, Wu Y, Wu R, Lee J, Fu H, Rao M, Sussel L, Rubenstein J, Qiu M (2001) 
Control of oligodendrocyte differentiation by the Nkx2.2 homeodomain 
transcription factor. Development 128:2723-2733. 
Raff MC (1989) Glial cell diversification in the rat optic nerve. Science 243:1450-1455. 
 140 
Raff MC, Hart IK, Richardson WD, Lillien LE (1990) An analysis of the cell-cell 
interactions that control the proliferation and differentiation of a bipotential glial 
progenitor cell in culture. Cold Spring Harb Symp Quant Biol 55:235-238. 
Raff MC, Abney ER, Cohen J, Lindsay R, Noble M (1983) Two types of astrocytes in 
cultures of developing rat white matter: differences in morphology, surface 
gangliosides, and growth characteristics. J Neurosci 3:1289-1300. 
Rajan P, Panchision DM, Newell LF, McKay RD (2003) BMPs signal alternately through 
a SMAD or FRAP-STAT pathway to regulate fate choice in CNS stem cells. J 
Cell Biol 161:911-921. 
Ranscht B, Clapschaw PA, Price J, Noble M, Seifert W (1982) Development of 
oligodendrocytes and Schwann cells studied with a monoclonal antibody against 
galactocerebroside. Proc Natl Acad Sci USA 79:2709-2713. 
Rasband MN, Tayler J, Kaga Y, Yang Y, Lappe-Siefke C, Nave KA, Bansal R (2005) 
CNP is required for maintenance of axon-glia interactions at nodes of Ranvier in 
the CNS. Glia 50:86-90. 
Richardson WD, Pringle NP, YU WP, Hall AC (1997) Origins of spinal cord 
oligodendrocytes: Possible development and evolutionary relationships with 
motor neurons. Dev Neurosci 19:58-68. 
Richardson WD, Pringle N, Mosely MJ, Westermark B, Dubois-Dalcq M (1988) A role 
for platelet-derived growth factor (PDGF) and PDGF receptor genes in the central 
nervous system. Cell 53:309-319. 
Rockman SP, Currie SA, Ciavarella M, Vincan E, Dow C, Thomas RJ, Phillips WA 
(2001) Id2 is a target of the beta-catenin/T cell factor pathway in colon 
carcinoma. J Biol Chem 276:45113-45119. 
Roelink H, Porter JA, Chiang C, Tanabe Y, Chang DT, Beachy PA, Jessell TM (1995) 
Floor plate and motor neuron induction by different concentrations of the amino-
terminal cleavage product of sonic hedgehog autoproteolysis. Cell 81:445-455. 
Roelink H, Augsburger A, Heemskerk J, Korzh V, Norlin S, Ruiz i Altaba A, Tanabe Y, 
Placzek M, Edlund T, Jessell TM, et al. (1994) Floor plate and motor neuron 
induction by vhh-1, a vertebrate homolog of hedgehog expressed by the 
notochord. Cell 76:761-775. 
Rubinfeld B, Albert I, Porfiri E, Fiol C, Munemitsu S, Polakis P (1996) Binding of 
GSK3beta to the APC-beta-catenin complex and regulation of complex assembly. 
Science 272:1023-1026. 
Samanta J, Kessler JA (2004) Interactions between ID and OLIG proteins mediate the 
inhibitory effects of BMP4 on oligodendroglial differentiation. Development 
131:4131-4142. 
Scherer SS, Xu YT, Nelles E, Fischbeck K, Willecke K, Bone LJ (1998) Connexin32-
null mice develop demyelinating peripheral neuropathy. Glia 24:8-20. 
See J, Mamontov P, Ahn K, Wine-Lee L, Crenshaw EB, 3rd, Grinspan JB (2007) BMP 
signaling mutant mice exhibit glial cell maturation defects. Mol Cell Neurosci 
35:171-182. 
See J, Zhang X, Eraydin N, Mun SB, Mamontov P, Golden JA, Grinspan JB (2004) 
Oligodendrocyte maturation is inhibited by bone morphogenetic protein. Mol Cell 
Neurosci 26:481-492. 
 141 
See JM, Grinspan JB (2009) Sending mixed signals: bone morphogenetic protein in 
myelination and demyelination. J Neuropathol Exp Neurol 68:595-604. 
Semenov MV, Tamai K, Brott BK, Kuhl M, Sokol S, He X (2001) Head inducer 
Dickkopf-1 is a ligand for Wnt coreceptor LRP6. Curr Biol 11:951-961. 
Setoguchi T, Yone K, Matsuoka E, Takenouchi H, Nakashima K, Sakou T, Komiya S, 
Izumo S (2001) Traumatic injury-induced BMP 7 expression in the adult rat 
spinal cord. Brain Res 921:219-225. 
Setoguchi T, Nakashima K, Takizawa T, Yanagisawa M, Ochiai W, Okabe M, Yone K, 
Komiya S, Taga T (2004) Treatment of spinal cord injury by transplantation of 
fetal neural precursors cells engineered to express BMP inhibitor. Exp Neurol 
189:33-44. 
Sheldahl LC, Slusarski DC, Pandur P, Miller JR, Kuhl M, Moon RT (2003) Dishevelled 
activates Ca2+ flux, PKC, and CamKII in vertebrate embryos. J Cell Biol 
161:769-777. 
Shen S, Li J, Casaccia-Bonnefil P (2005) Histone modifications affect timing of 
oligodendrocyte progenitor differentiation in the developing rat brain. J Cell Biol 
169:577-589. 
Shields SA, Gilson JM, Blakemore WF, Franklin RJ (1999) Remyelination occurs as 
extensively but more slowly in old rats compared to young rats following 
gliotoxin-induced CNS demyelination. Glia 28:77-83. 
Shimizu H, Julius MA, Giarre M, Zheng Z, Brown AM, Kitajewski J (1997) 
Transformation by Wnt family proteins correlates with regulation of beta-catenin. 
Cell Growth Differ 8:1349-1358. 
Shimizu T, Kagawa T, Wada T, Muroyama Y, Takada S, Ikenaka K (2005) Wnt 
signaling controls the timing of oligodendrocyte development in the spinal cord. 
Dev Biol 282:397-410. 
Slusarski DC, Yang-Snyder J, Busa WB, Moon RT (1997) Modulation of embryonic 
intracellular Ca2+ signaling by Wnt-5A. Dev Biol 182:114-120. 
Soriano P (1999) Generalized lacZ expression with the ROSA26 Cre reporter strain. 
Nature Genetics 21:70-71. 
Soshnikova N, Zechner D, Huelsken J, Mishina Y, Behringer RR, Taketo MM, Crenshaw 
EB, 3rd, Birchmeier W (2003) Genetic interaction between Wnt/beta-catenin and 
BMP receptor signaling during formation of the AER and the dorsal-ventral axis 
in the limb. Genes Dev 17:1963-1968. 
Staal F, Van Noort, M., Strous, G., and Clevers, H. (2002) Wnt signals are transmitted 
through N-terminally dephosphorylated Beta-Catenin. Embo Reports 3:63-68. 
Stadeli R, Basler K (2005) Dissecting nuclear Wingless signalling: recruitment of the 
transcriptional co-activator Pygopus by a chain of adaptor proteins. Mech Dev 
122:1171-1182. 
Stadeli R, Hoffmans R, Basler K (2006) Transcription under the control of nuclear 
Arm/beta-catenin. Curr Biol 16:R378-385. 
Stolt CC, Lommes P, Sock E, Chaboissier MC, Schedl A, Wegner M (2003) The Sox9 
transcription factor determines glial fate choice in the developing spinal cord. 
Genes Dev 17:1677-1689. 
 142 
Stolt CC, Rehberg S, Ader M, Lommes P, Riethmacher D, Schachner M, Bartsch U, 
Wegner M (2002) Terminal differentiation of myelin-forming oligodendrocytes 
depends on the transcription factor Sox10. Genes Dev 16:165-170. 
Stolt CC, Rehberg, S., Ader, M., Lommes, P., Riethmacher, D., Schachner, M., Bartsch, 
U., Wegner, M. (2002) Terminal differentiation of mylein-forming 
oligodendroyctes depends on the transcription factor Sox 10. Genes and 
Development 16:165-170. 
Tamai K, Zeng X, Liu C, Zhang X, Harada Y, Chang Z, He X (2004) A mechanism for 
Wnt coreceptor activation. Mol Cell 13:149-156. 
Tang DG, Tokumoto YM, Raff MC (2000) Long-term culture of purified postnatal 
oligodendrocyte precursor cells. Evidence for an intrinsic maturation program that 
plays out over months. J Cell Biol 148:971-984. 
Tatsumi K, Takebayashi H, Manabe T, Tanaka KF, Makinodan M, Yamauchi T, 
Makinodan E, Matsuyoshi H, Okuda H, Ikenaka K, Wanaka A (2008) Genetic 
fate mapping of Olig2 progenitors in the injured adult cerebral cortex reveals 
preferential differentiation into astrocytes. J Neurosci Res 86:3494-3502. 
Theil T, Aydin S, Koch S, Grotewold L, Ruther U (2002) Wnt and Bmp signalling 
cooperatively regulate graded Emx2 expression in the dorsal telencephalon. 
Development 129:3045-3054. 
Timmer JR, Wang C, Niswander L (2002) BMP signaling patterns the dorsal and 
intermediate neural tube via regulation of homeobox and helix-loop-helix 
transcription factors. Development 129:2459-2472. 
Trapp BD, Peterson J, Ransohoff RM, Rudick R, Mork S, Bo L (1998) Axonal 
transection in the lesions of multiple sclerosis. N Engl J Med 338:278-285. 
Trousse F, Giess MC, Soula C, Ghandour S, Duprat AM, Cochard P (1995) Notochord 
and floor plate stimulate oligodendrocyte differentiation in cultures of the chick 
dorsal neural tube. J Neurosci Res 41:552-560. 
Ulloa F, Marti E (2010) Wnt won the war: antagonistic role of Wnt over Shh controls 
dorso-ventral patterning of the vertebrate neural tube. Dev Dyn 239:69-76. 
Vallstedt A, Klos JM, Ericson J (2005) Multiple dorsoventral origins of oligodendrocyte 
generation in the spinal cord and hindbrain. Neuron 45:55-67. 
van Amerongen R, Nusse R (2009) Towards an integrated view of Wnt signaling in 
development. Development 136:3205-3214. 
van Noort M, Meeldijk J, van der Zee R, Destree O, Clevers H (2002) Wnt signaling 
controls the phosphorylation status of beta-catenin. J Biol Chem 277:17901-
17905. 
Vartanian T, Fischbach G, Miller R (1999) Failure of spinal cord oligodendrocyte 
development in mice lacking neuregulin. Proc Natl Acad Sci U S A 96:731-735. 
Veeman MT, Axelrod JD, Moon RT (2003) A second canon. Functions and mechanisms 
of beta-catenin-independent Wnt signaling. Dev Cell 5:367-377. 
Villacorte M, Suzuki K, Hayashi K, de Sousa Lopes SC, Haraguchi R, Taketo MM, 
Nakagata N, Yamada G (2010) Antagonistic crosstalk of Wnt/beta-catenin/Bmp 
signaling within the Apical Ectodermal Ridge (AER) regulates interdigit 
formation. Biochem Biophys Res Commun 391:1653-1657. 
Volpe JJ (2001) Neurobiology of periventricular leukomalacia in the premature infant. 
Pediatr Res 50:553-562. 
 143 
Wada T, Kagawa T, Ivanova A, Zalc B, Shirasaki R, Murakami F, Iemura S, Ueno N, 
Ikenaka K (2000) Dorsal spinal cord inhibits oligodendrocyte development. 
Developmental Biology 227:42-55. 
Wallingford JB, Rowning BA, Vogeli KM, Rothbacher U, Fraser SE, Harland RM 
(2000) Dishevelled controls cell polarity during Xenopus gastrulation. Nature 
405:81-85. 
Wang S, Sdrulla A, Johnson JE, Yokota Y, Barres BA (2001a) A role for the helix-loop-
helix protein Id2 in the control of oligodendrocyte development. Neuron 29:603-
614. 
Wang S, Sdrulla AD, diSibio G, Bush G, Nofziger D, Hicks C, Weinmaster G, Barres BA 
(1998) Notch receptor activation inhibits oligodendrocyte differentiation. Neuron 
21:63-75. 
Wang SL, Sdrulla A, Johnson JE, Yokota Y, Barres BA (2001b) A role for the helix-
loop-helix protein Id2 in the control of oligodendrocyte development. Neuron 
29:603-614. 
Warf BC, Fok-Seang J, Miller RH (1991) Evidence for the ventral origin of 
oligodendrocyte precursors in the rat spinal cord. J Neurosci 11:2477-2488. 
Waxman SG, Ransom BR, Stys PK (1991) Non-synaptic mechanisms of Ca(2+)-
mediated injury in CNS white matter. Trends Neurosci 14:461-468. 
White BD, Nathe RJ, Maris DO, Nguyen NK, Goodson JM, Moon RT, Horner PJ (2010) 
Beta-catenin signaling increases in proliferating NG2+ progenitors and astrocytes 
during post-traumatic gliogenesis in the adult brain. Stem Cells 28:297-307. 
Willert J, Epping M, Pollack JR, Brown PO, Nusse R (2002) A transcriptional response 
to Wnt protein in human embryonic carcinoma cells. BMC Dev Biol 2:8. 
Willert K, Jones KA (2006) Wnt signaling: is the party in the nucleus? Genes Dev 
20:1394-1404. 
Wine-Lee L, Ahn KJ, Richardson RD, Mishina Y, Lyons KM, Crenshaw EB, 3rd (2004) 
Signaling through BMP type 1 receptors is required for development of 
interneuron cell types in the dorsal spinal cord. Development 131:5393-5403. 
Wodarz A, Nusse R (1998) Mechanisms of Wnt signaling in development. Annu Rev 
Cell Dev Biol 14:59-88. 
Wrana JL, Attisano L, Wieser R, Ventura F, Massague J (1994) Mechanism of activation 
of the TGF-beta receptor. Nature 370:341-347. 
Wu Q, Miller RH, Ransohoff RM, Robinson S, Bu J, NIshiyama A (2000) Elevated 
levels of the chemokine GRO-1 correlate with elevated oligodendorycte 
progenitor proliferation in the jimpy mutant. J Neurosci 20:2609-2617. 
Xie M, Tobin JE, Budde MD, Chen CI, Trinkaus K, Cross AH, McDaniel DP, Song SK, 
Armstrong RC (2010) Rostrocaudal analysis of corpus callosum demyelination 
and axon damage across disease stages refines diffusion tensor imaging 
correlations with pathological features. J Neuropathol Exp Neurol 69:704-716. 
Xin M, Yue T, Ma Z, Wu FF, Gow A, Lu QR (2005) Myelinogenesis and axonal 
recognition by oligodendrocytes in brain are uncoupled in Olig1-null mice. J 
Neurosci 25:1354-1365. 
Yamamoto H, Kishida S, Kishida M, Ikeda S, Takada S, Kikuchi A (1999) 
Phosphorylation of axin, a Wnt signal negative regulator, by glycogen synthase 
kinase-3beta regulates its stability. J Biol Chem 274:10681-10684. 
 144 
Yang L, Yamasaki K, Shirakata Y, Dai X, Tokumaru S, Yahata Y, Tohyama M, 
Hanakawa Y, Sayama K, Hashimoto K (2006) Bone morphogenetic protein-2 
modulates Wnt and frizzled expression and enhances the canonical pathway of 
Wnt signaling in normal keratinocytes. J Dermatol Sci. 
Ye F, Chen Y, Hoang T, Montgomery RL, Zhao XH, Bu H, Hu T, Taketo MM, van Es 
JH, Clevers H, Hsieh J, Bassel-Duby R, Olson EN, Lu QR (2009) HDAC1 and 
HDAC2 regulate oligodendrocyte differentiation by disrupting the beta-catenin-
TCF interaction. Nat Neurosci 12:829-838. 
Yi SE, Daluiski A, Pederson R, Rosen V, Lyons KM (2000) The type I BMP receptor 
BMPRIB is required for chondrogenesis in the mouse limb. Development 
127:621-630. 
Yin ZS, Zu B, Chang J, Zhang H (2008) Repair effect of Wnt3a protein on the contused 
adult rat spinal cord. Neurol Res 30:480-486. 
Yost C, Torres M, Miller JR, Huang E, Kimelman D, Moon RT (1996) The axis-inducing 
activity, stability, and subcellular distribution of beta-catenin is regulated in 
Xenopus embryos by glycogen synthase kinase 3. Genes Dev 10:1443-1454. 
Yu W, McDonnell K, Taketo MM, Bai CB (2008) Wnt signaling determines ventral 
spinal cord cell fates in a time-dependent manner. Development 135:3687-3696. 
Zechner D, Fujita Y, Hulsken J, Muller T, Walther I, Taketo MM, Crenshaw EB, 3rd, 
Birchmeier W, Birchmeier C (2003) beta-Catenin signals regulate cell growth and 
the balance between progenitor cell expansion and differentiation in the nervous 
system. Dev Biol 258:406-418. 
Zechner D, Muller T, Wende H, Walther I, Taketo MM, Crenshaw EB, 3rd, Treier M, 
Birchmeier W, Birchmeier C (2007) Bmp and Wnt/beta-catenin signals control 
expression of the transcription factor Olig3 and the specification of spinal cord 
neurons. Dev Biol 303:181-190. 
Zeng X, Tamai K, Doble B, Li S, Huang H, Habas R, Okamura H, Woodgett J, He X 
(2005) A dual-kinase mechanism for Wnt co-receptor phosphorylation and 
activation. Nature 438:873-877. 
Zhang H, Miller RH (1996) Density-dependent feedback inhbition of oligodendrocyte 
precursor expansion. J Neurosci 16:6886-6895. 
Zhang Y, Argaw AT, Gurfein BT, Zameer A, Snyder BJ, Ge C, Lu QR, Rowitch DH, 
Raine CS, Brosnan CF, John GR (2009) Notch1 signaling plays a role in 
regulating precursor differentiation during CNS remyelination. Proc Natl Acad 
Sci U S A 106:19162-19167. 
Zhou Q, Anderson DJ (2002) The bHLH transcription factors OLIG2 and OLIG1 couple 
neuronal and glial subtype specification. Cell 109:61-73. 
Zhou Q, Wang S, Anderson DJ (2000) Indentification of a novel family of 
oligodendrocyte lineage-specific basic helix-loop-helix transcription factors. 
Neuron 25:331-343. 
Zhou Q, Choi G, Anderson DJ (2001) The bHLH Transcription Factor Olig2 Promotes 
Oligodendrocyte Differentiation in Collaboration with Nkx2.2. Neuron 31:791-
807. 
 
 
